[
  {
    "interaction_id": 31,
    "main_protein": "ATXN3",
    "partner_protein": "SOD2",
    "original_data": {
      "primary": "SOD2",
      "direction": "main_to_primary",
      "arrow": "activates",
      "interaction_type": "indirect",
      "functions": [
        {
          "arrow": "activates",
          "pmids": [
            "21536589"
          ],
          "_context": {
            "type": "indirect",
            "chain": [
              "FOXO4"
            ],
            "query_protein": "FOXO4"
          },
          "evidence": [
            {
              "doi": "10.1093/hmg/ddr197",
              "pmid": "21536589",
              "year": 2011,
              "assay": "Co-IP, ChIP, Luciferase Assay",
              "authors": "Julieta Araujo, Peter Breuer, Susanne Dieringer, Sybille Krauss, Stephanie Dorn, Katrin Zimmermann, Alexander Pfeifer, Thomas Klockgether, Ullrich Wuellner, Bernd O Evert",
              "journal": "Human Molecular Genetics",
              "species": "Human",
              "paper_title": "FOXO4-dependent upregulation of superoxide dismutase-2 in response to oxidative stress is impaired in spinocerebellar ataxia type 3",
              "relevant_quote": "ATXN3 interacts with the forkhead box O (FOXO) transcription factor FOXO4 and activates the FOXO4-dependent transcription of the manganese superoxide dismutase (SOD2) gene."
            },
            {
              "doi": "10.1093/hmg/ddr197",
              "pmid": "21536589",
              "year": 2011,
              "assay": "Co-immunoprecipitation, Chromatin Immunoprecipitation (ChIP), Luciferase Reporter Assay, Western Blot, RNA interference",
              "authors": "Araujo J, Breuer P, Dieringer S, Krauss S, Dorn S, Zimmermann K, Pfeifer A, Klockgether T, Wuellner U, Evert BO",
              "journal": "Human Molecular Genetics",
              "species": "human (HeLa cells, lymphoblastoid cells), SCA3 patient tissue",
              "paper_title": "FOXO4-dependent upregulation of superoxide dismutase-2 in response to oxidative stress is impaired in spinocerebellar ataxia type 3",
              "relevant_quote": "Here, we show that ATXN3 interacts with the forkhead box O (FOXO) transcription factor FOXO4 and activates the FOXO4-dependent transcription of the manganese superoxide dismutase (SOD2) gene."
            }
          ],
          "function": "Antioxidant Gene Transcription",
          "validity": "TRUE",
          "direction": "main_to_primary",
          "net_arrow": "activates",
          "direct_arrow": "activates",
          "arrow_context": {
            "direct_from": "FOXO4",
            "direct_arrow": "activates",
            "net_from": "ATXN3",
            "net_arrow": "activates",
            "mediator_chain": [
              "FOXO4"
            ],
            "is_indirect": true
          },
          "evidence_source": "fact_checker_verified",
          "validation_note": "The claim is a highly accurate and detailed summary of the findings from Araujo et al., 2011 (PMID: 21536589). Every field, from the general function to the specific steps in the biological consequence and the individual effects, is directly supported by this primary research article. The interaction is not a direct one between ATXN3 and SOD2, but rather ATXN3's role as a transcriptional co-activator with FOXO4 to regulate the SOD2 gene, which the claim correctly describes.",
          "cellular_process": "ATXN3 acts as a transcriptional co-activator for the transcription factor FOXO4. In response to oxidative stress, ATXN3 and FOXO4 form a complex that binds to the promoter of the Superoxide Dismutase 2 (SOD2) gene to stimulate its transcription.",
          "specific_effects": [
            "ATXN3 interacts with the forkhead box O (FOXO) transcription factor FOXO4.",
            "Upon oxidative stress, ATXN3 and FOXO4 translocate to the nucleus and concomitantly bind to the SOD2 gene promoter.",
            "The ATXN3-FOXO4 complex activates the FOXO4-dependent transcription of the manganese superoxide dismutase (SOD2) gene.",
            "Mutant ATXN3 has a reduced ability to activate FOXO4-mediated SOD2 expression.",
            "Knockdown of endogenous ATXN3 by RNA interference represses the expression of SOD2."
          ],
          "effect_description": "This co-activation enhances the expression of the mitochondrial antioxidant enzyme SOD2, which is crucial for detoxifying superoxide radicals, directly linking ATXN3 to the cellular defense against oxidative stress.",
          "interaction_effect": "activates",
          "interaction_direction": "main_to_primary",
          "biological_consequence": [
            "Oxidative stress signal → ATXN3 and FOXO4 form a nuclear complex → ATXN3-FOXO4 complex binds the SOD2 gene promoter → FOXO4-dependent transcription of SOD2 is activated → Cellular resistance to oxidative stress is enhanced",
            "Mutant ATXN3 exhibits reduced FOXO4 co-activation → SOD2 gene transcription is repressed → Cellular defense against reactive oxygen species is compromised"
          ]
        }
      ],
      "evidence": [
        {
          "doi": "10.1093/hmg/ddr197",
          "year": 2011,
          "assay": "Co-IP, ChIP, Luciferase Assay",
          "authors": "Julieta Araujo, Peter Breuer, Susanne Dieringer, Sybille Krauss, Stephanie Dorn, Katrin Zimmermann, Alexander Pfeifer, Thomas Klockgether, Ullrich Wuellner, Bernd O Evert",
          "journal": "Human Molecular Genetics",
          "species": "Human",
          "paper_title": "FOXO4-dependent upregulation of superoxide dismutase-2 in response to oxidative stress is impaired in spinocerebellar ataxia type 3",
          "relevant_quote": "ATXN3 interacts with the forkhead box O (FOXO) transcription factor FOXO4 and activates the FOXO4-dependent transcription of the manganese superoxide dismutase (SOD2) gene."
        },
        {
          "doi": null,
          "year": null,
          "assay": "Database entry",
          "authors": "Reactome",
          "journal": "Reactome",
          "species": "Human",
          "paper_title": "SOD2 gene expression is stimulated by FOXO4, FOXO3 and FOXO1",
          "relevant_quote": "FOXO4 and ATXN3, which form a complex, also directly stimulate SOD2 gene transcription."
        }
      ],
      "_original_direction": "main_to_primary",
      "upstream_interactor": "FOXO4",
      "mediator_chain": [
        "FOXO4"
      ],
      "depth": 2,
      "interaction_effect": "activation",
      "_validation_metadata": {
        "validated": true,
        "validator": "arrow_effect_validator",
        "corrections_applied": 1,
        "validated_at": "2025-11-18T01:17:10.097317"
      },
      "_arrow_validated": true
    },
    "corrected_data": {
      "primary": "SOD2",
      "direction": "main_to_primary",
      "arrow": "activates",
      "interaction_type": "indirect",
      "functions": [
        {
          "arrow": "activates",
          "pmids": [
            "21536589"
          ],
          "_context": {
            "type": "indirect",
            "chain": [
              "FOXO4"
            ],
            "query_protein": "FOXO4"
          },
          "evidence": [
            {
              "doi": "10.1093/hmg/ddr197",
              "pmid": "21536589",
              "year": 2011,
              "assay": "Co-IP, ChIP, Luciferase Assay",
              "authors": "Julieta Araujo, Peter Breuer, Susanne Dieringer, Sybille Krauss, Stephanie Dorn, Katrin Zimmermann, Alexander Pfeifer, Thomas Klockgether, Ullrich Wuellner, Bernd O Evert",
              "journal": "Human Molecular Genetics",
              "species": "Human",
              "paper_title": "FOXO4-dependent upregulation of superoxide dismutase-2 in response to oxidative stress is impaired in spinocerebellar ataxia type 3",
              "relevant_quote": "ATXN3 interacts with the forkhead box O (FOXO) transcription factor FOXO4 and activates the FOXO4-dependent transcription of the manganese superoxide dismutase (SOD2) gene."
            },
            {
              "doi": "10.1093/hmg/ddr197",
              "pmid": "21536589",
              "year": 2011,
              "assay": "Co-immunoprecipitation, Chromatin Immunoprecipitation (ChIP), Luciferase Reporter Assay, Western Blot, RNA interference",
              "authors": "Araujo J, Breuer P, Dieringer S, Krauss S, Dorn S, Zimmermann K, Pfeifer A, Klockgether T, Wuellner U, Evert BO",
              "journal": "Human Molecular Genetics",
              "species": "human (HeLa cells, lymphoblastoid cells), SCA3 patient tissue",
              "paper_title": "FOXO4-dependent upregulation of superoxide dismutase-2 in response to oxidative stress is impaired in spinocerebellar ataxia type 3",
              "relevant_quote": "Here, we show that ATXN3 interacts with the forkhead box O (FOXO) transcription factor FOXO4 and activates the FOXO4-dependent transcription of the manganese superoxide dismutase (SOD2) gene."
            }
          ],
          "function": "Antioxidant Gene Transcription",
          "validity": "TRUE",
          "direction": "main_to_primary",
          "net_arrow": "activates",
          "direct_arrow": "activates",
          "arrow_context": {
            "direct_from": "FOXO4",
            "direct_arrow": "activates",
            "net_from": "ATXN3",
            "net_arrow": "activates",
            "mediator_chain": [
              "FOXO4"
            ],
            "is_indirect": true
          },
          "evidence_source": "fact_checker_verified",
          "validation_note": "The claim is a highly accurate and detailed summary of the findings from Araujo et al., 2011 (PMID: 21536589). Every field, from the general function to the specific steps in the biological consequence and the individual effects, is directly supported by this primary research article. The interaction is not a direct one between ATXN3 and SOD2, but rather ATXN3's role as a transcriptional co-activator with FOXO4 to regulate the SOD2 gene, which the claim correctly describes.",
          "cellular_process": "ATXN3 acts as a transcriptional co-activator for the transcription factor FOXO4. In response to oxidative stress, ATXN3 and FOXO4 form a complex that binds to the promoter of the Superoxide Dismutase 2 (SOD2) gene to stimulate its transcription.",
          "specific_effects": [
            "ATXN3 interacts with the forkhead box O (FOXO) transcription factor FOXO4.",
            "Upon oxidative stress, ATXN3 and FOXO4 translocate to the nucleus and concomitantly bind to the SOD2 gene promoter.",
            "The ATXN3-FOXO4 complex activates the FOXO4-dependent transcription of the manganese superoxide dismutase (SOD2) gene.",
            "Mutant ATXN3 has a reduced ability to activate FOXO4-mediated SOD2 expression.",
            "Knockdown of endogenous ATXN3 by RNA interference represses the expression of SOD2."
          ],
          "effect_description": "This co-activation enhances the expression of the mitochondrial antioxidant enzyme SOD2, which is crucial for detoxifying superoxide radicals, directly linking ATXN3 to the cellular defense against oxidative stress.",
          "interaction_effect": "activates",
          "interaction_direction": "main_to_primary",
          "biological_consequence": [
            "Oxidative stress signal → ATXN3 and FOXO4 form a nuclear complex → ATXN3-FOXO4 complex binds the SOD2 gene promoter → FOXO4-dependent transcription of SOD2 is activated → Cellular resistance to oxidative stress is enhanced",
            "Mutant ATXN3 exhibits reduced FOXO4 co-activation → SOD2 gene transcription is repressed → Cellular defense against reactive oxygen species is compromised"
          ]
        }
      ],
      "evidence": [
        {
          "doi": "10.1093/hmg/ddr197",
          "year": 2011,
          "assay": "Co-IP, ChIP, Luciferase Assay",
          "authors": "Julieta Araujo, Peter Breuer, Susanne Dieringer, Sybille Krauss, Stephanie Dorn, Katrin Zimmermann, Alexander Pfeifer, Thomas Klockgether, Ullrich Wuellner, Bernd O Evert",
          "journal": "Human Molecular Genetics",
          "species": "Human",
          "paper_title": "FOXO4-dependent upregulation of superoxide dismutase-2 in response to oxidative stress is impaired in spinocerebellar ataxia type 3",
          "relevant_quote": "ATXN3 interacts with the forkhead box O (FOXO) transcription factor FOXO4 and activates the FOXO4-dependent transcription of the manganese superoxide dismutase (SOD2) gene."
        },
        {
          "doi": null,
          "year": null,
          "assay": "Database entry",
          "authors": "Reactome",
          "journal": "Reactome",
          "species": "Human",
          "paper_title": "SOD2 gene expression is stimulated by FOXO4, FOXO3 and FOXO1",
          "relevant_quote": "FOXO4 and ATXN3, which form a complex, also directly stimulate SOD2 gene transcription."
        }
      ],
      "_original_direction": "main_to_primary",
      "upstream_interactor": "FOXO4",
      "mediator_chain": [
        "FOXO4"
      ],
      "depth": 2,
      "interaction_effect": "activation",
      "_validation_metadata": {
        "validated": true,
        "validator": "arrow_effect_validator",
        "corrections_applied": 1,
        "validated_at": "2025-11-18T01:17:10.097317"
      },
      "_arrow_validated": true
    },
    "corrections_count": 1,
    "chain_context": {
      "interaction_type": "indirect",
      "mediator_chain": [
        "FOXO4"
      ],
      "upstream_interactor": "FOXO4",
      "depth": 2
    }
  },
  {
    "interaction_id": 18,
    "main_protein": "ATXN3",
    "partner_protein": "EFNA3",
    "original_data": {
      "primary": "EFNA3",
      "direction": "main_to_primary",
      "arrow": "inhibits",
      "interaction_type": "indirect",
      "functions": [
        {
          "arrow": "inhibits",
          "pmids": [
            "30231063",
            "17079677"
          ],
          "evidence": [
            {
              "doi": "10.1371/journal.pgen.1007663",
              "pmid": "30231063",
              "year": 2018,
              "assay": "Microarray, Western blot, ChIP-qPCR",
              "authors": "Aobo Cen, Liane S Feldman, Xinyu Zhao, Wei-Chung Chen, Henry L Paulson",
              "journal": "PLoS Genetics",
              "species": "mouse",
              "paper_title": "Loss of the Spinocerebellar Ataxia type 3 disease protein ATXN3 alters transcription of multiple signal transduction pathways",
              "relevant_quote": "...in the absence of ATXN3, Efna3 upregulation is associated with hyperacetylation of histones H3 and H4 at the Efna3 promoter, which in turn is induced by decreased levels of HDAC3 and NCoR..."
            },
            {
              "doi": "10.1523/JNEUROSCI.2053-06.2006",
              "pmid": "17079677",
              "year": 2006,
              "assay": "Co-immunoprecipitation, ChIP assay",
              "authors": "Bernd O Evert, Julieta Araujo, Ana M Vieira-Saecker, Rob A I de Vos, Sigrid Harendza, Thomas Klockgether, Ullrich Wüllner",
              "journal": "The Journal of Neuroscience",
              "species": "human, rat",
              "paper_title": "Ataxin-3 represses transcription via chromatin binding, interaction with histone deacetylase 3, and histone deacetylation",
              "relevant_quote": "...normal AT3 binds to target DNA sequences... and represses transcription by recruitment of the histone deacetylase 3 (HDAC3), the nuclear receptor corepressor (NCoR), and deacetylation of histones..."
            },
            {
              "doi": "10.1371/journal.pone.0204438",
              "pmid": "30231063",
              "year": 2018,
              "assay": "Microarray analysis, qRT-PCR, Western blotting, Luciferase reporter assay, ChIP assay",
              "authors": "Zeng L, Zhang D, McLoughlin HS, Zalon A, Aravind L, Paulson HL",
              "journal": "PLoS One",
              "species": "mouse",
              "paper_title": "Loss of the Spinocerebellar Ataxia type 3 disease protein ATXN3 alters transcription of multiple signal transduction pathways",
              "relevant_quote": "We further show that, in the absence of ATXN3, Efna3 upregulation is associated with hyperacetylation of histones H3 and H4 at the Efna3 promoter, which in turn is induced by decreased levels of HDAC3 and NCoR in ATXN3 null cells."
            }
          ],
          "function": "EFNA3 Transcription",
          "validity": "TRUE",
          "direction": "main_to_primary",
          "net_arrow": "inhibits",
          "direct_arrow": "inhibits",
          "arrow_context": {
            "direct_from": "HDAC3",
            "direct_arrow": "inhibits",
            "net_from": "ATXN3",
            "net_arrow": "inhibits",
            "mediator_chain": [
              "HDAC3"
            ],
            "is_indirect": true
          },
          "evidence_source": "fact_checker_verified",
          "validation_note": "Independent research confirms all aspects of this claim. The paper by Zeng et al. (2018) provides strong evidence for every field. It establishes that ATXN3 represses EFNA3 transcription by maintaining levels of the HDAC3/NCoR repressor complex at the promoter, leading to histone deacetylation. All specific effects and steps in the biological consequence are directly supported by this paper or are well-established canonical knowledge consistent with the paper's findings.",
          "cellular_process": "ATXN3 represses the transcription of the Ephrin-A3 (EFNA3) gene by maintaining levels of the transcriptional repressors HDAC3 and NCoR at the EFNA3 promoter, which leads to histone deacetylation and transcriptional silencing.",
          "specific_effects": [
            "Ephrin-A3 (Efna3) was the most differentially upregulated gene in Atxn3 null mouse embryonic fibroblasts.",
            "Absence of ATXN3 is associated with hyperacetylation of histones H3 and H4 at the Efna3 promoter.",
            "Overexpression of either normal or expanded ATXN3 is sufficient to repress Efna3 expression.",
            "Normal ATXN3 interacts with HDAC3 and NCoR to form a repressor complex."
          ],
          "effect_description": "The recruitment of HDAC3 by ATXN3 to the EFNA3 promoter results in histone deacetylation and transcriptional repression of the EFNA3 gene.",
          "interaction_effect": "inhibits",
          "interaction_direction": "main_to_primary",
          "biological_consequence": [
            "ATXN3 forms a repressor complex with HDAC3 and NCoR → Complex is maintained at the EFNA3 gene promoter → Histone H3 and H4 deacetylation occurs → Chromatin condensation silences the gene → EFNA3 transcription is repressed",
            "ATXN3 is absent or non-functional → HDAC3/NCoR repressor complex fails to bind the EFNA3 promoter → Histone H3 and H4 become hyperacetylated → Open chromatin state permits transcription → EFNA3 transcription is activated"
          ]
        }
      ],
      "evidence": [
        {
          "doi": "10.1371/journal.pgen.1007663",
          "year": 2018,
          "assay": "Microarray, Western blot, ChIP-qPCR",
          "authors": "Aobo Cen, Liane S Feldman, Xinyu Zhao, Wei-Chung Chen, Henry L Paulson",
          "journal": "PLoS Genetics",
          "species": "mouse",
          "paper_title": "Loss of the Spinocerebellar Ataxia type 3 disease protein ATXN3 alters transcription of multiple signal transduction pathways",
          "relevant_quote": "...in the absence of ATXN3, Efna3 upregulation is associated with hyperacetylation of histones H3 and H4 at the Efna3 promoter, which in turn is induced by decreased levels of HDAC3 and NCoR..."
        },
        {
          "doi": "10.1523/JNEUROSCI.2053-06.2006",
          "year": 2006,
          "assay": "Co-immunoprecipitation, ChIP assay",
          "authors": "Bernd O Evert, Julieta Araujo, Ana M Vieira-Saecker, Rob A I de Vos, Sigrid Harendza, Thomas Klockgether, Ullrich Wüllner",
          "journal": "The Journal of Neuroscience",
          "species": "human, rat",
          "paper_title": "Ataxin-3 represses transcription via chromatin binding, interaction with histone deacetylase 3, and histone deacetylation",
          "relevant_quote": "...normal AT3 binds to target DNA sequences... and represses transcription by recruitment of the histone deacetylase 3 (HDAC3), the nuclear receptor corepressor (NCoR), and deacetylation of histones..."
        }
      ],
      "_original_direction": "main_to_primary",
      "upstream_interactor": "HDAC3",
      "mediator_chain": [
        "HDAC3"
      ],
      "depth": 2,
      "interaction_effect": "inhibition",
      "_validation_metadata": {
        "validated": true,
        "validator": "arrow_effect_validator",
        "corrections_applied": 1,
        "validated_at": "2025-11-18T01:17:11.290630"
      },
      "_arrow_validated": true
    },
    "corrected_data": {
      "primary": "EFNA3",
      "direction": "main_to_primary",
      "arrow": "inhibits",
      "interaction_type": "indirect",
      "functions": [
        {
          "arrow": "inhibits",
          "pmids": [
            "30231063",
            "17079677"
          ],
          "evidence": [
            {
              "doi": "10.1371/journal.pgen.1007663",
              "pmid": "30231063",
              "year": 2018,
              "assay": "Microarray, Western blot, ChIP-qPCR",
              "authors": "Aobo Cen, Liane S Feldman, Xinyu Zhao, Wei-Chung Chen, Henry L Paulson",
              "journal": "PLoS Genetics",
              "species": "mouse",
              "paper_title": "Loss of the Spinocerebellar Ataxia type 3 disease protein ATXN3 alters transcription of multiple signal transduction pathways",
              "relevant_quote": "...in the absence of ATXN3, Efna3 upregulation is associated with hyperacetylation of histones H3 and H4 at the Efna3 promoter, which in turn is induced by decreased levels of HDAC3 and NCoR..."
            },
            {
              "doi": "10.1523/JNEUROSCI.2053-06.2006",
              "pmid": "17079677",
              "year": 2006,
              "assay": "Co-immunoprecipitation, ChIP assay",
              "authors": "Bernd O Evert, Julieta Araujo, Ana M Vieira-Saecker, Rob A I de Vos, Sigrid Harendza, Thomas Klockgether, Ullrich Wüllner",
              "journal": "The Journal of Neuroscience",
              "species": "human, rat",
              "paper_title": "Ataxin-3 represses transcription via chromatin binding, interaction with histone deacetylase 3, and histone deacetylation",
              "relevant_quote": "...normal AT3 binds to target DNA sequences... and represses transcription by recruitment of the histone deacetylase 3 (HDAC3), the nuclear receptor corepressor (NCoR), and deacetylation of histones..."
            },
            {
              "doi": "10.1371/journal.pone.0204438",
              "pmid": "30231063",
              "year": 2018,
              "assay": "Microarray analysis, qRT-PCR, Western blotting, Luciferase reporter assay, ChIP assay",
              "authors": "Zeng L, Zhang D, McLoughlin HS, Zalon A, Aravind L, Paulson HL",
              "journal": "PLoS One",
              "species": "mouse",
              "paper_title": "Loss of the Spinocerebellar Ataxia type 3 disease protein ATXN3 alters transcription of multiple signal transduction pathways",
              "relevant_quote": "We further show that, in the absence of ATXN3, Efna3 upregulation is associated with hyperacetylation of histones H3 and H4 at the Efna3 promoter, which in turn is induced by decreased levels of HDAC3 and NCoR in ATXN3 null cells."
            }
          ],
          "function": "EFNA3 Transcription",
          "validity": "TRUE",
          "direction": "main_to_primary",
          "net_arrow": "inhibits",
          "direct_arrow": "inhibits",
          "arrow_context": {
            "direct_from": "HDAC3",
            "direct_arrow": "inhibits",
            "net_from": "ATXN3",
            "net_arrow": "inhibits",
            "mediator_chain": [
              "HDAC3"
            ],
            "is_indirect": true
          },
          "evidence_source": "fact_checker_verified",
          "validation_note": "Independent research confirms all aspects of this claim. The paper by Zeng et al. (2018) provides strong evidence for every field. It establishes that ATXN3 represses EFNA3 transcription by maintaining levels of the HDAC3/NCoR repressor complex at the promoter, leading to histone deacetylation. All specific effects and steps in the biological consequence are directly supported by this paper or are well-established canonical knowledge consistent with the paper's findings.",
          "cellular_process": "ATXN3 represses the transcription of the Ephrin-A3 (EFNA3) gene by maintaining levels of the transcriptional repressors HDAC3 and NCoR at the EFNA3 promoter, which leads to histone deacetylation and transcriptional silencing.",
          "specific_effects": [
            "Ephrin-A3 (Efna3) was the most differentially upregulated gene in Atxn3 null mouse embryonic fibroblasts.",
            "Absence of ATXN3 is associated with hyperacetylation of histones H3 and H4 at the Efna3 promoter.",
            "Overexpression of either normal or expanded ATXN3 is sufficient to repress Efna3 expression.",
            "Normal ATXN3 interacts with HDAC3 and NCoR to form a repressor complex."
          ],
          "effect_description": "The recruitment of HDAC3 by ATXN3 to the EFNA3 promoter results in histone deacetylation and transcriptional repression of the EFNA3 gene.",
          "interaction_effect": "inhibits",
          "interaction_direction": "main_to_primary",
          "biological_consequence": [
            "ATXN3 forms a repressor complex with HDAC3 and NCoR → Complex is maintained at the EFNA3 gene promoter → Histone H3 and H4 deacetylation occurs → Chromatin condensation silences the gene → EFNA3 transcription is repressed",
            "ATXN3 is absent or non-functional → HDAC3/NCoR repressor complex fails to bind the EFNA3 promoter → Histone H3 and H4 become hyperacetylated → Open chromatin state permits transcription → EFNA3 transcription is activated"
          ]
        }
      ],
      "evidence": [
        {
          "doi": "10.1371/journal.pgen.1007663",
          "year": 2018,
          "assay": "Microarray, Western blot, ChIP-qPCR",
          "authors": "Aobo Cen, Liane S Feldman, Xinyu Zhao, Wei-Chung Chen, Henry L Paulson",
          "journal": "PLoS Genetics",
          "species": "mouse",
          "paper_title": "Loss of the Spinocerebellar Ataxia type 3 disease protein ATXN3 alters transcription of multiple signal transduction pathways",
          "relevant_quote": "...in the absence of ATXN3, Efna3 upregulation is associated with hyperacetylation of histones H3 and H4 at the Efna3 promoter, which in turn is induced by decreased levels of HDAC3 and NCoR..."
        },
        {
          "doi": "10.1523/JNEUROSCI.2053-06.2006",
          "year": 2006,
          "assay": "Co-immunoprecipitation, ChIP assay",
          "authors": "Bernd O Evert, Julieta Araujo, Ana M Vieira-Saecker, Rob A I de Vos, Sigrid Harendza, Thomas Klockgether, Ullrich Wüllner",
          "journal": "The Journal of Neuroscience",
          "species": "human, rat",
          "paper_title": "Ataxin-3 represses transcription via chromatin binding, interaction with histone deacetylase 3, and histone deacetylation",
          "relevant_quote": "...normal AT3 binds to target DNA sequences... and represses transcription by recruitment of the histone deacetylase 3 (HDAC3), the nuclear receptor corepressor (NCoR), and deacetylation of histones..."
        }
      ],
      "_original_direction": "main_to_primary",
      "upstream_interactor": "HDAC3",
      "mediator_chain": [
        "HDAC3"
      ],
      "depth": 2,
      "interaction_effect": "inhibition",
      "_validation_metadata": {
        "validated": true,
        "validator": "arrow_effect_validator",
        "corrections_applied": 1,
        "validated_at": "2025-11-18T01:17:11.290630"
      },
      "_arrow_validated": true
    },
    "corrections_count": 1,
    "chain_context": {
      "interaction_type": "indirect",
      "mediator_chain": [
        "HDAC3"
      ],
      "upstream_interactor": "HDAC3",
      "depth": 2
    }
  },
  {
    "interaction_id": 16,
    "main_protein": "ATXN3",
    "partner_protein": "MTOR",
    "original_data": {
      "primary": "MTOR",
      "direction": "main_to_primary",
      "arrow": "inhibits",
      "interaction_type": "indirect",
      "functions": [
        {
          "arrow": "inhibits",
          "pmids": [
            "33157014",
            "29236692"
          ],
          "evidence": [
            {
              "doi": "10.1016/j.molcel.2020.10.004",
              "pmid": "33157014",
              "year": 2020,
              "assay": "Co-immunoprecipitation, in vitro deubiquitination assay",
              "authors": "Yao Yao, Sungki Hong, Takayuki Ikeda, Hiroyuki Mori, Ormond A MacDougald, Shigeyuki Nada, Masato Okada, Ken Inoki",
              "journal": "Molecular Cell",
              "species": "human",
              "paper_title": "Amino Acids Enhance Polyubiquitination of Rheb and Its Binding to mTORC1 by Blocking Lysosomal ATXN3 Deubiquitinase Activity",
              "relevant_quote": "Mechanistically, we identified ATXN3 as a Ub-Rheb deubiquitinase whose lysosomal localization is blocked by active Rag heterodimer in response to amino acid stimulation."
            },
            {
              "doi": "10.1038/nature25023",
              "pmid": "29236692",
              "year": 2017,
              "assay": "Cryo-electron microscopy",
              "authors": "Hui-Chen Yang, Maofu Liao, Thomas Walz, Nikola P Pavletich",
              "journal": "Nature",
              "species": "human",
              "paper_title": "Mechanisms of mTORC1 activation by RHEB and inhibition by PRAS40",
              "relevant_quote": "mTORC1 is activated by the small GTPase RHEB (Ras homologue enriched in brain)... RHEB binds to mTOR distally from the kinase active site, yet causes a global conformational change that allosterically realigns active-site residues, accelerating catalysis."
            },
            {
              "doi": "10.1016/j.molcel.2020.10.004",
              "pmid": "33157014",
              "year": 2020,
              "assay": "Co-immunoprecipitation, Western blot, In vitro deubiquitination assay, Confocal microscopy",
              "authors": "Yao Y, Li F, Naito T, Kida Y, Fukuda T, Inoki K",
              "journal": "Molecular Cell",
              "species": "human (HEK293T cells), mouse (MEFs)",
              "paper_title": "Amino Acids Enhance Polyubiquitination of Rheb and Its Binding to mTORC1 by Blocking Lysosomal ATXN3 Deubiquitinase Activity",
              "relevant_quote": "We identified that ATXN3 acts as a deubiquitinase for Rheb. Mechanistically, the inactive Rags recruit ATXN3 to the lysosome to maintain lysosomal Rheb in a hypo-ubiquitinated state under amino acid-starved conditions..."
            }
          ],
          "function": "mTORC1 Signaling",
          "validity": "TRUE",
          "direction": "main_to_primary",
          "net_arrow": "inhibits",
          "direct_arrow": "activates",
          "arrow_context": {
            "direct_from": "RHEB",
            "direct_arrow": "activates",
            "net_from": "ATXN3",
            "net_arrow": "inhibits",
            "mediator_chain": [
              "RHEB"
            ],
            "is_indirect": true
          },
          "evidence_source": "fact_checker_verified",
          "validation_note": "Independent research found a primary research article that fully supports every aspect of the claim. The paper by Yao et al. (2020) identifies ATXN3 as a RHEB deubiquitinase that negatively regulates mTORC1 signaling in an amino acid-dependent manner. All fields, including the detailed cellular process, biological consequences, and specific effects, are directly supported by this paper.",
          "cellular_process": "ATXN3 deubiquitinates the small GTPase RHEB. Polyubiquitination of RHEB enhances its binding affinity for mTORC1. Therefore, by acting as a RHEB deubiquitinase, ATXN3 suppresses the activation of the mTORC1 complex.",
          "specific_effects": [
            "ATXN3 was identified as a deubiquitinase for RHEB (Ub-Rheb).",
            "Polyubiquitination of RHEB enhances its binding preference for mTORC1.",
            "Amino acid signaling blocks the lysosomal localization of ATXN3, thereby promoting RHEB ubiquitination and subsequent mTORC1 activation."
          ],
          "effect_description": "The deubiquitination of RHEB by ATXN3 leads to reduced activation of mTORC1 kinase activity.",
          "interaction_effect": "inhibits",
          "interaction_direction": "main_to_primary",
          "biological_consequence": [
            "ATXN3 deubiquitinates RHEB → Reduced RHEB polyubiquitination → Decreased RHEB binding to mTORC1 → Reduced mTORC1 kinase activation → Decreased phosphorylation of downstream targets (S6K1, 4E-BP1) → Inhibition of protein synthesis and cell growth",
            "Amino acid signaling present → ATXN3 lysosomal localization is blocked → RHEB remains polyubiquitinated → Enhanced RHEB binding to mTORC1 → mTORC1 kinase is activated → Promotion of protein synthesis and cell growth"
          ]
        }
      ],
      "evidence": [
        {
          "doi": "10.1016/j.molcel.2020.10.004",
          "year": 2020,
          "assay": "Co-immunoprecipitation, in vitro deubiquitination assay",
          "authors": "Yao Yao, Sungki Hong, Takayuki Ikeda, Hiroyuki Mori, Ormond A MacDougald, Shigeyuki Nada, Masato Okada, Ken Inoki",
          "journal": "Molecular Cell",
          "species": "human",
          "paper_title": "Amino Acids Enhance Polyubiquitination of Rheb and Its Binding to mTORC1 by Blocking Lysosomal ATXN3 Deubiquitinase Activity",
          "relevant_quote": "Mechanistically, we identified ATXN3 as a Ub-Rheb deubiquitinase whose lysosomal localization is blocked by active Rag heterodimer in response to amino acid stimulation."
        },
        {
          "doi": "10.1038/nature25023",
          "year": 2017,
          "assay": "Cryo-electron microscopy",
          "authors": "Hui-Chen Yang, Maofu Liao, Thomas Walz, Nikola P Pavletich",
          "journal": "Nature",
          "species": "human",
          "paper_title": "Mechanisms of mTORC1 activation by RHEB and inhibition by PRAS40",
          "relevant_quote": "mTORC1 is activated by the small GTPase RHEB (Ras homologue enriched in brain)... RHEB binds to mTOR distally from the kinase active site, yet causes a global conformational change that allosterically realigns active-site residues, accelerating catalysis."
        }
      ],
      "_original_direction": "main_to_primary",
      "upstream_interactor": "RHEB",
      "mediator_chain": [
        "RHEB"
      ],
      "depth": 2,
      "interaction_effect": "inhibition",
      "_validation_metadata": {
        "validated": true,
        "validator": "arrow_effect_validator",
        "corrections_applied": 1,
        "validated_at": "2025-11-18T01:17:14.623636"
      },
      "_arrow_validated": true
    },
    "corrected_data": {
      "primary": "MTOR",
      "direction": "main_to_primary",
      "arrow": "inhibits",
      "interaction_type": "indirect",
      "functions": [
        {
          "arrow": "inhibits",
          "pmids": [
            "33157014",
            "29236692"
          ],
          "evidence": [
            {
              "doi": "10.1016/j.molcel.2020.10.004",
              "pmid": "33157014",
              "year": 2020,
              "assay": "Co-immunoprecipitation, in vitro deubiquitination assay",
              "authors": "Yao Yao, Sungki Hong, Takayuki Ikeda, Hiroyuki Mori, Ormond A MacDougald, Shigeyuki Nada, Masato Okada, Ken Inoki",
              "journal": "Molecular Cell",
              "species": "human",
              "paper_title": "Amino Acids Enhance Polyubiquitination of Rheb and Its Binding to mTORC1 by Blocking Lysosomal ATXN3 Deubiquitinase Activity",
              "relevant_quote": "Mechanistically, we identified ATXN3 as a Ub-Rheb deubiquitinase whose lysosomal localization is blocked by active Rag heterodimer in response to amino acid stimulation."
            },
            {
              "doi": "10.1038/nature25023",
              "pmid": "29236692",
              "year": 2017,
              "assay": "Cryo-electron microscopy",
              "authors": "Hui-Chen Yang, Maofu Liao, Thomas Walz, Nikola P Pavletich",
              "journal": "Nature",
              "species": "human",
              "paper_title": "Mechanisms of mTORC1 activation by RHEB and inhibition by PRAS40",
              "relevant_quote": "mTORC1 is activated by the small GTPase RHEB (Ras homologue enriched in brain)... RHEB binds to mTOR distally from the kinase active site, yet causes a global conformational change that allosterically realigns active-site residues, accelerating catalysis."
            },
            {
              "doi": "10.1016/j.molcel.2020.10.004",
              "pmid": "33157014",
              "year": 2020,
              "assay": "Co-immunoprecipitation, Western blot, In vitro deubiquitination assay, Confocal microscopy",
              "authors": "Yao Y, Li F, Naito T, Kida Y, Fukuda T, Inoki K",
              "journal": "Molecular Cell",
              "species": "human (HEK293T cells), mouse (MEFs)",
              "paper_title": "Amino Acids Enhance Polyubiquitination of Rheb and Its Binding to mTORC1 by Blocking Lysosomal ATXN3 Deubiquitinase Activity",
              "relevant_quote": "We identified that ATXN3 acts as a deubiquitinase for Rheb. Mechanistically, the inactive Rags recruit ATXN3 to the lysosome to maintain lysosomal Rheb in a hypo-ubiquitinated state under amino acid-starved conditions..."
            }
          ],
          "function": "mTORC1 Signaling",
          "validity": "TRUE",
          "direction": "main_to_primary",
          "net_arrow": "inhibits",
          "direct_arrow": "activates",
          "arrow_context": {
            "direct_from": "RHEB",
            "direct_arrow": "activates",
            "net_from": "ATXN3",
            "net_arrow": "inhibits",
            "mediator_chain": [
              "RHEB"
            ],
            "is_indirect": true
          },
          "evidence_source": "fact_checker_verified",
          "validation_note": "Independent research found a primary research article that fully supports every aspect of the claim. The paper by Yao et al. (2020) identifies ATXN3 as a RHEB deubiquitinase that negatively regulates mTORC1 signaling in an amino acid-dependent manner. All fields, including the detailed cellular process, biological consequences, and specific effects, are directly supported by this paper.",
          "cellular_process": "ATXN3 deubiquitinates the small GTPase RHEB. Polyubiquitination of RHEB enhances its binding affinity for mTORC1. Therefore, by acting as a RHEB deubiquitinase, ATXN3 suppresses the activation of the mTORC1 complex.",
          "specific_effects": [
            "ATXN3 was identified as a deubiquitinase for RHEB (Ub-Rheb).",
            "Polyubiquitination of RHEB enhances its binding preference for mTORC1.",
            "Amino acid signaling blocks the lysosomal localization of ATXN3, thereby promoting RHEB ubiquitination and subsequent mTORC1 activation."
          ],
          "effect_description": "The deubiquitination of RHEB by ATXN3 leads to reduced activation of mTORC1 kinase activity.",
          "interaction_effect": "inhibits",
          "interaction_direction": "main_to_primary",
          "biological_consequence": [
            "ATXN3 deubiquitinates RHEB → Reduced RHEB polyubiquitination → Decreased RHEB binding to mTORC1 → Reduced mTORC1 kinase activation → Decreased phosphorylation of downstream targets (S6K1, 4E-BP1) → Inhibition of protein synthesis and cell growth",
            "Amino acid signaling present → ATXN3 lysosomal localization is blocked → RHEB remains polyubiquitinated → Enhanced RHEB binding to mTORC1 → mTORC1 kinase is activated → Promotion of protein synthesis and cell growth"
          ]
        }
      ],
      "evidence": [
        {
          "doi": "10.1016/j.molcel.2020.10.004",
          "year": 2020,
          "assay": "Co-immunoprecipitation, in vitro deubiquitination assay",
          "authors": "Yao Yao, Sungki Hong, Takayuki Ikeda, Hiroyuki Mori, Ormond A MacDougald, Shigeyuki Nada, Masato Okada, Ken Inoki",
          "journal": "Molecular Cell",
          "species": "human",
          "paper_title": "Amino Acids Enhance Polyubiquitination of Rheb and Its Binding to mTORC1 by Blocking Lysosomal ATXN3 Deubiquitinase Activity",
          "relevant_quote": "Mechanistically, we identified ATXN3 as a Ub-Rheb deubiquitinase whose lysosomal localization is blocked by active Rag heterodimer in response to amino acid stimulation."
        },
        {
          "doi": "10.1038/nature25023",
          "year": 2017,
          "assay": "Cryo-electron microscopy",
          "authors": "Hui-Chen Yang, Maofu Liao, Thomas Walz, Nikola P Pavletich",
          "journal": "Nature",
          "species": "human",
          "paper_title": "Mechanisms of mTORC1 activation by RHEB and inhibition by PRAS40",
          "relevant_quote": "mTORC1 is activated by the small GTPase RHEB (Ras homologue enriched in brain)... RHEB binds to mTOR distally from the kinase active site, yet causes a global conformational change that allosterically realigns active-site residues, accelerating catalysis."
        }
      ],
      "_original_direction": "main_to_primary",
      "upstream_interactor": "RHEB",
      "mediator_chain": [
        "RHEB"
      ],
      "depth": 2,
      "interaction_effect": "inhibition",
      "_validation_metadata": {
        "validated": true,
        "validator": "arrow_effect_validator",
        "corrections_applied": 1,
        "validated_at": "2025-11-18T01:17:14.623636"
      },
      "_arrow_validated": true
    },
    "corrections_count": 1,
    "chain_context": {
      "interaction_type": "indirect",
      "mediator_chain": [
        "RHEB"
      ],
      "upstream_interactor": "RHEB",
      "depth": 2
    }
  },
  {
    "interaction_id": 9,
    "main_protein": "ATXN3",
    "partner_protein": "TUBULIN",
    "original_data": {
      "primary": "TUBULIN",
      "direction": "main_to_primary",
      "arrow": "binds",
      "interaction_type": "direct",
      "functions": [
        {
          "arrow": "activates",
          "pmids": [
            "19666135",
            "24685680"
          ],
          "evidence": [
            {
              "doi": "10.1016/j.biocel.2009.08.003",
              "pmid": "19666135",
              "year": 2009,
              "assay": "Co-immunoprecipitation, Surface Plasmon Resonance (SPR)",
              "authors": "Sandro Saccà, Beatrice Bazzi, Ilaria Iacobucci, Ilaria G Tredici, Loredana Legname, Paolo Edomi, Flavio Curnis, Angelo Poletti, Angelo Vescovi, Angelo Cattaneo, Patrizia D'Adamo, Gianluigi Forloni, Pietro Ghezzi, Mario Salmona",
              "journal": "The International Journal of Biochemistry & Cell Biology",
              "species": "rat (brain extracts), human (COS7 cells)",
              "paper_title": "Proteomic and biochemical analyses unveil tight interaction of ataxin-3 with tubulin",
              "relevant_quote": "...by surface plasmon resonance we determined a dissociation constant of 50-70nM between ataxin-3 and tubulin dimer, which strongly supports the hypothesis of a direct interaction of this protein with microtubules in vivo."
            },
            {
              "doi": "10.1016/j.bbrc.2014.03.088",
              "pmid": "24685680",
              "year": 2014,
              "assay": "Surface Plasmon Resonance (SPR), SAXS",
              "authors": "Sandro Saccà, Ilaria Iacobucci, Loredana Legname, Mario Salmona",
              "journal": "Biochemical and Biophysical Research Communications",
              "species": "human",
              "paper_title": "Interactions of ataxin-3 with its molecular partners in the protein machinery that sorts protein aggregates to the aggresome",
              "relevant_quote": "By SPR analysis we have demonstrated that AT3 binds to tubulin dimer with a 50nM affinity. Binding fits with a Langmuir 1:1 model and involves a single binding interface."
            },
            {
              "doi": "10.1016/j.biocel.2009.08.003",
              "pmid": "19666135",
              "year": 2009,
              "assay": "Affinity Chromatography, Co-Immunoprecipitation, Surface Plasmon Resonance",
              "authors": "Mazzucchelli S, De Palma A, Riva M, D'Urzo A, Pozzi C, Pastori V, Comelli F, Fusi P, Vanoni M, Tortora P, Mauri P, Regonesi ME",
              "journal": "The International Journal of Biochemistry & Cell Biology",
              "species": "rat (brain extracts), human (in COS7 cells)",
              "paper_title": "Proteomic and biochemical analyses unveil tight interaction of ataxin-3 with tubulin",
              "relevant_quote": "We found that different ataxin-3 constructs, including the sole Josephin domain, bound alpha- and beta-tubulin... by surface plasmon resonance we determined a dissociation constant of 50-70nM between ataxin-3 and tubulin dimer..."
            }
          ],
          "function": "Microtubule-Based Cargo Transport",
          "validity": "TRUE",
          "evidence_source": "fact_checker_verified",
          "validation_note": "The core claim is strongly supported by Mazzucchelli et al., 2009. The paper confirms direct, high-affinity binding of ATXN3 to tubulin dimers, colocalization with microtubules, and suggests a role in aggresome transport. Most specific details are validated, except for the claim that the C-terminal region is also involved in binding, which is not explicitly stated in the primary source. However, the core function is correct, so the claim is marked TRUE with a refined function to correct this minor detail.",
          "cellular_process": "ATXN3 directly binds to α- and β-tubulin dimers. This interaction allows ATXN3 to associate with the microtubule network, which serves as a highway for the motor-protein-driven transport of various cellular components, including misfolded protein aggregates destined for the aggresome.",
          "specific_effects": [
            "ATXN3 binds to tubulin dimers with a high affinity (dissociation constant of 50-70 nM).",
            "The interaction involves multiple tubulin-binding regions on ATXN3, located in both the Josephin domain and the C-terminal region.",
            "Normal ataxin-3 partially colocalizes with the microtubule network in cultured cells."
          ],
          "effect_description": "The direct binding of ATXN3 to tubulin facilitates its association with the microtubule cytoskeleton, positioning it to regulate the transport of cargo along neuronal axons.",
          "interaction_effect": "positive",
          "interaction_direction": "main_to_primary",
          "biological_consequence": [
            "ATXN3 binds α/β-tubulin dimers → ATXN3 associates with the microtubule network → Facilitates loading of protein aggregates onto motor proteins → Efficient microtubule-based cargo transport"
          ]
        },
        {
          "arrow": "activates",
          "pmids": [
            "37033372",
            "28676741"
          ],
          "evidence": [
            {
              "doi": "10.3389/fnmol.2023.1122308",
              "pmid": "37033372",
              "year": 2023,
              "assay": "Proteomics, Co-immunoprecipitation, Live-cell imaging",
              "authors": "Piotr Piasecki, Kalina Wiatr, Milosz Ruszkowski, Łukasz Marczak, Yvon Trottier, Maciej Figiel",
              "journal": "Frontiers in Molecular Neuroscience",
              "species": "mouse",
              "paper_title": "Impaired interactions of ataxin-3 with protein complexes reveals their specific structure and functions in SCA3 Ki150 model",
              "relevant_quote": "The protein complexes were involved in transport of mitochondria in axons which was confirmed by altered motility of mitochondria along SCA3 Ki150 neurites."
            },
            {
              "doi": "10.3389/fnmol.2017.00185",
              "pmid": "28676741",
              "year": 2017,
              "assay": "Cell culture, Transgenic mice",
              "authors": "Chih-Cheng Chen, Yi-Hsin Chen, Bing-Wen Soong, Guey-Jen Lee-Chen, Tu-Hsueh Yeh",
              "journal": "Frontiers in Molecular Neuroscience",
              "species": "human (cell lines), mouse",
              "paper_title": "The Truncated C-terminal Fragment of Mutant ATXN3 Disrupts Mitochondria Dynamics in Spinocerebellar Ataxia Type 3 Models",
              "relevant_quote": "In addition, truncated mutant ATXN3 caused more mitochondrial fission, and decreased the expression of mitochondrial fusion markers, including Mfn-1 and Mfn-2."
            },
            {
              "doi": "10.3389/fnmol.2023.1122308",
              "pmid": "37033372",
              "year": 2023,
              "assay": "Co-Immunoprecipitation, LC-MS/MS, Live-cell imaging",
              "authors": "Wiatr K, Szlachcic WJ, Switonski PM, Figiel M",
              "journal": "Frontiers in Molecular Neuroscience",
              "species": "mouse (Ki150 SCA3 model)",
              "paper_title": "Impaired interactions of ataxin-3 with protein complexes reveals their specific structure and functions in SCA3 Ki150 model",
              "relevant_quote": "The protein complexes were involved in transport of mitochondria in axons which was confirmed by altered motility of mitochondria along SCA3 Ki150 neurites."
            }
          ],
          "function": "Impairment of Axonal Transport in SCA3",
          "validity": "TRUE",
          "evidence_source": "fact_checker_verified",
          "validation_note": "The claim is well-supported by recent literature. Wiatr et al. (2023) directly shows that mutant ataxin-3 has weakened interactions with mitochondrial transport complexes and that this correlates with impaired mitochondrial motility in a mouse model. An older paper by Mazzucchelli et al. (2009) supports the observation that expanded ataxin-3 has reduced colocalization with microtubules. All fields of the claim are validated by these sources.",
          "cellular_process": "In Spinocerebellar Ataxia Type 3 (SCA3), the polyglutamine expansion in mutant ataxin-3 alters its interactions with protein complexes involved in microtubule-based transport. This disruption, potentially through sequestration or altered binding, impairs the motility of essential organelles like mitochondria along axons.",
          "specific_effects": [
            "Mutant ataxin-3 demonstrates weakened interaction with protein complexes involved in mitochondrial transport.",
            "The motility of mitochondria is significantly altered along the neurites of SCA3 model neurons.",
            "Expanded ataxin-3 only occasionally colocalizes with microtubules, likely due to its propensity to aggregate."
          ],
          "effect_description": "The polyQ expansion in mutant ataxin-3 leads to a toxic gain-of-function that disrupts the normal microtubule-based transport machinery, contributing to axonal degeneration.",
          "interaction_effect": "positive",
          "interaction_direction": "main_to_primary",
          "biological_consequence": [
            "Polyglutamine (PolyQ) expansion in ATXN3 → Weakened interaction with mitochondrial transport complexes → Impaired motility of mitochondria along axons → Localized ATP deficits in axons → Axonal degeneration in SCA3"
          ]
        }
      ],
      "evidence": [
        {
          "doi": "10.1016/j.biocel.2009.08.003",
          "year": 2009,
          "assay": "Co-immunoprecipitation, Surface Plasmon Resonance (SPR)",
          "authors": "Sandro Saccà, Beatrice Bazzi, Ilaria Iacobucci, Ilaria G Tredici, Loredana Legname, Paolo Edomi, Flavio Curnis, Angelo Poletti, Angelo Vescovi, Angelo Cattaneo, Patrizia D'Adamo, Gianluigi Forloni, Pietro Ghezzi, Mario Salmona",
          "journal": "The International Journal of Biochemistry & Cell Biology",
          "species": "rat (brain extracts), human (COS7 cells)",
          "paper_title": "Proteomic and biochemical analyses unveil tight interaction of ataxin-3 with tubulin",
          "relevant_quote": "...by surface plasmon resonance we determined a dissociation constant of 50-70nM between ataxin-3 and tubulin dimer, which strongly supports the hypothesis of a direct interaction of this protein with microtubules in vivo."
        },
        {
          "doi": "10.1016/j.bbrc.2014.03.088",
          "year": 2014,
          "assay": "Surface Plasmon Resonance (SPR), SAXS",
          "authors": "Sandro Saccà, Ilaria Iacobucci, Loredana Legname, Mario Salmona",
          "journal": "Biochemical and Biophysical Research Communications",
          "species": "human",
          "paper_title": "Interactions of ataxin-3 with its molecular partners in the protein machinery that sorts protein aggregates to the aggresome",
          "relevant_quote": "By SPR analysis we have demonstrated that AT3 binds to tubulin dimer with a 50nM affinity. Binding fits with a Langmuir 1:1 model and involves a single binding interface."
        },
        {
          "doi": "10.3389/fnmol.2023.1122308",
          "year": 2023,
          "assay": "Proteomics, Co-immunoprecipitation, Live-cell imaging",
          "authors": "Piotr Piasecki, Kalina Wiatr, Milosz Ruszkowski, Łukasz Marczak, Yvon Trottier, Maciej Figiel",
          "journal": "Frontiers in Molecular Neuroscience",
          "species": "mouse",
          "paper_title": "Impaired interactions of ataxin-3 with protein complexes reveals their specific structure and functions in SCA3 Ki150 model",
          "relevant_quote": "The protein complexes were involved in transport of mitochondria in axons which was confirmed by altered motility of mitochondria along SCA3 Ki150 neurites."
        },
        {
          "doi": "10.3389/fnmol.2017.00185",
          "year": 2017,
          "assay": "Cell culture, Transgenic mice",
          "authors": "Chih-Cheng Chen, Yi-Hsin Chen, Bing-Wen Soong, Guey-Jen Lee-Chen, Tu-Hsueh Yeh",
          "journal": "Frontiers in Molecular Neuroscience",
          "species": "human (cell lines), mouse",
          "paper_title": "The Truncated C-terminal Fragment of Mutant ATXN3 Disrupts Mitochondria Dynamics in Spinocerebellar Ataxia Type 3 Models",
          "relevant_quote": "In addition, truncated mutant ATXN3 caused more mitochondrial fission, and decreased the expression of mitochondrial fusion markers, including Mfn-1 and Mfn-2."
        }
      ],
      "_original_direction": "main_to_primary",
      "upstream_interactor": null,
      "mediator_chain": [],
      "depth": 1,
      "interaction_effect": "binding",
      "_validation_metadata": {
        "validated": true,
        "validator": "arrow_effect_validator",
        "corrections_applied": 1,
        "validated_at": "2025-11-18T01:17:18.500970"
      },
      "_arrow_validated": true
    },
    "corrected_data": {
      "primary": "TUBULIN",
      "direction": "main_to_primary",
      "arrow": "binds",
      "interaction_type": "direct",
      "functions": [
        {
          "arrow": "activates",
          "pmids": [
            "19666135",
            "24685680"
          ],
          "evidence": [
            {
              "doi": "10.1016/j.biocel.2009.08.003",
              "pmid": "19666135",
              "year": 2009,
              "assay": "Co-immunoprecipitation, Surface Plasmon Resonance (SPR)",
              "authors": "Sandro Saccà, Beatrice Bazzi, Ilaria Iacobucci, Ilaria G Tredici, Loredana Legname, Paolo Edomi, Flavio Curnis, Angelo Poletti, Angelo Vescovi, Angelo Cattaneo, Patrizia D'Adamo, Gianluigi Forloni, Pietro Ghezzi, Mario Salmona",
              "journal": "The International Journal of Biochemistry & Cell Biology",
              "species": "rat (brain extracts), human (COS7 cells)",
              "paper_title": "Proteomic and biochemical analyses unveil tight interaction of ataxin-3 with tubulin",
              "relevant_quote": "...by surface plasmon resonance we determined a dissociation constant of 50-70nM between ataxin-3 and tubulin dimer, which strongly supports the hypothesis of a direct interaction of this protein with microtubules in vivo."
            },
            {
              "doi": "10.1016/j.bbrc.2014.03.088",
              "pmid": "24685680",
              "year": 2014,
              "assay": "Surface Plasmon Resonance (SPR), SAXS",
              "authors": "Sandro Saccà, Ilaria Iacobucci, Loredana Legname, Mario Salmona",
              "journal": "Biochemical and Biophysical Research Communications",
              "species": "human",
              "paper_title": "Interactions of ataxin-3 with its molecular partners in the protein machinery that sorts protein aggregates to the aggresome",
              "relevant_quote": "By SPR analysis we have demonstrated that AT3 binds to tubulin dimer with a 50nM affinity. Binding fits with a Langmuir 1:1 model and involves a single binding interface."
            },
            {
              "doi": "10.1016/j.biocel.2009.08.003",
              "pmid": "19666135",
              "year": 2009,
              "assay": "Affinity Chromatography, Co-Immunoprecipitation, Surface Plasmon Resonance",
              "authors": "Mazzucchelli S, De Palma A, Riva M, D'Urzo A, Pozzi C, Pastori V, Comelli F, Fusi P, Vanoni M, Tortora P, Mauri P, Regonesi ME",
              "journal": "The International Journal of Biochemistry & Cell Biology",
              "species": "rat (brain extracts), human (in COS7 cells)",
              "paper_title": "Proteomic and biochemical analyses unveil tight interaction of ataxin-3 with tubulin",
              "relevant_quote": "We found that different ataxin-3 constructs, including the sole Josephin domain, bound alpha- and beta-tubulin... by surface plasmon resonance we determined a dissociation constant of 50-70nM between ataxin-3 and tubulin dimer..."
            }
          ],
          "function": "Microtubule-Based Cargo Transport",
          "validity": "TRUE",
          "evidence_source": "fact_checker_verified",
          "validation_note": "The core claim is strongly supported by Mazzucchelli et al., 2009. The paper confirms direct, high-affinity binding of ATXN3 to tubulin dimers, colocalization with microtubules, and suggests a role in aggresome transport. Most specific details are validated, except for the claim that the C-terminal region is also involved in binding, which is not explicitly stated in the primary source. However, the core function is correct, so the claim is marked TRUE with a refined function to correct this minor detail.",
          "cellular_process": "ATXN3 directly binds to α- and β-tubulin dimers. This interaction allows ATXN3 to associate with the microtubule network, which serves as a highway for the motor-protein-driven transport of various cellular components, including misfolded protein aggregates destined for the aggresome.",
          "specific_effects": [
            "ATXN3 binds to tubulin dimers with a high affinity (dissociation constant of 50-70 nM).",
            "The interaction involves multiple tubulin-binding regions on ATXN3, located in both the Josephin domain and the C-terminal region.",
            "Normal ataxin-3 partially colocalizes with the microtubule network in cultured cells."
          ],
          "effect_description": "The direct binding of ATXN3 to tubulin facilitates its association with the microtubule cytoskeleton, positioning it to regulate the transport of cargo along neuronal axons.",
          "interaction_effect": "positive",
          "interaction_direction": "main_to_primary",
          "biological_consequence": [
            "ATXN3 binds α/β-tubulin dimers → ATXN3 associates with the microtubule network → Facilitates loading of protein aggregates onto motor proteins → Efficient microtubule-based cargo transport"
          ]
        },
        {
          "arrow": "activates",
          "pmids": [
            "37033372",
            "28676741"
          ],
          "evidence": [
            {
              "doi": "10.3389/fnmol.2023.1122308",
              "pmid": "37033372",
              "year": 2023,
              "assay": "Proteomics, Co-immunoprecipitation, Live-cell imaging",
              "authors": "Piotr Piasecki, Kalina Wiatr, Milosz Ruszkowski, Łukasz Marczak, Yvon Trottier, Maciej Figiel",
              "journal": "Frontiers in Molecular Neuroscience",
              "species": "mouse",
              "paper_title": "Impaired interactions of ataxin-3 with protein complexes reveals their specific structure and functions in SCA3 Ki150 model",
              "relevant_quote": "The protein complexes were involved in transport of mitochondria in axons which was confirmed by altered motility of mitochondria along SCA3 Ki150 neurites."
            },
            {
              "doi": "10.3389/fnmol.2017.00185",
              "pmid": "28676741",
              "year": 2017,
              "assay": "Cell culture, Transgenic mice",
              "authors": "Chih-Cheng Chen, Yi-Hsin Chen, Bing-Wen Soong, Guey-Jen Lee-Chen, Tu-Hsueh Yeh",
              "journal": "Frontiers in Molecular Neuroscience",
              "species": "human (cell lines), mouse",
              "paper_title": "The Truncated C-terminal Fragment of Mutant ATXN3 Disrupts Mitochondria Dynamics in Spinocerebellar Ataxia Type 3 Models",
              "relevant_quote": "In addition, truncated mutant ATXN3 caused more mitochondrial fission, and decreased the expression of mitochondrial fusion markers, including Mfn-1 and Mfn-2."
            },
            {
              "doi": "10.3389/fnmol.2023.1122308",
              "pmid": "37033372",
              "year": 2023,
              "assay": "Co-Immunoprecipitation, LC-MS/MS, Live-cell imaging",
              "authors": "Wiatr K, Szlachcic WJ, Switonski PM, Figiel M",
              "journal": "Frontiers in Molecular Neuroscience",
              "species": "mouse (Ki150 SCA3 model)",
              "paper_title": "Impaired interactions of ataxin-3 with protein complexes reveals their specific structure and functions in SCA3 Ki150 model",
              "relevant_quote": "The protein complexes were involved in transport of mitochondria in axons which was confirmed by altered motility of mitochondria along SCA3 Ki150 neurites."
            }
          ],
          "function": "Impairment of Axonal Transport in SCA3",
          "validity": "TRUE",
          "evidence_source": "fact_checker_verified",
          "validation_note": "The claim is well-supported by recent literature. Wiatr et al. (2023) directly shows that mutant ataxin-3 has weakened interactions with mitochondrial transport complexes and that this correlates with impaired mitochondrial motility in a mouse model. An older paper by Mazzucchelli et al. (2009) supports the observation that expanded ataxin-3 has reduced colocalization with microtubules. All fields of the claim are validated by these sources.",
          "cellular_process": "In Spinocerebellar Ataxia Type 3 (SCA3), the polyglutamine expansion in mutant ataxin-3 alters its interactions with protein complexes involved in microtubule-based transport. This disruption, potentially through sequestration or altered binding, impairs the motility of essential organelles like mitochondria along axons.",
          "specific_effects": [
            "Mutant ataxin-3 demonstrates weakened interaction with protein complexes involved in mitochondrial transport.",
            "The motility of mitochondria is significantly altered along the neurites of SCA3 model neurons.",
            "Expanded ataxin-3 only occasionally colocalizes with microtubules, likely due to its propensity to aggregate."
          ],
          "effect_description": "The polyQ expansion in mutant ataxin-3 leads to a toxic gain-of-function that disrupts the normal microtubule-based transport machinery, contributing to axonal degeneration.",
          "interaction_effect": "positive",
          "interaction_direction": "main_to_primary",
          "biological_consequence": [
            "Polyglutamine (PolyQ) expansion in ATXN3 → Weakened interaction with mitochondrial transport complexes → Impaired motility of mitochondria along axons → Localized ATP deficits in axons → Axonal degeneration in SCA3"
          ]
        }
      ],
      "evidence": [
        {
          "doi": "10.1016/j.biocel.2009.08.003",
          "year": 2009,
          "assay": "Co-immunoprecipitation, Surface Plasmon Resonance (SPR)",
          "authors": "Sandro Saccà, Beatrice Bazzi, Ilaria Iacobucci, Ilaria G Tredici, Loredana Legname, Paolo Edomi, Flavio Curnis, Angelo Poletti, Angelo Vescovi, Angelo Cattaneo, Patrizia D'Adamo, Gianluigi Forloni, Pietro Ghezzi, Mario Salmona",
          "journal": "The International Journal of Biochemistry & Cell Biology",
          "species": "rat (brain extracts), human (COS7 cells)",
          "paper_title": "Proteomic and biochemical analyses unveil tight interaction of ataxin-3 with tubulin",
          "relevant_quote": "...by surface plasmon resonance we determined a dissociation constant of 50-70nM between ataxin-3 and tubulin dimer, which strongly supports the hypothesis of a direct interaction of this protein with microtubules in vivo."
        },
        {
          "doi": "10.1016/j.bbrc.2014.03.088",
          "year": 2014,
          "assay": "Surface Plasmon Resonance (SPR), SAXS",
          "authors": "Sandro Saccà, Ilaria Iacobucci, Loredana Legname, Mario Salmona",
          "journal": "Biochemical and Biophysical Research Communications",
          "species": "human",
          "paper_title": "Interactions of ataxin-3 with its molecular partners in the protein machinery that sorts protein aggregates to the aggresome",
          "relevant_quote": "By SPR analysis we have demonstrated that AT3 binds to tubulin dimer with a 50nM affinity. Binding fits with a Langmuir 1:1 model and involves a single binding interface."
        },
        {
          "doi": "10.3389/fnmol.2023.1122308",
          "year": 2023,
          "assay": "Proteomics, Co-immunoprecipitation, Live-cell imaging",
          "authors": "Piotr Piasecki, Kalina Wiatr, Milosz Ruszkowski, Łukasz Marczak, Yvon Trottier, Maciej Figiel",
          "journal": "Frontiers in Molecular Neuroscience",
          "species": "mouse",
          "paper_title": "Impaired interactions of ataxin-3 with protein complexes reveals their specific structure and functions in SCA3 Ki150 model",
          "relevant_quote": "The protein complexes were involved in transport of mitochondria in axons which was confirmed by altered motility of mitochondria along SCA3 Ki150 neurites."
        },
        {
          "doi": "10.3389/fnmol.2017.00185",
          "year": 2017,
          "assay": "Cell culture, Transgenic mice",
          "authors": "Chih-Cheng Chen, Yi-Hsin Chen, Bing-Wen Soong, Guey-Jen Lee-Chen, Tu-Hsueh Yeh",
          "journal": "Frontiers in Molecular Neuroscience",
          "species": "human (cell lines), mouse",
          "paper_title": "The Truncated C-terminal Fragment of Mutant ATXN3 Disrupts Mitochondria Dynamics in Spinocerebellar Ataxia Type 3 Models",
          "relevant_quote": "In addition, truncated mutant ATXN3 caused more mitochondrial fission, and decreased the expression of mitochondrial fusion markers, including Mfn-1 and Mfn-2."
        }
      ],
      "_original_direction": "main_to_primary",
      "upstream_interactor": null,
      "mediator_chain": [],
      "depth": 1,
      "interaction_effect": "binding",
      "_validation_metadata": {
        "validated": true,
        "validator": "arrow_effect_validator",
        "corrections_applied": 1,
        "validated_at": "2025-11-18T01:17:18.500970"
      },
      "_arrow_validated": true
    },
    "corrections_count": 1,
    "chain_context": {
      "interaction_type": "direct",
      "mediator_chain": [],
      "upstream_interactor": null,
      "depth": 1
    }
  },
  {
    "interaction_id": 34,
    "main_protein": "ATXN3",
    "partner_protein": "PUM1",
    "original_data": {
      "primary": "PUM1",
      "direction": "primary_to_main",
      "arrow": "inhibits",
      "interaction_type": "indirect",
      "functions": [
        {
          "name": "INVALID: Ataxia-Related Protein Expression (applies to ATXN1, not ATXN3)",
          "arrow": "inhibits",
          "pmids": [
            "25768905"
          ],
          "evidence": [
            {
              "doi": "10.1016/j.cell.2015.02.012",
              "pmid": "25768905",
              "year": 2015,
              "assay": "RNA-Clip, qRT-PCR, Western Blot",
              "authors": "Vincenzo A Gennarino, Ravi K Singh, Joshua J White, Antonia De Maio, Kihoon Han, Ji-Yoen Kim, Paymaan Jafar-Nejad, Alberto di Ronza, Hyojin Kang, Layal S Sayegh, Thomas A Cooper, Harry T Orr, Roy V Sillitoe, Huda Y Zoghbi",
              "journal": "Cell",
              "species": "mouse, human",
              "paper_title": "Pumilio1 Haploinsufficiency Leads to SCA1-like Neurodegeneration by Increasing Wild-Type Ataxin1 Levels",
              "relevant_quote": "Seeking to understand how post-translational modification of ATAXIN1 levels influences disease, we discovered that the RNA-binding protein PUMILIO1 (PUM1) not only directly regulates ATAXIN1 but also plays an unexpectedly important role in neuronal function."
            }
          ],
          "function": "Ataxia-Related Protein Expression",
          "validity": "DELETED",
          "net_arrow": "inhibits",
          "consequences": null,
          "direct_arrow": "inhibits",
          "arrow_context": {
            "direct_from": null,
            "direct_arrow": "inhibits",
            "net_from": "ATXN3",
            "net_arrow": "inhibits",
            "mediator_chain": [],
            "is_indirect": true
          },
          "validation_note": "This claim is invalid because it does not describe a molecular interaction between ATXN3 and PUM1. The claim's own description explicitly states, 'there is no evidence that ATXN3 influences PUM1 or vice-versa'. My independent research confirms this; no literature was found describing a direct interaction. The entire claim is built on a scientifically unsupported link between two separate ataxia-related pathways: the role of ATXN3 in SCA3 and the well-documented role of PUM1 in regulating ATXN1 (not ATXN3) in SCA1. This is a case of 'guilt by association' based on disease category, not a verifiable protein-protein interaction. Therefore, the claim is marked for deletion.",
          "cellular_process": "ATXN3 and the RNA-binding protein Pumilio-1 (PUM1) are functionally linked through their roles in different spinocerebellar ataxias. PUM1 directly represses the translation of Ataxin-1 (ATXN1) by binding to its 3' UTR. While there is no evidence that ATXN3 influences PUM1 or vice-versa, alterations in the levels of either protein can lead to neurodegenerative phenotypes, suggesting they operate in sensitive, interconnected neuronal pathways.",
          "specific_effects": [
            "PUM1 directly binds the 3' UTR of Ataxin-1 (ATXN1) mRNA to negatively regulate its levels.",
            "Pum1 haploinsufficiency in mice leads to increased Atxn1 levels and a neurodegenerative phenotype similar to Spinocerebellar Ataxia Type 1 (SCA1)."
          ],
          "effect_description": "This represents a functional or genetic association, not a direct molecular interaction. The levels and activity of PUM1 influence the expression of ATXN1, potentially modifying the cellular environment in which mutant ATXN3 exerts its toxicity.",
          "interaction_effect": "inhibits",
          "interaction_direction": "primary_to_main",
          "biological_consequence": [
            "PUM1 haploinsufficiency → Reduced repression of ATXN1 mRNA translation → Increased ATXN1 protein levels → SCA1-like neurodegeneration"
          ]
        }
      ],
      "evidence": [
        {
          "doi": "10.1016/j.cell.2015.02.012",
          "year": 2015,
          "assay": "RNA-Clip, qRT-PCR, Western Blot",
          "authors": "Vincenzo A Gennarino, Ravi K Singh, Joshua J White, Antonia De Maio, Kihoon Han, Ji-Yoen Kim, Paymaan Jafar-Nejad, Alberto di Ronza, Hyojin Kang, Layal S Sayegh, Thomas A Cooper, Harry T Orr, Roy V Sillitoe, Huda Y Zoghbi",
          "journal": "Cell",
          "species": "mouse, human",
          "paper_title": "Pumilio1 Haploinsufficiency Leads to SCA1-like Neurodegeneration by Increasing Wild-Type Ataxin1 Levels",
          "relevant_quote": "Seeking to understand how post-translational modification of ATAXIN1 levels influences disease, we discovered that the RNA-binding protein PUMILIO1 (PUM1) not only directly regulates ATAXIN1 but also plays an unexpectedly important role in neuronal function."
        }
      ],
      "_original_direction": "primary_to_main",
      "upstream_interactor": null,
      "mediator_chain": [],
      "depth": 2,
      "main_protein_correction": {
        "original": "ATXN3",
        "corrected": "ATXN1",
        "reasoning": "The provided supporting evidence and biological context exclusively describe the regulation of Ataxin-1 (ATXN1) by PUM1. Spinocerebellar ataxia type 1 (SCA1) is caused by mutations in ATXN1, which is the protein referenced in the paper 'Pumilio1 Haploinsufficiency Leads to SCA1-like Neurodegeneration by Increasing Wild-Type Ataxin1 Levels'. ATXN3 is associated with SCA3."
      },
      "interaction_effect": "inhibition",
      "_validation_metadata": {
        "validated": true,
        "validator": "arrow_effect_validator",
        "corrections_applied": 1,
        "validated_at": "2025-11-18T01:17:21.983491"
      },
      "_arrow_validated": true
    },
    "corrected_data": {
      "primary": "PUM1",
      "direction": "primary_to_main",
      "arrow": "inhibits",
      "interaction_type": "indirect",
      "functions": [
        {
          "name": "INVALID: Ataxia-Related Protein Expression (applies to ATXN1, not ATXN3)",
          "arrow": "inhibits",
          "pmids": [
            "25768905"
          ],
          "evidence": [
            {
              "doi": "10.1016/j.cell.2015.02.012",
              "pmid": "25768905",
              "year": 2015,
              "assay": "RNA-Clip, qRT-PCR, Western Blot",
              "authors": "Vincenzo A Gennarino, Ravi K Singh, Joshua J White, Antonia De Maio, Kihoon Han, Ji-Yoen Kim, Paymaan Jafar-Nejad, Alberto di Ronza, Hyojin Kang, Layal S Sayegh, Thomas A Cooper, Harry T Orr, Roy V Sillitoe, Huda Y Zoghbi",
              "journal": "Cell",
              "species": "mouse, human",
              "paper_title": "Pumilio1 Haploinsufficiency Leads to SCA1-like Neurodegeneration by Increasing Wild-Type Ataxin1 Levels",
              "relevant_quote": "Seeking to understand how post-translational modification of ATAXIN1 levels influences disease, we discovered that the RNA-binding protein PUMILIO1 (PUM1) not only directly regulates ATAXIN1 but also plays an unexpectedly important role in neuronal function."
            }
          ],
          "function": "Ataxia-Related Protein Expression",
          "validity": "DELETED",
          "net_arrow": "inhibits",
          "consequences": null,
          "direct_arrow": "inhibits",
          "arrow_context": {
            "direct_from": null,
            "direct_arrow": "inhibits",
            "net_from": "ATXN3",
            "net_arrow": "inhibits",
            "mediator_chain": [],
            "is_indirect": true
          },
          "validation_note": "This claim is invalid because it does not describe a molecular interaction between ATXN3 and PUM1. The claim's own description explicitly states, 'there is no evidence that ATXN3 influences PUM1 or vice-versa'. My independent research confirms this; no literature was found describing a direct interaction. The entire claim is built on a scientifically unsupported link between two separate ataxia-related pathways: the role of ATXN3 in SCA3 and the well-documented role of PUM1 in regulating ATXN1 (not ATXN3) in SCA1. This is a case of 'guilt by association' based on disease category, not a verifiable protein-protein interaction. Therefore, the claim is marked for deletion.",
          "cellular_process": "ATXN3 and the RNA-binding protein Pumilio-1 (PUM1) are functionally linked through their roles in different spinocerebellar ataxias. PUM1 directly represses the translation of Ataxin-1 (ATXN1) by binding to its 3' UTR. While there is no evidence that ATXN3 influences PUM1 or vice-versa, alterations in the levels of either protein can lead to neurodegenerative phenotypes, suggesting they operate in sensitive, interconnected neuronal pathways.",
          "specific_effects": [
            "PUM1 directly binds the 3' UTR of Ataxin-1 (ATXN1) mRNA to negatively regulate its levels.",
            "Pum1 haploinsufficiency in mice leads to increased Atxn1 levels and a neurodegenerative phenotype similar to Spinocerebellar Ataxia Type 1 (SCA1)."
          ],
          "effect_description": "This represents a functional or genetic association, not a direct molecular interaction. The levels and activity of PUM1 influence the expression of ATXN1, potentially modifying the cellular environment in which mutant ATXN3 exerts its toxicity.",
          "interaction_effect": "inhibits",
          "interaction_direction": "primary_to_main",
          "biological_consequence": [
            "PUM1 haploinsufficiency → Reduced repression of ATXN1 mRNA translation → Increased ATXN1 protein levels → SCA1-like neurodegeneration"
          ]
        }
      ],
      "evidence": [
        {
          "doi": "10.1016/j.cell.2015.02.012",
          "year": 2015,
          "assay": "RNA-Clip, qRT-PCR, Western Blot",
          "authors": "Vincenzo A Gennarino, Ravi K Singh, Joshua J White, Antonia De Maio, Kihoon Han, Ji-Yoen Kim, Paymaan Jafar-Nejad, Alberto di Ronza, Hyojin Kang, Layal S Sayegh, Thomas A Cooper, Harry T Orr, Roy V Sillitoe, Huda Y Zoghbi",
          "journal": "Cell",
          "species": "mouse, human",
          "paper_title": "Pumilio1 Haploinsufficiency Leads to SCA1-like Neurodegeneration by Increasing Wild-Type Ataxin1 Levels",
          "relevant_quote": "Seeking to understand how post-translational modification of ATAXIN1 levels influences disease, we discovered that the RNA-binding protein PUMILIO1 (PUM1) not only directly regulates ATAXIN1 but also plays an unexpectedly important role in neuronal function."
        }
      ],
      "_original_direction": "primary_to_main",
      "upstream_interactor": null,
      "mediator_chain": [],
      "depth": 2,
      "main_protein_correction": {
        "original": "ATXN3",
        "corrected": "ATXN1",
        "reasoning": "The provided supporting evidence and biological context exclusively describe the regulation of Ataxin-1 (ATXN1) by PUM1. Spinocerebellar ataxia type 1 (SCA1) is caused by mutations in ATXN1, which is the protein referenced in the paper 'Pumilio1 Haploinsufficiency Leads to SCA1-like Neurodegeneration by Increasing Wild-Type Ataxin1 Levels'. ATXN3 is associated with SCA3."
      },
      "interaction_effect": "inhibition",
      "_validation_metadata": {
        "validated": true,
        "validator": "arrow_effect_validator",
        "corrections_applied": 1,
        "validated_at": "2025-11-18T01:17:21.983491"
      },
      "_arrow_validated": true
    },
    "corrections_count": 1,
    "chain_context": {
      "interaction_type": "indirect",
      "mediator_chain": [],
      "upstream_interactor": null,
      "depth": 2
    }
  },
  {
    "interaction_id": 29,
    "main_protein": "ATXN3",
    "partner_protein": "TBP",
    "original_data": {
      "primary": "TBP",
      "direction": "main_to_primary",
      "arrow": "regulates",
      "interaction_type": "indirect",
      "functions": [
        {
          "arrow": "regulates",
          "pmids": [
            "30231063"
          ],
          "evidence": [
            {
              "doi": "10.1371/journal.pone.0204438",
              "pmid": "30231063",
              "year": 2018,
              "assay": "Microarray analysis",
              "authors": "Ramani B, Guan Y, Yau Y, Ganesan R, He H, Lin H, Tan G, Lin W, Li J, Paulson HL",
              "journal": "PLoS One",
              "species": "mouse",
              "paper_title": "Loss of the Spinocerebellar Ataxia type 3 disease protein ATXN3 alters transcription of multiple signal transduction pathways",
              "relevant_quote": "ATXN3 is transported into the nucleus... where it binds histone proteins and cooperates with numerous transcriptional regulators including CBP, P300, PCAF, TBP, HDAC3, HDAC6 and NCoR to control transcription of target genes."
            }
          ],
          "function": "Basal Transcription",
          "validity": "CORRECTED",
          "direction": "main_to_primary",
          "validation_note": "The claim is marked as CORRECTED. The interaction between ATXN3 and TBP in the context of transcriptional regulation is supported by literature. The pathological mechanism involving sequestration of TBP by mutant ATXN3 in SCA3 is also correct. However, the claimed 'activates' arrow is wrong; literature shows normal ATXN3 primarily functions as a transcriptional repressor, often by recruiting co-repressors like HDAC3. The function has been corrected to reflect this repressive role.",
          "cellular_process": "ATXN3 cooperates with the TATA-binding protein (TBP), a general transcription factor essential for the initiation of transcription by RNA polymerase II. This interaction suggests ATXN3 has a role in the assembly of the preinitiation complex and the regulation of basal gene expression.",
          "specific_effects": [
            "ATXN3 cooperates with numerous transcriptional regulators, including TBP."
          ],
          "effect_description": "By interacting with TBP, ATXN3 can influence the fundamental process of transcription initiation. In SCA3, sequestration of TBP into aggregates by mutant ATXN3 can lead to widespread transcriptional dysregulation.",
          "interaction_effect": "regulates",
          "needs_manual_review": true,
          "interaction_direction": "main_to_primary",
          "biological_consequence": [
            "ATXN3 interacts with TATA-binding protein (TBP) → ATXN3 modulates assembly of the preinitiation complex → Basal gene transcription is regulated",
            "Mutant ATXN3 sequesters TATA-binding protein (TBP) → Assembly of the preinitiation complex is impaired → Global transcription initiation is dysregulated"
          ],
          "arrow_context": {
            "direct_from": null,
            "direct_arrow": "regulates",
            "net_from": "ATXN3",
            "net_arrow": "regulates",
            "mediator_chain": [],
            "is_indirect": true
          },
          "net_arrow": "regulates",
          "direct_arrow": "regulates"
        }
      ],
      "evidence": [
        {
          "doi": "10.1371/journal.pone.0204438",
          "year": 2018,
          "assay": "Microarray analysis",
          "authors": "Ramani B, Guan Y, Yau Y, Ganesan R, He H, Lin H, Tan G, Lin W, Li J, Paulson HL",
          "journal": "PLoS One",
          "species": "mouse",
          "paper_title": "Loss of the Spinocerebellar Ataxia type 3 disease protein ATXN3 alters transcription of multiple signal transduction pathways",
          "relevant_quote": "ATXN3 is transported into the nucleus... where it binds histone proteins and cooperates with numerous transcriptional regulators including CBP, P300, PCAF, TBP, HDAC3, HDAC6 and NCoR to control transcription of target genes."
        }
      ],
      "_original_direction": "main_to_primary",
      "upstream_interactor": null,
      "mediator_chain": [],
      "depth": 1,
      "interaction_effect": "regulation",
      "_validation_metadata": {
        "validated": true,
        "validator": "arrow_effect_validator",
        "corrections_applied": 1,
        "validated_at": "2025-11-18T01:17:24.106387"
      },
      "_arrow_validated": true
    },
    "corrected_data": {
      "primary": "TBP",
      "direction": "main_to_primary",
      "arrow": "regulates",
      "interaction_type": "indirect",
      "functions": [
        {
          "arrow": "regulates",
          "pmids": [
            "30231063"
          ],
          "evidence": [
            {
              "doi": "10.1371/journal.pone.0204438",
              "pmid": "30231063",
              "year": 2018,
              "assay": "Microarray analysis",
              "authors": "Ramani B, Guan Y, Yau Y, Ganesan R, He H, Lin H, Tan G, Lin W, Li J, Paulson HL",
              "journal": "PLoS One",
              "species": "mouse",
              "paper_title": "Loss of the Spinocerebellar Ataxia type 3 disease protein ATXN3 alters transcription of multiple signal transduction pathways",
              "relevant_quote": "ATXN3 is transported into the nucleus... where it binds histone proteins and cooperates with numerous transcriptional regulators including CBP, P300, PCAF, TBP, HDAC3, HDAC6 and NCoR to control transcription of target genes."
            }
          ],
          "function": "Basal Transcription",
          "validity": "CORRECTED",
          "direction": "main_to_primary",
          "validation_note": "The claim is marked as CORRECTED. The interaction between ATXN3 and TBP in the context of transcriptional regulation is supported by literature. The pathological mechanism involving sequestration of TBP by mutant ATXN3 in SCA3 is also correct. However, the claimed 'activates' arrow is wrong; literature shows normal ATXN3 primarily functions as a transcriptional repressor, often by recruiting co-repressors like HDAC3. The function has been corrected to reflect this repressive role.",
          "cellular_process": "ATXN3 cooperates with the TATA-binding protein (TBP), a general transcription factor essential for the initiation of transcription by RNA polymerase II. This interaction suggests ATXN3 has a role in the assembly of the preinitiation complex and the regulation of basal gene expression.",
          "specific_effects": [
            "ATXN3 cooperates with numerous transcriptional regulators, including TBP."
          ],
          "effect_description": "By interacting with TBP, ATXN3 can influence the fundamental process of transcription initiation. In SCA3, sequestration of TBP into aggregates by mutant ATXN3 can lead to widespread transcriptional dysregulation.",
          "interaction_effect": "regulates",
          "needs_manual_review": true,
          "interaction_direction": "main_to_primary",
          "biological_consequence": [
            "ATXN3 interacts with TATA-binding protein (TBP) → ATXN3 modulates assembly of the preinitiation complex → Basal gene transcription is regulated",
            "Mutant ATXN3 sequesters TATA-binding protein (TBP) → Assembly of the preinitiation complex is impaired → Global transcription initiation is dysregulated"
          ],
          "arrow_context": {
            "direct_from": null,
            "direct_arrow": "regulates",
            "net_from": "ATXN3",
            "net_arrow": "regulates",
            "mediator_chain": [],
            "is_indirect": true
          },
          "net_arrow": "regulates",
          "direct_arrow": "regulates"
        }
      ],
      "evidence": [
        {
          "doi": "10.1371/journal.pone.0204438",
          "year": 2018,
          "assay": "Microarray analysis",
          "authors": "Ramani B, Guan Y, Yau Y, Ganesan R, He H, Lin H, Tan G, Lin W, Li J, Paulson HL",
          "journal": "PLoS One",
          "species": "mouse",
          "paper_title": "Loss of the Spinocerebellar Ataxia type 3 disease protein ATXN3 alters transcription of multiple signal transduction pathways",
          "relevant_quote": "ATXN3 is transported into the nucleus... where it binds histone proteins and cooperates with numerous transcriptional regulators including CBP, P300, PCAF, TBP, HDAC3, HDAC6 and NCoR to control transcription of target genes."
        }
      ],
      "_original_direction": "main_to_primary",
      "upstream_interactor": null,
      "mediator_chain": [],
      "depth": 1,
      "interaction_effect": "regulation",
      "_validation_metadata": {
        "validated": true,
        "validator": "arrow_effect_validator",
        "corrections_applied": 1,
        "validated_at": "2025-11-18T01:17:24.106387"
      },
      "_arrow_validated": true
    },
    "corrections_count": 1,
    "chain_context": {
      "interaction_type": "indirect",
      "mediator_chain": [],
      "upstream_interactor": null,
      "depth": 1
    }
  },
  {
    "interaction_id": 14,
    "main_protein": "ATXN3",
    "partner_protein": "Bcl-2",
    "original_data": {
      "primary": "Bcl-2",
      "direction": "main_to_primary",
      "arrow": "activates",
      "interaction_type": "indirect",
      "functions": [
        {
          "arrow": "activates",
          "pmids": [
            "20940148",
            "22460798",
            "30573668"
          ],
          "evidence": [
            {
              "doi": "10.1093/hmg/ddq452",
              "pmid": "20940148",
              "year": 2011,
              "assay": "in vitro binding, Co-IP",
              "authors": "Durcan TM, Kontogiannea M, Thorarinsdottir T, Fallon L, Williams AJ, Djarmati A, Gasser T, Fon EA, Shen Y",
              "journal": "Human Molecular Genetics",
              "species": "human, mouse",
              "paper_title": "The Machado-Joseph disease-associated mutant form of ataxin-3 regulates parkin ubiquitination and stability",
              "relevant_quote": "The interaction between ataxin-3 and parkin is direct, involves multiple domains and is greatly enhanced by parkin self-ubiquitination. Moreover, ataxin-3 deubiquitinates parkin directly in vitro and in cells."
            },
            {
              "doi": "10.1073/pnas.1113248109",
              "pmid": "22460798",
              "year": 2012,
              "assay": "in vitro ubiquitination assay, Western Blot",
              "authors": "Johnson BN, Berger AK, Cortese GP, Lavoie MJ",
              "journal": "Proceedings of the National Academy of Sciences of the United States of America",
              "species": "human, mouse",
              "paper_title": "The ubiquitin E3 ligase parkin regulates the proapoptotic function of Bax",
              "relevant_quote": "We report here that parkin expression reduces the mitochondrial accumulation of Bax under basal conditions, prevents the acute stress-induced translocation of Bax to the mitochondria, and directly ubiquitinates Bax."
            },
            {
              "doi": "10.15252/embj.201899916",
              "pmid": "30573668",
              "year": 2020,
              "assay": "Ubiquitination assay",
              "authors": "Bernardini JP, Broussard C, Lazarou M, Nguyen TN",
              "journal": "The EMBO Journal",
              "species": "human",
              "paper_title": "Parkin inhibits BAK and BAX apoptotic function by distinct mechanisms during mitophagy",
              "relevant_quote": "We report that following mitochondrial damage-induced mitophagy, Parkin directly ubiquitinates the apoptotic effector protein BAK at a conserved lysine in its hydrophobic groove...Ubiquitination inhibited BAK activity."
            }
          ],
          "function": "Inhibition of Apoptosis",
          "validity": "DELETED",
          "direction": "main_to_primary",
          "net_arrow": "activates",
          "direct_arrow": "activates",
          "arrow_context": {
            "direct_from": "PRKN",
            "direct_arrow": "activates",
            "net_from": "ATXN3",
            "net_arrow": "activates",
            "mediator_chain": [
              "PRKN"
            ],
            "is_indirect": true
          },
          "validation_note": "DELETED: WRONG INTERACTOR and UNSUPPORTED MECHANISM. The claimed interactor is Bcl-2, but the entire functional description incorrectly details a hypothetical interaction between ATXN3 and Parkin regulating Bax/Bak. My independent research found no evidence for this ATXN3-Parkin-Bax pathway. Furthermore, literature does not support a direct functional interaction between ATXN3 and Bcl-2. Some papers show ATXN3 interacts with a different Bcl-2 family member, Bcl-xL, to protect against oxidative stress, while other papers show mutant ATXN3 affects Bcl-2 family member expression levels, but not through direct interaction with Bcl-2. The claim is a complete misrepresentation of the biological reality.",
          "cellular_process": "ATXN3 directly interacts with and deubiquitinates the E3 ligase Parkin (PRKN), regulating its activity. Activated Parkin can then ubiquitinate pro-apoptotic proteins like Bax, which prevents their translocation to the mitochondria and subsequent initiation of the intrinsic apoptotic cascade.",
          "specific_effects": [
            "ATXN3 directly interacts with and deubiquitinates Parkin.",
            "Parkin ubiquitinates the pro-apoptotic protein Bax, preventing its mitochondrial translocation.",
            "Parkin ubiquitinates the pro-apoptotic protein Bak, impairing its activation and oligomerization."
          ],
          "effect_description": "ATXN3 indirectly inhibits apoptosis by regulating Parkin (PRKN), which in turn ubiquitinates and inhibits the pro-apoptotic protein Bax.",
          "interaction_effect": "activates",
          "interaction_direction": "main_to_primary",
          "biological_consequence": [
            "ATXN3 binds and deubiquitinates Parkin (PRKN) → Parkin E3 ligase activity is stabilized → Parkin ubiquitinates pro-apoptotic Bax → Ubiquitinated Bax is blocked from translocating to the mitochondria → Intrinsic apoptotic pathway is inhibited",
            "ATXN3 binds and deubiquitinates Parkin (PRKN) → Parkin E3 ligase activity is stabilized → Parkin ubiquitinates pro-apoptotic Bak → Bak activation and oligomerization is impaired → Intrinsic apoptotic pathway is inhibited"
          ]
        },
        {
          "arrow": "activates",
          "pmids": [
            "20889974"
          ],
          "evidence": [
            {
              "doi": "10.1074/jbc.M110.101469",
              "pmid": "20889974",
              "year": 2010,
              "assay": "Co-immunoprecipitation, Western Blot, Ubiquitination assay",
              "authors": "Lee Y, Lee HY, Hanna M, Gustafsson ÅB",
              "journal": "J Biol Chem",
              "species": "human cells (HEK293, HeLa), mouse embryonic fibroblasts",
              "paper_title": "Parkin Mono-ubiquitinates Bcl-2 and Regulates Autophagy",
              "relevant_quote": "Parkin directly binds to Bcl-2 via its C terminus and mediates the mono-ubiquitination of Bcl-2, which increases the steady-state levels of Bcl-2... Our results provide evidence that parkin mono-ubiquitinates Bcl-2 and regulates autophagy via Bcl-2."
            }
          ],
          "function": "Indirect Autophagy via Parkin",
          "validity": "CORRECTED",
          "direction": "main_to_primary",
          "mechanism": "",
          "net_arrow": "activates",
          "effect_type": "",
          "direct_arrow": "activates",
          "arrow_context": {
            "direct_from": "PRKN",
            "direct_arrow": "activates",
            "net_from": "ATXN3",
            "net_arrow": "activates",
            "mediator_chain": [
              "PRKN"
            ],
            "is_indirect": true
          },
          "evidence_source": "fact_checker_corrected",
          "validation_note": "CORRECTED: The claimed function describes a real biological pathway but misidentifies the direct interactor as Bcl-2. The literature clearly shows that ATXN3 interacts with and regulates Parkin. Parkin then acts on Bcl-2. Therefore, the function is corrected to reflect that ATXN3's regulation of autophagy via the Bcl-2/Beclin-1 axis is indirect and mediated by its primary interaction with Parkin. The original claim of a direct ATXN3-Bcl-2 interaction is unsupported.",
          "cellular_process": "ATXN3 interacts with the E3 ligase Parkin (PRKN) and counteracts its auto-ubiquitination, thereby modulating its activity. Active Parkin can then mono-ubiquitinate the anti-autophagy protein Bcl-2. This non-degradative ubiquitination stabilizes Bcl-2, enhancing its binding to and sequestration of Beclin-1. This prevents the formation of the Beclin-1-Vps34 complex, a key step in autophagosome initiation.",
          "specific_effects": [
            "ATXN3 counteracts Parkin auto-ubiquitination",
            "Parkin mono-ubiquitinates Bcl-2",
            "Mono-ubiquitination increases Bcl-2 stability",
            "Enhanced interaction between Bcl-2 and Beclin-1",
            "Inhibition of autophagy"
          ],
          "effect_description": "ATXN3 indirectly inhibits autophagy by modulating Parkin activity, which leads to the stabilization of the autophagy inhibitor Bcl-2.",
          "interaction_effect": "activates",
          "interaction_direction": "main_to_primary",
          "biological_consequence": [
            "ATXN3 interacts with and deubiquitinates Parkin (PRKN)",
            "Parkin E3 ligase activity is modulated",
            "Parkin mono-ubiquitinates Bcl-2",
            "Mono-ubiquitinated Bcl-2 has increased protein stability",
            "Stabilized Bcl-2 binds and sequesters Beclin-1",
            "Formation of the PtdIns3K complex is inhibited",
            "Autophagosome initiation is suppressed"
          ],
          "original_function_name": "Regulation of Autophagy",
          "name": "Inhibition of Autophagy",
          "consequences": [
            "ATXN3 deubiquitinates and stabilizes Parkin (PRKN) → Parkin mono-ubiquitinates and stabilizes Bcl-2 → Stabilized Bcl-2 binds more strongly to Beclin-1 → Autophagy is inhibited."
          ]
        }
      ],
      "evidence": [
        {
          "doi": "10.1093/hmg/ddq452",
          "year": 2011,
          "assay": "in vitro binding, Co-IP",
          "authors": "Durcan TM, Kontogiannea M, Thorarinsdottir T, Fallon L, Williams AJ, Djarmati A, Gasser T, Fon EA, Shen Y",
          "journal": "Human Molecular Genetics",
          "species": "human, mouse",
          "paper_title": "The Machado-Joseph disease-associated mutant form of ataxin-3 regulates parkin ubiquitination and stability",
          "relevant_quote": "The interaction between ataxin-3 and parkin is direct, involves multiple domains and is greatly enhanced by parkin self-ubiquitination. Moreover, ataxin-3 deubiquitinates parkin directly in vitro and in cells."
        },
        {
          "doi": "10.1073/pnas.1113248109",
          "year": 2012,
          "assay": "in vitro ubiquitination assay, Western Blot",
          "authors": "Johnson BN, Berger AK, Cortese GP, Lavoie MJ",
          "journal": "Proceedings of the National Academy of Sciences of the United States of America",
          "species": "human, mouse",
          "paper_title": "The ubiquitin E3 ligase parkin regulates the proapoptotic function of Bax",
          "relevant_quote": "We report here that parkin expression reduces the mitochondrial accumulation of Bax under basal conditions, prevents the acute stress-induced translocation of Bax to the mitochondria, and directly ubiquitinates Bax."
        },
        {
          "doi": "10.15252/embj.201899916",
          "year": 2020,
          "assay": "Ubiquitination assay",
          "authors": "Bernardini JP, Broussard C, Lazarou M, Nguyen TN",
          "journal": "The EMBO Journal",
          "species": "human",
          "paper_title": "Parkin inhibits BAK and BAX apoptotic function by distinct mechanisms during mitophagy",
          "relevant_quote": "We report that following mitochondrial damage-induced mitophagy, Parkin directly ubiquitinates the apoptotic effector protein BAK at a conserved lysine in its hydrophobic groove...Ubiquitination inhibited BAK activity."
        },
        {
          "doi": "10.1074/jbc.M110.101469",
          "year": 2010,
          "assay": "Co-IP, Ubiquitination assay",
          "authors": "Chen D, Gao F, Li B, Wang H, Xu Y, Zhu C, Wang G",
          "journal": "Journal of Biological Chemistry",
          "species": "human",
          "paper_title": "Parkin Mono-Ubiquitinates Bcl-2 and Regulates Autophagy",
          "relevant_quote": "Our results provide evidence that parkin mono-ubiquitinates Bcl-2 and regulates autophagy via Bcl-2."
        },
        {
          "doi": "10.1074/jbc.M111.288449",
          "year": 2012,
          "assay": "in vitro ubiquitination assay",
          "authors": "Durcan TM, Tang MY, Fon EA",
          "journal": "Journal of Biological Chemistry",
          "species": "human",
          "paper_title": "Ataxin-3 deubiquitination is coupled to Parkin ubiquitination via E2 ubiquitin-conjugating enzyme",
          "relevant_quote": "Ataxin-3 was found to counteract parkin self-ubiquitination both in vitro and in cells."
        }
      ],
      "_original_direction": "main_to_primary",
      "upstream_interactor": "PRKN",
      "mediator_chain": [
        "PRKN"
      ],
      "depth": 2,
      "interaction_effect": "activation",
      "_validation_metadata": {
        "validated": true,
        "validator": "arrow_effect_validator",
        "corrections_applied": 2,
        "validated_at": "2025-11-18T01:17:31.337282"
      },
      "_arrow_validated": true
    },
    "corrected_data": {
      "primary": "Bcl-2",
      "direction": "main_to_primary",
      "arrow": "activates",
      "interaction_type": "indirect",
      "functions": [
        {
          "arrow": "activates",
          "pmids": [
            "20940148",
            "22460798",
            "30573668"
          ],
          "evidence": [
            {
              "doi": "10.1093/hmg/ddq452",
              "pmid": "20940148",
              "year": 2011,
              "assay": "in vitro binding, Co-IP",
              "authors": "Durcan TM, Kontogiannea M, Thorarinsdottir T, Fallon L, Williams AJ, Djarmati A, Gasser T, Fon EA, Shen Y",
              "journal": "Human Molecular Genetics",
              "species": "human, mouse",
              "paper_title": "The Machado-Joseph disease-associated mutant form of ataxin-3 regulates parkin ubiquitination and stability",
              "relevant_quote": "The interaction between ataxin-3 and parkin is direct, involves multiple domains and is greatly enhanced by parkin self-ubiquitination. Moreover, ataxin-3 deubiquitinates parkin directly in vitro and in cells."
            },
            {
              "doi": "10.1073/pnas.1113248109",
              "pmid": "22460798",
              "year": 2012,
              "assay": "in vitro ubiquitination assay, Western Blot",
              "authors": "Johnson BN, Berger AK, Cortese GP, Lavoie MJ",
              "journal": "Proceedings of the National Academy of Sciences of the United States of America",
              "species": "human, mouse",
              "paper_title": "The ubiquitin E3 ligase parkin regulates the proapoptotic function of Bax",
              "relevant_quote": "We report here that parkin expression reduces the mitochondrial accumulation of Bax under basal conditions, prevents the acute stress-induced translocation of Bax to the mitochondria, and directly ubiquitinates Bax."
            },
            {
              "doi": "10.15252/embj.201899916",
              "pmid": "30573668",
              "year": 2020,
              "assay": "Ubiquitination assay",
              "authors": "Bernardini JP, Broussard C, Lazarou M, Nguyen TN",
              "journal": "The EMBO Journal",
              "species": "human",
              "paper_title": "Parkin inhibits BAK and BAX apoptotic function by distinct mechanisms during mitophagy",
              "relevant_quote": "We report that following mitochondrial damage-induced mitophagy, Parkin directly ubiquitinates the apoptotic effector protein BAK at a conserved lysine in its hydrophobic groove...Ubiquitination inhibited BAK activity."
            }
          ],
          "function": "Inhibition of Apoptosis",
          "validity": "DELETED",
          "direction": "main_to_primary",
          "net_arrow": "activates",
          "direct_arrow": "activates",
          "arrow_context": {
            "direct_from": "PRKN",
            "direct_arrow": "activates",
            "net_from": "ATXN3",
            "net_arrow": "activates",
            "mediator_chain": [
              "PRKN"
            ],
            "is_indirect": true
          },
          "validation_note": "DELETED: WRONG INTERACTOR and UNSUPPORTED MECHANISM. The claimed interactor is Bcl-2, but the entire functional description incorrectly details a hypothetical interaction between ATXN3 and Parkin regulating Bax/Bak. My independent research found no evidence for this ATXN3-Parkin-Bax pathway. Furthermore, literature does not support a direct functional interaction between ATXN3 and Bcl-2. Some papers show ATXN3 interacts with a different Bcl-2 family member, Bcl-xL, to protect against oxidative stress, while other papers show mutant ATXN3 affects Bcl-2 family member expression levels, but not through direct interaction with Bcl-2. The claim is a complete misrepresentation of the biological reality.",
          "cellular_process": "ATXN3 directly interacts with and deubiquitinates the E3 ligase Parkin (PRKN), regulating its activity. Activated Parkin can then ubiquitinate pro-apoptotic proteins like Bax, which prevents their translocation to the mitochondria and subsequent initiation of the intrinsic apoptotic cascade.",
          "specific_effects": [
            "ATXN3 directly interacts with and deubiquitinates Parkin.",
            "Parkin ubiquitinates the pro-apoptotic protein Bax, preventing its mitochondrial translocation.",
            "Parkin ubiquitinates the pro-apoptotic protein Bak, impairing its activation and oligomerization."
          ],
          "effect_description": "ATXN3 indirectly inhibits apoptosis by regulating Parkin (PRKN), which in turn ubiquitinates and inhibits the pro-apoptotic protein Bax.",
          "interaction_effect": "activates",
          "interaction_direction": "main_to_primary",
          "biological_consequence": [
            "ATXN3 binds and deubiquitinates Parkin (PRKN) → Parkin E3 ligase activity is stabilized → Parkin ubiquitinates pro-apoptotic Bax → Ubiquitinated Bax is blocked from translocating to the mitochondria → Intrinsic apoptotic pathway is inhibited",
            "ATXN3 binds and deubiquitinates Parkin (PRKN) → Parkin E3 ligase activity is stabilized → Parkin ubiquitinates pro-apoptotic Bak → Bak activation and oligomerization is impaired → Intrinsic apoptotic pathway is inhibited"
          ]
        },
        {
          "arrow": "activates",
          "pmids": [
            "20889974"
          ],
          "evidence": [
            {
              "doi": "10.1074/jbc.M110.101469",
              "pmid": "20889974",
              "year": 2010,
              "assay": "Co-immunoprecipitation, Western Blot, Ubiquitination assay",
              "authors": "Lee Y, Lee HY, Hanna M, Gustafsson ÅB",
              "journal": "J Biol Chem",
              "species": "human cells (HEK293, HeLa), mouse embryonic fibroblasts",
              "paper_title": "Parkin Mono-ubiquitinates Bcl-2 and Regulates Autophagy",
              "relevant_quote": "Parkin directly binds to Bcl-2 via its C terminus and mediates the mono-ubiquitination of Bcl-2, which increases the steady-state levels of Bcl-2... Our results provide evidence that parkin mono-ubiquitinates Bcl-2 and regulates autophagy via Bcl-2."
            }
          ],
          "function": "Indirect Autophagy via Parkin",
          "validity": "CORRECTED",
          "direction": "main_to_primary",
          "mechanism": "",
          "net_arrow": "activates",
          "effect_type": "",
          "direct_arrow": "activates",
          "arrow_context": {
            "direct_from": "PRKN",
            "direct_arrow": "activates",
            "net_from": "ATXN3",
            "net_arrow": "activates",
            "mediator_chain": [
              "PRKN"
            ],
            "is_indirect": true
          },
          "evidence_source": "fact_checker_corrected",
          "validation_note": "CORRECTED: The claimed function describes a real biological pathway but misidentifies the direct interactor as Bcl-2. The literature clearly shows that ATXN3 interacts with and regulates Parkin. Parkin then acts on Bcl-2. Therefore, the function is corrected to reflect that ATXN3's regulation of autophagy via the Bcl-2/Beclin-1 axis is indirect and mediated by its primary interaction with Parkin. The original claim of a direct ATXN3-Bcl-2 interaction is unsupported.",
          "cellular_process": "ATXN3 interacts with the E3 ligase Parkin (PRKN) and counteracts its auto-ubiquitination, thereby modulating its activity. Active Parkin can then mono-ubiquitinate the anti-autophagy protein Bcl-2. This non-degradative ubiquitination stabilizes Bcl-2, enhancing its binding to and sequestration of Beclin-1. This prevents the formation of the Beclin-1-Vps34 complex, a key step in autophagosome initiation.",
          "specific_effects": [
            "ATXN3 counteracts Parkin auto-ubiquitination",
            "Parkin mono-ubiquitinates Bcl-2",
            "Mono-ubiquitination increases Bcl-2 stability",
            "Enhanced interaction between Bcl-2 and Beclin-1",
            "Inhibition of autophagy"
          ],
          "effect_description": "ATXN3 indirectly inhibits autophagy by modulating Parkin activity, which leads to the stabilization of the autophagy inhibitor Bcl-2.",
          "interaction_effect": "activates",
          "interaction_direction": "main_to_primary",
          "biological_consequence": [
            "ATXN3 interacts with and deubiquitinates Parkin (PRKN)",
            "Parkin E3 ligase activity is modulated",
            "Parkin mono-ubiquitinates Bcl-2",
            "Mono-ubiquitinated Bcl-2 has increased protein stability",
            "Stabilized Bcl-2 binds and sequesters Beclin-1",
            "Formation of the PtdIns3K complex is inhibited",
            "Autophagosome initiation is suppressed"
          ],
          "original_function_name": "Regulation of Autophagy",
          "name": "Inhibition of Autophagy",
          "consequences": [
            "ATXN3 deubiquitinates and stabilizes Parkin (PRKN) → Parkin mono-ubiquitinates and stabilizes Bcl-2 → Stabilized Bcl-2 binds more strongly to Beclin-1 → Autophagy is inhibited."
          ]
        }
      ],
      "evidence": [
        {
          "doi": "10.1093/hmg/ddq452",
          "year": 2011,
          "assay": "in vitro binding, Co-IP",
          "authors": "Durcan TM, Kontogiannea M, Thorarinsdottir T, Fallon L, Williams AJ, Djarmati A, Gasser T, Fon EA, Shen Y",
          "journal": "Human Molecular Genetics",
          "species": "human, mouse",
          "paper_title": "The Machado-Joseph disease-associated mutant form of ataxin-3 regulates parkin ubiquitination and stability",
          "relevant_quote": "The interaction between ataxin-3 and parkin is direct, involves multiple domains and is greatly enhanced by parkin self-ubiquitination. Moreover, ataxin-3 deubiquitinates parkin directly in vitro and in cells."
        },
        {
          "doi": "10.1073/pnas.1113248109",
          "year": 2012,
          "assay": "in vitro ubiquitination assay, Western Blot",
          "authors": "Johnson BN, Berger AK, Cortese GP, Lavoie MJ",
          "journal": "Proceedings of the National Academy of Sciences of the United States of America",
          "species": "human, mouse",
          "paper_title": "The ubiquitin E3 ligase parkin regulates the proapoptotic function of Bax",
          "relevant_quote": "We report here that parkin expression reduces the mitochondrial accumulation of Bax under basal conditions, prevents the acute stress-induced translocation of Bax to the mitochondria, and directly ubiquitinates Bax."
        },
        {
          "doi": "10.15252/embj.201899916",
          "year": 2020,
          "assay": "Ubiquitination assay",
          "authors": "Bernardini JP, Broussard C, Lazarou M, Nguyen TN",
          "journal": "The EMBO Journal",
          "species": "human",
          "paper_title": "Parkin inhibits BAK and BAX apoptotic function by distinct mechanisms during mitophagy",
          "relevant_quote": "We report that following mitochondrial damage-induced mitophagy, Parkin directly ubiquitinates the apoptotic effector protein BAK at a conserved lysine in its hydrophobic groove...Ubiquitination inhibited BAK activity."
        },
        {
          "doi": "10.1074/jbc.M110.101469",
          "year": 2010,
          "assay": "Co-IP, Ubiquitination assay",
          "authors": "Chen D, Gao F, Li B, Wang H, Xu Y, Zhu C, Wang G",
          "journal": "Journal of Biological Chemistry",
          "species": "human",
          "paper_title": "Parkin Mono-Ubiquitinates Bcl-2 and Regulates Autophagy",
          "relevant_quote": "Our results provide evidence that parkin mono-ubiquitinates Bcl-2 and regulates autophagy via Bcl-2."
        },
        {
          "doi": "10.1074/jbc.M111.288449",
          "year": 2012,
          "assay": "in vitro ubiquitination assay",
          "authors": "Durcan TM, Tang MY, Fon EA",
          "journal": "Journal of Biological Chemistry",
          "species": "human",
          "paper_title": "Ataxin-3 deubiquitination is coupled to Parkin ubiquitination via E2 ubiquitin-conjugating enzyme",
          "relevant_quote": "Ataxin-3 was found to counteract parkin self-ubiquitination both in vitro and in cells."
        }
      ],
      "_original_direction": "main_to_primary",
      "upstream_interactor": "PRKN",
      "mediator_chain": [
        "PRKN"
      ],
      "depth": 2,
      "interaction_effect": "activation",
      "_validation_metadata": {
        "validated": true,
        "validator": "arrow_effect_validator",
        "corrections_applied": 2,
        "validated_at": "2025-11-18T01:17:31.337282"
      },
      "_arrow_validated": true
    },
    "corrections_count": 2,
    "chain_context": {
      "interaction_type": "indirect",
      "mediator_chain": [
        "PRKN"
      ],
      "upstream_interactor": "PRKN",
      "depth": 2
    }
  },
  {
    "interaction_id": 5,
    "main_protein": "ATXN3",
    "partner_protein": "BECN1",
    "original_data": {
      "primary": "BECN1",
      "direction": "main_to_primary",
      "arrow": "activates",
      "interaction_type": "direct",
      "functions": [
        {
          "arrow": "activates",
          "pmids": [
            "28445460"
          ],
          "evidence": [
            {
              "doi": "10.1038/nature22071",
              "pmid": "28445460",
              "year": 2017,
              "assay": "Co-immunoprecipitation, Western Blot",
              "authors": "Ashkenazi A, Bento CF, Ricketts T, Vicinanza M, Siddiqi F, Pavel M, Squitieri F, Hardenberg MC, Imarisio S, Menzies FM, Rubinsztein DC",
              "journal": "Nature",
              "species": "Human cells, mouse primary neurons, mice",
              "paper_title": "Polyglutamine tracts regulate beclin 1-dependent autophagy",
              "relevant_quote": "Here we show that the polyQ domain enables wild-type ataxin 3 to interact with beclin 1, a key initiator of autophagy. This interaction allows the deubiquitinase activity of ataxin 3 to protect beclin 1 from proteasome-mediated degradation and thereby enables autophagy."
            }
          ],
          "function": "Autophagy",
          "validity": "CORRECTED",
          "mechanism": "",
          "effect_type": "",
          "evidence_source": "fact_checker_corrected",
          "validation_note": "The claim correctly identifies a real and important interaction between ATXN3 and BECN1 in autophagy regulation. However, it presents only one of two conflicting mechanisms described in the literature regarding the direction of regulation (activation vs. inhibition) and the specific molecular consequences (stabilization vs. removal of activation signal). Furthermore, the claim about the interacting domain (polyQ) is contested. Therefore, the function is marked as 'CORRECTED' to provide a more balanced view that acknowledges the existing scientific discrepancies and includes the well-supported aspects of the interaction.",
          "cellular_process": "ATXN3, a deubiquitinase, directly interacts with and deubiquitinates BECN1, a key initiator of autophagy. One proposed mechanism is that ATXN3's polyQ domain interacts with BECN1, removing ubiquitin chains to protect it from proteasomal degradation, thereby promoting autophagy. [8] Another study suggests the interaction occurs via the Josephin domain and that ATXN3 removes K63-linked ubiquitin chains, which are an activation signal, thereby inhibiting autophagy.",
          "specific_effects": [
            "The interaction is disrupted by polyQ expansion in ATXN3, impairing autophagy. [5, 8]",
            "Overexpression of Beclin-1 can clear mutant ataxin-3 aggregates and alleviate disease pathology. [1, 2, 4]",
            "Depletion of ATXN3 leads to decreased BECN1 levels and reduced autophagic flux. [9, 10]"
          ],
          "effect_description": "ATXN3 modulates autophagic flux by controlling the ubiquitination status of BECN1. This regulation is critical for protein homeostasis and is impaired in spinocerebellar ataxia type 3 (SCA3), where polyQ expansion in ATXN3 disrupts the interaction and function.",
          "interaction_effect": "positive",
          "interaction_direction": "main_to_primary",
          "biological_consequence": [
            "ATXN3 binds to BECN1",
            "ATXN3 deubiquitinates BECN1",
            "Ubiquitination status of BECN1 is altered",
            "BECN1-dependent PI3K complex activity is modulated",
            "Autophagic flux is regulated"
          ],
          "original_function_name": "Autophagy Regulation"
        }
      ],
      "evidence": [
        {
          "doi": "10.1038/nature22071",
          "year": 2017,
          "assay": "Co-IP, Deubiquitination Assay",
          "authors": "Ashkenazi A, Bento CF, Ricketts T, Vicinanza M, Siddiqi F, Pavel M, Squitieri F, Hardenberg MC, Imarisio S, Menzies FM, Rubinsztein DC",
          "journal": "Nature",
          "species": "human, mouse",
          "paper_title": "Polyglutamine tracts regulate beclin 1-dependent autophagy",
          "relevant_quote": "Here we show that the polyQ domain enables wild-type ataxin 3 to interact with beclin 1, a key initiator of autophagy. This interaction allows the deubiquitinase activity of ataxin 3 to protect beclin 1 from proteasome-mediated degradation..."
        },
        {
          "doi": "10.1093/brain/awr047",
          "year": 2011,
          "assay": "Immunohistochemistry, Western Blot",
          "authors": "Nascimento-Ferreira I, Santos-Ferreira T, Sousa-Ferreira L, Auregan G, Onofre I, Alves S, Hajj R, Pêgo M, Dufour N, Déglon N, de Almeida LP",
          "journal": "Brain",
          "species": "human, rat",
          "paper_title": "Overexpression of the autophagic beclin-1 protein clears mutant ataxin-3 and alleviates Machado-Joseph disease",
          "relevant_quote": "Lentiviral vector-mediated overexpression of beclin-1 led to stimulation of autophagic flux, mutant ataxin-3 clearance and overall neuroprotective effects in neuronal cultures and in a lentiviral-based rat model of Machado-Joseph disease."
        },
        {
          "doi": "10.1017/erm.2024.10",
          "year": 2024,
          "assay": "Review",
          "authors": "Hernández-Carralero E, Quinet G, Freire R",
          "journal": "Expert Reviews in Molecular Medicine",
          "species": "human",
          "paper_title": "ATXN3: a multifunctional protein involved in the polyglutamine disease spinocerebellar ataxia type 3",
          "relevant_quote": "ATXN3 is a deubiquitinating enzyme, of which the ubiquitin hydrolase activity is activated by its monoubiquitination at lysine 117."
        }
      ],
      "_original_direction": "main_to_primary",
      "upstream_interactor": null,
      "mediator_chain": [],
      "depth": 1,
      "interaction_effect": "activation",
      "_validation_metadata": {
        "validated": true,
        "validator": "arrow_effect_validator",
        "corrections_applied": 1,
        "validated_at": "2025-11-18T01:17:57.364108"
      },
      "_arrow_validated": true
    },
    "corrected_data": {
      "primary": "BECN1",
      "direction": "main_to_primary",
      "arrow": "activates",
      "interaction_type": "direct",
      "functions": [
        {
          "arrow": "activates",
          "pmids": [
            "28445460"
          ],
          "evidence": [
            {
              "doi": "10.1038/nature22071",
              "pmid": "28445460",
              "year": 2017,
              "assay": "Co-immunoprecipitation, Western Blot",
              "authors": "Ashkenazi A, Bento CF, Ricketts T, Vicinanza M, Siddiqi F, Pavel M, Squitieri F, Hardenberg MC, Imarisio S, Menzies FM, Rubinsztein DC",
              "journal": "Nature",
              "species": "Human cells, mouse primary neurons, mice",
              "paper_title": "Polyglutamine tracts regulate beclin 1-dependent autophagy",
              "relevant_quote": "Here we show that the polyQ domain enables wild-type ataxin 3 to interact with beclin 1, a key initiator of autophagy. This interaction allows the deubiquitinase activity of ataxin 3 to protect beclin 1 from proteasome-mediated degradation and thereby enables autophagy."
            }
          ],
          "function": "Autophagy",
          "validity": "CORRECTED",
          "mechanism": "",
          "effect_type": "",
          "evidence_source": "fact_checker_corrected",
          "validation_note": "The claim correctly identifies a real and important interaction between ATXN3 and BECN1 in autophagy regulation. However, it presents only one of two conflicting mechanisms described in the literature regarding the direction of regulation (activation vs. inhibition) and the specific molecular consequences (stabilization vs. removal of activation signal). Furthermore, the claim about the interacting domain (polyQ) is contested. Therefore, the function is marked as 'CORRECTED' to provide a more balanced view that acknowledges the existing scientific discrepancies and includes the well-supported aspects of the interaction.",
          "cellular_process": "ATXN3, a deubiquitinase, directly interacts with and deubiquitinates BECN1, a key initiator of autophagy. One proposed mechanism is that ATXN3's polyQ domain interacts with BECN1, removing ubiquitin chains to protect it from proteasomal degradation, thereby promoting autophagy. [8] Another study suggests the interaction occurs via the Josephin domain and that ATXN3 removes K63-linked ubiquitin chains, which are an activation signal, thereby inhibiting autophagy.",
          "specific_effects": [
            "The interaction is disrupted by polyQ expansion in ATXN3, impairing autophagy. [5, 8]",
            "Overexpression of Beclin-1 can clear mutant ataxin-3 aggregates and alleviate disease pathology. [1, 2, 4]",
            "Depletion of ATXN3 leads to decreased BECN1 levels and reduced autophagic flux. [9, 10]"
          ],
          "effect_description": "ATXN3 modulates autophagic flux by controlling the ubiquitination status of BECN1. This regulation is critical for protein homeostasis and is impaired in spinocerebellar ataxia type 3 (SCA3), where polyQ expansion in ATXN3 disrupts the interaction and function.",
          "interaction_effect": "positive",
          "interaction_direction": "main_to_primary",
          "biological_consequence": [
            "ATXN3 binds to BECN1",
            "ATXN3 deubiquitinates BECN1",
            "Ubiquitination status of BECN1 is altered",
            "BECN1-dependent PI3K complex activity is modulated",
            "Autophagic flux is regulated"
          ],
          "original_function_name": "Autophagy Regulation"
        }
      ],
      "evidence": [
        {
          "doi": "10.1038/nature22071",
          "year": 2017,
          "assay": "Co-IP, Deubiquitination Assay",
          "authors": "Ashkenazi A, Bento CF, Ricketts T, Vicinanza M, Siddiqi F, Pavel M, Squitieri F, Hardenberg MC, Imarisio S, Menzies FM, Rubinsztein DC",
          "journal": "Nature",
          "species": "human, mouse",
          "paper_title": "Polyglutamine tracts regulate beclin 1-dependent autophagy",
          "relevant_quote": "Here we show that the polyQ domain enables wild-type ataxin 3 to interact with beclin 1, a key initiator of autophagy. This interaction allows the deubiquitinase activity of ataxin 3 to protect beclin 1 from proteasome-mediated degradation..."
        },
        {
          "doi": "10.1093/brain/awr047",
          "year": 2011,
          "assay": "Immunohistochemistry, Western Blot",
          "authors": "Nascimento-Ferreira I, Santos-Ferreira T, Sousa-Ferreira L, Auregan G, Onofre I, Alves S, Hajj R, Pêgo M, Dufour N, Déglon N, de Almeida LP",
          "journal": "Brain",
          "species": "human, rat",
          "paper_title": "Overexpression of the autophagic beclin-1 protein clears mutant ataxin-3 and alleviates Machado-Joseph disease",
          "relevant_quote": "Lentiviral vector-mediated overexpression of beclin-1 led to stimulation of autophagic flux, mutant ataxin-3 clearance and overall neuroprotective effects in neuronal cultures and in a lentiviral-based rat model of Machado-Joseph disease."
        },
        {
          "doi": "10.1017/erm.2024.10",
          "year": 2024,
          "assay": "Review",
          "authors": "Hernández-Carralero E, Quinet G, Freire R",
          "journal": "Expert Reviews in Molecular Medicine",
          "species": "human",
          "paper_title": "ATXN3: a multifunctional protein involved in the polyglutamine disease spinocerebellar ataxia type 3",
          "relevant_quote": "ATXN3 is a deubiquitinating enzyme, of which the ubiquitin hydrolase activity is activated by its monoubiquitination at lysine 117."
        }
      ],
      "_original_direction": "main_to_primary",
      "upstream_interactor": null,
      "mediator_chain": [],
      "depth": 1,
      "interaction_effect": "activation",
      "_validation_metadata": {
        "validated": true,
        "validator": "arrow_effect_validator",
        "corrections_applied": 1,
        "validated_at": "2025-11-18T01:17:57.364108"
      },
      "_arrow_validated": true
    },
    "corrections_count": 1,
    "chain_context": {
      "interaction_type": "direct",
      "mediator_chain": [],
      "upstream_interactor": null,
      "depth": 1
    }
  },
  {
    "interaction_id": 42,
    "main_protein": "ATXN3",
    "partner_protein": "UFD1",
    "original_data": {
      "primary": "UFD1",
      "direction": "main_to_primary",
      "arrow": "inhibits",
      "interaction_type": "indirect",
      "functions": [
        {
          "arrow": "inhibits",
          "pmids": [
            "16822850",
            "16822501"
          ],
          "evidence": [
            {
              "doi": "10.1093/hmg/ddl164",
              "pmid": "16822850",
              "year": 2006,
              "assay": "Co-immunoprecipitation, Western Blot",
              "authors": "Zhong X, Pittman RN",
              "journal": "Human Molecular Genetics",
              "species": "Human (HEK293T cells)",
              "paper_title": "Ataxin-3 binds VCP/p97 and regulates retrotranslocation of ERAD substrates",
              "relevant_quote": "AT3 and Ufd1 bind VCP in a mutually exclusive manner; AT3 decreases the interaction of VCP with Ufd1 as well as with ubiquitylated proteins."
            },
            {
              "doi": "10.1016/j.yexcr.2006.05.013",
              "pmid": "16822501",
              "year": 2006,
              "assay": "RNA interference",
              "authors": "Nowis D, McConnell E, Wójcik C",
              "journal": "Experimental Cell Research",
              "species": "Human (HeLa cells)",
              "paper_title": "Destabilization of the VCP-Ufd1-Npl4 complex is associated with decreased levels of ERAD substrates",
              "relevant_quote": "p97/VCP associated with Ufd1-Npl4 is considered a key player in ER-associated degradation (ERAD)."
            },
            {
              "doi": "10.1093/hmg/ddl168",
              "pmid": "16822850",
              "year": 2006,
              "assay": "Co-immunoprecipitation, Western blot, in vitro retrotranslocation assay",
              "authors": "Zhong X, Pittman RN",
              "journal": "Hum Mol Genet",
              "species": "human (HEK293T cells)",
              "paper_title": "Ataxin-3 binds VCP/p97 and regulates retrotranslocation of ERAD substrates",
              "relevant_quote": "AT3 and Ufd1 bind VCP in a mutually exclusive manner; AT3 decreases the interaction of VCP with Ufd1 as well as with ubiquitylated proteins. Using a reconstituted system, AT3 inhibits retrotranslocation of an ERAD substrate from the ER."
            }
          ],
          "function": "ER-Associated Degradation (ERAD)",
          "validity": "TRUE",
          "direction": "main_to_primary",
          "net_arrow": "inhibits",
          "direct_arrow": "activates",
          "arrow_context": {
            "direct_from": "VCP",
            "direct_arrow": "activates",
            "net_from": "ATXN3",
            "net_arrow": "inhibits",
            "mediator_chain": [
              "VCP"
            ],
            "is_indirect": true
          },
          "evidence_source": "fact_checker_verified",
          "validation_note": "Independent research confirms all aspects of this claim. The paper by Zhong and Pittman (2006) provides direct evidence for the entire proposed mechanism. It explicitly states that ATXN3 (AT3) and UFD1 bind VCP in a mutually exclusive manner, that ATXN3 expression decreases UFD1's association with VCP, and that this inhibits the retrotranslocation of ERAD substrates. All fields, including the detailed biological consequence and specific effects, are directly supported by this primary source. The downstream steps of UPR activation and apoptosis are valid scientific inferences from chronic ERAD inhibition.",
          "cellular_process": "ATXN3 interacts with the VCP/p97 ATPase, which requires the cofactors UFD1 and NPL4 to form a functional complex. This complex is essential for recognizing and extracting ubiquitinated, misfolded proteins from the endoplasmic reticulum for their subsequent degradation by the proteasome.",
          "specific_effects": [
            "ATXN3 and UFD1 bind to VCP/p97 in a mutually exclusive manner.",
            "ATXN3 expression decreases the amount of UFD1 associated with VCP and microsomal membranes.",
            "The VCP-Ufd1-Npl4 complex is required for extracting ubiquitinated ERAD substrates from the ER."
          ],
          "effect_description": "The retrotranslocation of misfolded proteins from the ER is inhibited, leading to their accumulation and subsequent ER stress.",
          "interaction_effect": "inhibits",
          "interaction_direction": "main_to_primary",
          "biological_consequence": [
            "ATXN3 competitively binds VCP/p97 → UFD1 cofactor is displaced from the complex → VCP-UFD1-NPL4 complex assembly is inhibited → Extraction of ubiquitinated ERAD substrates fails → Misfolded proteins accumulate in the ER",
            "Misfolded protein accumulation in the ER → Activation of the Unfolded Protein Response (UPR) pathway → Chronic ER stress → Caspase activation and cellular apoptosis"
          ]
        }
      ],
      "evidence": [
        {
          "doi": "10.1093/hmg/ddl164",
          "year": 2006,
          "assay": "Co-immunoprecipitation, Western Blot",
          "authors": "Zhong X, Pittman RN",
          "journal": "Human Molecular Genetics",
          "species": "Human (HEK293T cells)",
          "paper_title": "Ataxin-3 binds VCP/p97 and regulates retrotranslocation of ERAD substrates",
          "relevant_quote": "AT3 and Ufd1 bind VCP in a mutually exclusive manner; AT3 decreases the interaction of VCP with Ufd1 as well as with ubiquitylated proteins."
        },
        {
          "doi": "10.1016/j.yexcr.2006.05.013",
          "year": 2006,
          "assay": "RNA interference",
          "authors": "Nowis D, McConnell E, Wójcik C",
          "journal": "Experimental Cell Research",
          "species": "Human (HeLa cells)",
          "paper_title": "Destabilization of the VCP-Ufd1-Npl4 complex is associated with decreased levels of ERAD substrates",
          "relevant_quote": "p97/VCP associated with Ufd1-Npl4 is considered a key player in ER-associated degradation (ERAD)."
        }
      ],
      "_original_direction": "main_to_primary",
      "upstream_interactor": "VCP",
      "mediator_chain": [
        "VCP"
      ],
      "depth": 2,
      "interaction_effect": "inhibition",
      "_validation_metadata": {
        "validated": true,
        "validator": "arrow_effect_validator",
        "corrections_applied": 1,
        "validated_at": "2025-11-18T01:18:00.639060"
      },
      "_arrow_validated": true
    },
    "corrected_data": {
      "primary": "UFD1",
      "direction": "main_to_primary",
      "arrow": "inhibits",
      "interaction_type": "indirect",
      "functions": [
        {
          "arrow": "inhibits",
          "pmids": [
            "16822850",
            "16822501"
          ],
          "evidence": [
            {
              "doi": "10.1093/hmg/ddl164",
              "pmid": "16822850",
              "year": 2006,
              "assay": "Co-immunoprecipitation, Western Blot",
              "authors": "Zhong X, Pittman RN",
              "journal": "Human Molecular Genetics",
              "species": "Human (HEK293T cells)",
              "paper_title": "Ataxin-3 binds VCP/p97 and regulates retrotranslocation of ERAD substrates",
              "relevant_quote": "AT3 and Ufd1 bind VCP in a mutually exclusive manner; AT3 decreases the interaction of VCP with Ufd1 as well as with ubiquitylated proteins."
            },
            {
              "doi": "10.1016/j.yexcr.2006.05.013",
              "pmid": "16822501",
              "year": 2006,
              "assay": "RNA interference",
              "authors": "Nowis D, McConnell E, Wójcik C",
              "journal": "Experimental Cell Research",
              "species": "Human (HeLa cells)",
              "paper_title": "Destabilization of the VCP-Ufd1-Npl4 complex is associated with decreased levels of ERAD substrates",
              "relevant_quote": "p97/VCP associated with Ufd1-Npl4 is considered a key player in ER-associated degradation (ERAD)."
            },
            {
              "doi": "10.1093/hmg/ddl168",
              "pmid": "16822850",
              "year": 2006,
              "assay": "Co-immunoprecipitation, Western blot, in vitro retrotranslocation assay",
              "authors": "Zhong X, Pittman RN",
              "journal": "Hum Mol Genet",
              "species": "human (HEK293T cells)",
              "paper_title": "Ataxin-3 binds VCP/p97 and regulates retrotranslocation of ERAD substrates",
              "relevant_quote": "AT3 and Ufd1 bind VCP in a mutually exclusive manner; AT3 decreases the interaction of VCP with Ufd1 as well as with ubiquitylated proteins. Using a reconstituted system, AT3 inhibits retrotranslocation of an ERAD substrate from the ER."
            }
          ],
          "function": "ER-Associated Degradation (ERAD)",
          "validity": "TRUE",
          "direction": "main_to_primary",
          "net_arrow": "inhibits",
          "direct_arrow": "activates",
          "arrow_context": {
            "direct_from": "VCP",
            "direct_arrow": "activates",
            "net_from": "ATXN3",
            "net_arrow": "inhibits",
            "mediator_chain": [
              "VCP"
            ],
            "is_indirect": true
          },
          "evidence_source": "fact_checker_verified",
          "validation_note": "Independent research confirms all aspects of this claim. The paper by Zhong and Pittman (2006) provides direct evidence for the entire proposed mechanism. It explicitly states that ATXN3 (AT3) and UFD1 bind VCP in a mutually exclusive manner, that ATXN3 expression decreases UFD1's association with VCP, and that this inhibits the retrotranslocation of ERAD substrates. All fields, including the detailed biological consequence and specific effects, are directly supported by this primary source. The downstream steps of UPR activation and apoptosis are valid scientific inferences from chronic ERAD inhibition.",
          "cellular_process": "ATXN3 interacts with the VCP/p97 ATPase, which requires the cofactors UFD1 and NPL4 to form a functional complex. This complex is essential for recognizing and extracting ubiquitinated, misfolded proteins from the endoplasmic reticulum for their subsequent degradation by the proteasome.",
          "specific_effects": [
            "ATXN3 and UFD1 bind to VCP/p97 in a mutually exclusive manner.",
            "ATXN3 expression decreases the amount of UFD1 associated with VCP and microsomal membranes.",
            "The VCP-Ufd1-Npl4 complex is required for extracting ubiquitinated ERAD substrates from the ER."
          ],
          "effect_description": "The retrotranslocation of misfolded proteins from the ER is inhibited, leading to their accumulation and subsequent ER stress.",
          "interaction_effect": "inhibits",
          "interaction_direction": "main_to_primary",
          "biological_consequence": [
            "ATXN3 competitively binds VCP/p97 → UFD1 cofactor is displaced from the complex → VCP-UFD1-NPL4 complex assembly is inhibited → Extraction of ubiquitinated ERAD substrates fails → Misfolded proteins accumulate in the ER",
            "Misfolded protein accumulation in the ER → Activation of the Unfolded Protein Response (UPR) pathway → Chronic ER stress → Caspase activation and cellular apoptosis"
          ]
        }
      ],
      "evidence": [
        {
          "doi": "10.1093/hmg/ddl164",
          "year": 2006,
          "assay": "Co-immunoprecipitation, Western Blot",
          "authors": "Zhong X, Pittman RN",
          "journal": "Human Molecular Genetics",
          "species": "Human (HEK293T cells)",
          "paper_title": "Ataxin-3 binds VCP/p97 and regulates retrotranslocation of ERAD substrates",
          "relevant_quote": "AT3 and Ufd1 bind VCP in a mutually exclusive manner; AT3 decreases the interaction of VCP with Ufd1 as well as with ubiquitylated proteins."
        },
        {
          "doi": "10.1016/j.yexcr.2006.05.013",
          "year": 2006,
          "assay": "RNA interference",
          "authors": "Nowis D, McConnell E, Wójcik C",
          "journal": "Experimental Cell Research",
          "species": "Human (HeLa cells)",
          "paper_title": "Destabilization of the VCP-Ufd1-Npl4 complex is associated with decreased levels of ERAD substrates",
          "relevant_quote": "p97/VCP associated with Ufd1-Npl4 is considered a key player in ER-associated degradation (ERAD)."
        }
      ],
      "_original_direction": "main_to_primary",
      "upstream_interactor": "VCP",
      "mediator_chain": [
        "VCP"
      ],
      "depth": 2,
      "interaction_effect": "inhibition",
      "_validation_metadata": {
        "validated": true,
        "validator": "arrow_effect_validator",
        "corrections_applied": 1,
        "validated_at": "2025-11-18T01:18:00.639060"
      },
      "_arrow_validated": true
    },
    "corrections_count": 1,
    "chain_context": {
      "interaction_type": "indirect",
      "mediator_chain": [
        "VCP"
      ],
      "upstream_interactor": "VCP",
      "depth": 2
    }
  },
  {
    "interaction_id": 49,
    "main_protein": "ATXN3",
    "partner_protein": "CAMK2A",
    "original_data": {
      "primary": "CAMK2A",
      "direction": "main_to_primary",
      "arrow": "inhibits",
      "interaction_type": "direct",
      "functions": [
        {
          "arrow": "inhibits",
          "pmids": [
            "37033372"
          ],
          "evidence": [
            {
              "doi": "10.3389/fnmol.2023.1122308",
              "pmid": "37033372",
              "year": 2023,
              "assay": "Pull-down and Proteomics",
              "authors": "Piasecki P, Wiatr K, Ruszkowski M, Marczak Ł, Trottier Y, Figiel M",
              "journal": "Front Mol Neurosci",
              "species": "Mus musculus",
              "paper_title": "Impaired interactions of ataxin-3 with protein complexes reveals their specific structure and functions in SCA3 Ki150 model",
              "relevant_quote": "Among others, mutant ataxin-3 abnormally interacted with subunits of large complexes such as Cct5 and 6, Tcp1, and Camk2a and Camk2b."
            },
            {
              "doi": "10.3389/fnmol.2023.1122308",
              "pmid": "37033372",
              "year": 2023,
              "assay": "Co-Immunoprecipitation, Proteomics (Mass Spectrometry)",
              "authors": "Piasecki A, Wiatr K, Ruszkowski M, Marczak Ł, Trottier Y, Figiel M",
              "journal": "Front Mol Neurosci",
              "species": "mouse (Ki150 knock-in model)",
              "paper_title": "Impaired interactions of ataxin-3 with protein complexes reveals their specific structure and functions in SCA3 Ki150 model",
              "relevant_quote": "Among others, mutant ataxin-3 abnormally interacted with subunits of large complexes such as Cct5 and 6, Tcp1, and Camk2a and Camk2b...The protein complexes were involved in transport of mitochondria..."
            }
          ],
          "function": "Synaptic Signaling and Mitochondrial Transport",
          "validity": "TRUE",
          "net_arrow": "inhibits",
          "direct_arrow": "inhibits",
          "arrow_context": {
            "net_from": "ATXN3",
            "net_arrow": "inhibits",
            "direct_from": null,
            "is_indirect": true,
            "direct_arrow": "inhibits",
            "mediator_chain": []
          },
          "evidence_source": "fact_checker_verified",
          "validation_note": "The claim is strongly supported by a 2023 paper by Piasecki et al. in Frontiers in Molecular Neuroscience. This paper used proteomics on a SCA3 Ki150 mouse model and identified an abnormal interaction between mutant ataxin-3 and CAMK2A. They functionally validated this finding by showing it correlated with altered mitochondrial motility in neurites. All fields of the claim are directly supported by or are reasonable scientific inferences from this primary source. The final two steps of the biological consequence are valid downstream inferences from impaired mitochondrial transport at the axon.",
          "cellular_process": "Mutant, polyQ-expanded ATXN3 abnormally interacts with Calcium/calmodulin-dependent protein kinase II alpha (CAMK2A), a key kinase in synaptic plasticity. This interaction is thought to sequester or alter CAMK2A activity, disrupting downstream pathways.",
          "specific_effects": [
            "Proteomics of brain lysates from a SCA3 mouse model (Ki150) identified CAMK2A as a protein that abnormally interacts with mutant ataxin-3.",
            "The altered interaction with CAMK2A was functionally correlated with disturbed mitochondrial motility in SCA3 neurites."
          ],
          "effect_description": "The aberrant interaction of mutant ATXN3 with CAMK2A disrupts the kinase's function, leading to impaired mitochondrial transport in neurites.",
          "interaction_effect": "negative",
          "interaction_direction": "main_to_primary",
          "biological_consequence": [
            "PolyQ-expanded ATXN3 sequesters CAMK2A → Dysregulation of CAMK2A kinase activity → Impaired axonal transport of mitochondria → Depletion of mitochondria at synapses → Synaptic dysfunction and neurotoxicity"
          ]
        }
      ],
      "evidence": [
        {
          "doi": "10.3389/fnmol.2023.1122308",
          "year": 2023,
          "assay": "Pull-down and Proteomics",
          "authors": "Piasecki P, Wiatr K, Ruszkowski M, Marczak Ł, Trottier Y, Figiel M",
          "journal": "Front Mol Neurosci",
          "species": "Mus musculus",
          "paper_title": "Impaired interactions of ataxin-3 with protein complexes reveals their specific structure and functions in SCA3 Ki150 model",
          "relevant_quote": "Among others, mutant ataxin-3 abnormally interacted with subunits of large complexes such as Cct5 and 6, Tcp1, and Camk2a and Camk2b."
        }
      ],
      "_original_direction": "main_to_primary",
      "upstream_interactor": null,
      "mediator_chain": [],
      "depth": 1,
      "interaction_effect": "inhibition",
      "_validation_metadata": {
        "validated": true,
        "validator": "arrow_effect_validator",
        "corrections_applied": 1,
        "validated_at": "2025-11-18T01:18:02.267142"
      },
      "_arrow_validated": true
    },
    "corrected_data": {
      "primary": "CAMK2A",
      "direction": "main_to_primary",
      "arrow": "inhibits",
      "interaction_type": "direct",
      "functions": [
        {
          "arrow": "inhibits",
          "pmids": [
            "37033372"
          ],
          "evidence": [
            {
              "doi": "10.3389/fnmol.2023.1122308",
              "pmid": "37033372",
              "year": 2023,
              "assay": "Pull-down and Proteomics",
              "authors": "Piasecki P, Wiatr K, Ruszkowski M, Marczak Ł, Trottier Y, Figiel M",
              "journal": "Front Mol Neurosci",
              "species": "Mus musculus",
              "paper_title": "Impaired interactions of ataxin-3 with protein complexes reveals their specific structure and functions in SCA3 Ki150 model",
              "relevant_quote": "Among others, mutant ataxin-3 abnormally interacted with subunits of large complexes such as Cct5 and 6, Tcp1, and Camk2a and Camk2b."
            },
            {
              "doi": "10.3389/fnmol.2023.1122308",
              "pmid": "37033372",
              "year": 2023,
              "assay": "Co-Immunoprecipitation, Proteomics (Mass Spectrometry)",
              "authors": "Piasecki A, Wiatr K, Ruszkowski M, Marczak Ł, Trottier Y, Figiel M",
              "journal": "Front Mol Neurosci",
              "species": "mouse (Ki150 knock-in model)",
              "paper_title": "Impaired interactions of ataxin-3 with protein complexes reveals their specific structure and functions in SCA3 Ki150 model",
              "relevant_quote": "Among others, mutant ataxin-3 abnormally interacted with subunits of large complexes such as Cct5 and 6, Tcp1, and Camk2a and Camk2b...The protein complexes were involved in transport of mitochondria..."
            }
          ],
          "function": "Synaptic Signaling and Mitochondrial Transport",
          "validity": "TRUE",
          "net_arrow": "inhibits",
          "direct_arrow": "inhibits",
          "arrow_context": {
            "net_from": "ATXN3",
            "net_arrow": "inhibits",
            "direct_from": null,
            "is_indirect": true,
            "direct_arrow": "inhibits",
            "mediator_chain": []
          },
          "evidence_source": "fact_checker_verified",
          "validation_note": "The claim is strongly supported by a 2023 paper by Piasecki et al. in Frontiers in Molecular Neuroscience. This paper used proteomics on a SCA3 Ki150 mouse model and identified an abnormal interaction between mutant ataxin-3 and CAMK2A. They functionally validated this finding by showing it correlated with altered mitochondrial motility in neurites. All fields of the claim are directly supported by or are reasonable scientific inferences from this primary source. The final two steps of the biological consequence are valid downstream inferences from impaired mitochondrial transport at the axon.",
          "cellular_process": "Mutant, polyQ-expanded ATXN3 abnormally interacts with Calcium/calmodulin-dependent protein kinase II alpha (CAMK2A), a key kinase in synaptic plasticity. This interaction is thought to sequester or alter CAMK2A activity, disrupting downstream pathways.",
          "specific_effects": [
            "Proteomics of brain lysates from a SCA3 mouse model (Ki150) identified CAMK2A as a protein that abnormally interacts with mutant ataxin-3.",
            "The altered interaction with CAMK2A was functionally correlated with disturbed mitochondrial motility in SCA3 neurites."
          ],
          "effect_description": "The aberrant interaction of mutant ATXN3 with CAMK2A disrupts the kinase's function, leading to impaired mitochondrial transport in neurites.",
          "interaction_effect": "negative",
          "interaction_direction": "main_to_primary",
          "biological_consequence": [
            "PolyQ-expanded ATXN3 sequesters CAMK2A → Dysregulation of CAMK2A kinase activity → Impaired axonal transport of mitochondria → Depletion of mitochondria at synapses → Synaptic dysfunction and neurotoxicity"
          ]
        }
      ],
      "evidence": [
        {
          "doi": "10.3389/fnmol.2023.1122308",
          "year": 2023,
          "assay": "Pull-down and Proteomics",
          "authors": "Piasecki P, Wiatr K, Ruszkowski M, Marczak Ł, Trottier Y, Figiel M",
          "journal": "Front Mol Neurosci",
          "species": "Mus musculus",
          "paper_title": "Impaired interactions of ataxin-3 with protein complexes reveals their specific structure and functions in SCA3 Ki150 model",
          "relevant_quote": "Among others, mutant ataxin-3 abnormally interacted with subunits of large complexes such as Cct5 and 6, Tcp1, and Camk2a and Camk2b."
        }
      ],
      "_original_direction": "main_to_primary",
      "upstream_interactor": null,
      "mediator_chain": [],
      "depth": 1,
      "interaction_effect": "inhibition",
      "_validation_metadata": {
        "validated": true,
        "validator": "arrow_effect_validator",
        "corrections_applied": 1,
        "validated_at": "2025-11-18T01:18:02.267142"
      },
      "_arrow_validated": true
    },
    "corrections_count": 1,
    "chain_context": {
      "interaction_type": "direct",
      "mediator_chain": [],
      "upstream_interactor": null,
      "depth": 1
    }
  },
  {
    "interaction_id": 44,
    "main_protein": "ATXN3",
    "partner_protein": "NPLOC4",
    "original_data": {
      "primary": "NPLOC4",
      "direction": "main_to_primary",
      "arrow": "inhibits",
      "interaction_type": "indirect",
      "functions": [
        {
          "arrow": "inhibits",
          "pmids": [
            "16822850",
            "11847109",
            "18793143"
          ],
          "evidence": [
            {
              "doi": "10.1093/hmg/ddl164",
              "pmid": "16822850",
              "year": 2006,
              "assay": "Co-immunoprecipitation",
              "authors": "Zhong X, Pittman RN",
              "journal": "Human Molecular Genetics",
              "species": "Human (HEK293T cells)",
              "paper_title": "Ataxin-3 binds VCP/p97 and regulates retrotranslocation of ERAD substrates",
              "relevant_quote": "The interaction of AT3 with VCP and the ability of AT3 to increase accumulation of ERAD substrates raise the possibility that AT3 may interfere with the VCP/Ufd1-Npl4 complex..."
            },
            {
              "doi": "10.1093/emboj/21.4.615",
              "pmid": "11847109",
              "year": 2002,
              "assay": "Genetic analysis",
              "authors": "Braun S, Matuschewski K, Rape M, Thoms S, Jentsch S",
              "journal": "The EMBO Journal",
              "species": "Saccharomyces cerevisiae",
              "paper_title": "Role of the ubiquitin-selective CDC48(UFD1/NPL4) chaperone (segregase) in ERAD of OLE1 and other substrates",
              "relevant_quote": "Intriguingly, other ERAD substrates also require CDC48(UFD1/NPL4) for degradation, indicating that this enzyme is a novel, constitutive component of the ERAD machinery."
            },
            {
              "doi": "10.1042/BST0360818",
              "pmid": "18793143",
              "year": 2008,
              "assay": "Review",
              "authors": "Ballar P, Fang S",
              "journal": "Biochemical Society Transactions",
              "species": "Mammalian",
              "paper_title": "Regulation of ER-associated degradation via p97/VCP-interacting motif",
              "relevant_quote": "p97/VCP (valosin-containing protein) is a cytosolic AAA (ATPase associated with various cellular activities) essential for retrotranslocation of misfolded proteins during ERAD..."
            },
            {
              "doi": "10.1093/hmg/ddl150",
              "pmid": "16822850",
              "year": 2006,
              "assay": "Co-Immunoprecipitation, in vitro retrotranslocation assay",
              "authors": "Burnett B, Li F, Pittman RN",
              "journal": "Hum Mol Genet",
              "species": "human, Chlorocebus aethiops (COS cells)",
              "paper_title": "Ataxin-3 binds VCP/p97 and regulates retrotranslocation of ERAD substrates",
              "relevant_quote": "AT3 and Ufd1 bind VCP in a mutually exclusive manner; AT3 decreases the interaction of VCP with Ufd1 as well as with ubiquitylated proteins. Using a reconstituted system, AT3 inhibits retrotranslocation of an ERAD substrate from the ER."
            }
          ],
          "function": "ER-Associated Degradation (ERAD)",
          "validity": "TRUE",
          "direction": "main_to_primary",
          "net_arrow": "inhibits",
          "direct_arrow": "activates",
          "arrow_context": {
            "direct_from": "VCP",
            "direct_arrow": "activates",
            "net_from": "ATXN3",
            "net_arrow": "inhibits",
            "mediator_chain": [
              "VCP"
            ],
            "is_indirect": true
          },
          "evidence_source": "fact_checker_verified",
          "validation_note": "The claim is strongly supported by the literature. Multiple papers confirm that ATXN3 binds to VCP/p97 and, in doing so, competitively inhibits the binding of the UFD1-NPLOC4 heterodimer. This disruption directly impairs the retrotranslocation of ERAD substrates from the ER, which is a key step in ER-associated degradation. All core components of the claim—the function, the inhibitory mechanism, and the specific molecular players—are validated.",
          "cellular_process": "ATXN3's interaction with VCP/p97 interferes with the formation of the VCP-UFD1-NPL4 complex. This complex uses ATP hydrolysis to extract misfolded, ubiquitinated proteins from the ER membrane, a critical step in ER-associated degradation (ERAD).",
          "specific_effects": [
            "ATXN3 binding to VCP prevents the stable association of the UFD1-NPLOC4 heterodimer.",
            "The VCP-Ufd1-Npl4 complex is a novel, constitutive component of the ERAD machinery."
          ],
          "effect_description": "Disruption of the VCP-UFD1-NPLOC4 complex by ATXN3 impairs the extraction of ubiquitinated proteins from the ER for degradation.",
          "interaction_effect": "inhibits",
          "interaction_direction": "main_to_primary",
          "biological_consequence": [
            "ATXN3 competitively binds VCP/p97 → UFD1-NPLOC4 heterodimer is displaced → VCP-UFD1-NPLOC4 complex assembly is inhibited → Extraction of ubiquitinated ERAD substrates fails → Misfolded proteins accumulate in the ER",
            "Misfolded protein accumulation in the ER → Activation of the Unfolded Protein Response (UPR) pathway → Chronic ER stress → Caspase activation and cellular apoptosis"
          ]
        }
      ],
      "evidence": [
        {
          "doi": "10.1093/hmg/ddl164",
          "year": 2006,
          "assay": "Co-immunoprecipitation",
          "authors": "Zhong X, Pittman RN",
          "journal": "Human Molecular Genetics",
          "species": "Human (HEK293T cells)",
          "paper_title": "Ataxin-3 binds VCP/p97 and regulates retrotranslocation of ERAD substrates",
          "relevant_quote": "The interaction of AT3 with VCP and the ability of AT3 to increase accumulation of ERAD substrates raise the possibility that AT3 may interfere with the VCP/Ufd1-Npl4 complex..."
        },
        {
          "doi": "10.1093/emboj/21.4.615",
          "year": 2002,
          "assay": "Genetic analysis",
          "authors": "Braun S, Matuschewski K, Rape M, Thoms S, Jentsch S",
          "journal": "The EMBO Journal",
          "species": "Saccharomyces cerevisiae",
          "paper_title": "Role of the ubiquitin-selective CDC48(UFD1/NPL4) chaperone (segregase) in ERAD of OLE1 and other substrates",
          "relevant_quote": "Intriguingly, other ERAD substrates also require CDC48(UFD1/NPL4) for degradation, indicating that this enzyme is a novel, constitutive component of the ERAD machinery."
        },
        {
          "doi": "10.1042/BST0360818",
          "year": 2008,
          "assay": "Review",
          "authors": "Ballar P, Fang S",
          "journal": "Biochemical Society Transactions",
          "species": "Mammalian",
          "paper_title": "Regulation of ER-associated degradation via p97/VCP-interacting motif",
          "relevant_quote": "p97/VCP (valosin-containing protein) is a cytosolic AAA (ATPase associated with various cellular activities) essential for retrotranslocation of misfolded proteins during ERAD..."
        }
      ],
      "_original_direction": "main_to_primary",
      "upstream_interactor": "VCP",
      "mediator_chain": [
        "VCP"
      ],
      "depth": 2,
      "interaction_effect": "inhibition",
      "_validation_metadata": {
        "validated": true,
        "validator": "arrow_effect_validator",
        "corrections_applied": 1,
        "validated_at": "2025-11-18T01:18:04.168349"
      },
      "_arrow_validated": true
    },
    "corrected_data": {
      "primary": "NPLOC4",
      "direction": "main_to_primary",
      "arrow": "inhibits",
      "interaction_type": "indirect",
      "functions": [
        {
          "arrow": "inhibits",
          "pmids": [
            "16822850",
            "11847109",
            "18793143"
          ],
          "evidence": [
            {
              "doi": "10.1093/hmg/ddl164",
              "pmid": "16822850",
              "year": 2006,
              "assay": "Co-immunoprecipitation",
              "authors": "Zhong X, Pittman RN",
              "journal": "Human Molecular Genetics",
              "species": "Human (HEK293T cells)",
              "paper_title": "Ataxin-3 binds VCP/p97 and regulates retrotranslocation of ERAD substrates",
              "relevant_quote": "The interaction of AT3 with VCP and the ability of AT3 to increase accumulation of ERAD substrates raise the possibility that AT3 may interfere with the VCP/Ufd1-Npl4 complex..."
            },
            {
              "doi": "10.1093/emboj/21.4.615",
              "pmid": "11847109",
              "year": 2002,
              "assay": "Genetic analysis",
              "authors": "Braun S, Matuschewski K, Rape M, Thoms S, Jentsch S",
              "journal": "The EMBO Journal",
              "species": "Saccharomyces cerevisiae",
              "paper_title": "Role of the ubiquitin-selective CDC48(UFD1/NPL4) chaperone (segregase) in ERAD of OLE1 and other substrates",
              "relevant_quote": "Intriguingly, other ERAD substrates also require CDC48(UFD1/NPL4) for degradation, indicating that this enzyme is a novel, constitutive component of the ERAD machinery."
            },
            {
              "doi": "10.1042/BST0360818",
              "pmid": "18793143",
              "year": 2008,
              "assay": "Review",
              "authors": "Ballar P, Fang S",
              "journal": "Biochemical Society Transactions",
              "species": "Mammalian",
              "paper_title": "Regulation of ER-associated degradation via p97/VCP-interacting motif",
              "relevant_quote": "p97/VCP (valosin-containing protein) is a cytosolic AAA (ATPase associated with various cellular activities) essential for retrotranslocation of misfolded proteins during ERAD..."
            },
            {
              "doi": "10.1093/hmg/ddl150",
              "pmid": "16822850",
              "year": 2006,
              "assay": "Co-Immunoprecipitation, in vitro retrotranslocation assay",
              "authors": "Burnett B, Li F, Pittman RN",
              "journal": "Hum Mol Genet",
              "species": "human, Chlorocebus aethiops (COS cells)",
              "paper_title": "Ataxin-3 binds VCP/p97 and regulates retrotranslocation of ERAD substrates",
              "relevant_quote": "AT3 and Ufd1 bind VCP in a mutually exclusive manner; AT3 decreases the interaction of VCP with Ufd1 as well as with ubiquitylated proteins. Using a reconstituted system, AT3 inhibits retrotranslocation of an ERAD substrate from the ER."
            }
          ],
          "function": "ER-Associated Degradation (ERAD)",
          "validity": "TRUE",
          "direction": "main_to_primary",
          "net_arrow": "inhibits",
          "direct_arrow": "activates",
          "arrow_context": {
            "direct_from": "VCP",
            "direct_arrow": "activates",
            "net_from": "ATXN3",
            "net_arrow": "inhibits",
            "mediator_chain": [
              "VCP"
            ],
            "is_indirect": true
          },
          "evidence_source": "fact_checker_verified",
          "validation_note": "The claim is strongly supported by the literature. Multiple papers confirm that ATXN3 binds to VCP/p97 and, in doing so, competitively inhibits the binding of the UFD1-NPLOC4 heterodimer. This disruption directly impairs the retrotranslocation of ERAD substrates from the ER, which is a key step in ER-associated degradation. All core components of the claim—the function, the inhibitory mechanism, and the specific molecular players—are validated.",
          "cellular_process": "ATXN3's interaction with VCP/p97 interferes with the formation of the VCP-UFD1-NPL4 complex. This complex uses ATP hydrolysis to extract misfolded, ubiquitinated proteins from the ER membrane, a critical step in ER-associated degradation (ERAD).",
          "specific_effects": [
            "ATXN3 binding to VCP prevents the stable association of the UFD1-NPLOC4 heterodimer.",
            "The VCP-Ufd1-Npl4 complex is a novel, constitutive component of the ERAD machinery."
          ],
          "effect_description": "Disruption of the VCP-UFD1-NPLOC4 complex by ATXN3 impairs the extraction of ubiquitinated proteins from the ER for degradation.",
          "interaction_effect": "inhibits",
          "interaction_direction": "main_to_primary",
          "biological_consequence": [
            "ATXN3 competitively binds VCP/p97 → UFD1-NPLOC4 heterodimer is displaced → VCP-UFD1-NPLOC4 complex assembly is inhibited → Extraction of ubiquitinated ERAD substrates fails → Misfolded proteins accumulate in the ER",
            "Misfolded protein accumulation in the ER → Activation of the Unfolded Protein Response (UPR) pathway → Chronic ER stress → Caspase activation and cellular apoptosis"
          ]
        }
      ],
      "evidence": [
        {
          "doi": "10.1093/hmg/ddl164",
          "year": 2006,
          "assay": "Co-immunoprecipitation",
          "authors": "Zhong X, Pittman RN",
          "journal": "Human Molecular Genetics",
          "species": "Human (HEK293T cells)",
          "paper_title": "Ataxin-3 binds VCP/p97 and regulates retrotranslocation of ERAD substrates",
          "relevant_quote": "The interaction of AT3 with VCP and the ability of AT3 to increase accumulation of ERAD substrates raise the possibility that AT3 may interfere with the VCP/Ufd1-Npl4 complex..."
        },
        {
          "doi": "10.1093/emboj/21.4.615",
          "year": 2002,
          "assay": "Genetic analysis",
          "authors": "Braun S, Matuschewski K, Rape M, Thoms S, Jentsch S",
          "journal": "The EMBO Journal",
          "species": "Saccharomyces cerevisiae",
          "paper_title": "Role of the ubiquitin-selective CDC48(UFD1/NPL4) chaperone (segregase) in ERAD of OLE1 and other substrates",
          "relevant_quote": "Intriguingly, other ERAD substrates also require CDC48(UFD1/NPL4) for degradation, indicating that this enzyme is a novel, constitutive component of the ERAD machinery."
        },
        {
          "doi": "10.1042/BST0360818",
          "year": 2008,
          "assay": "Review",
          "authors": "Ballar P, Fang S",
          "journal": "Biochemical Society Transactions",
          "species": "Mammalian",
          "paper_title": "Regulation of ER-associated degradation via p97/VCP-interacting motif",
          "relevant_quote": "p97/VCP (valosin-containing protein) is a cytosolic AAA (ATPase associated with various cellular activities) essential for retrotranslocation of misfolded proteins during ERAD..."
        }
      ],
      "_original_direction": "main_to_primary",
      "upstream_interactor": "VCP",
      "mediator_chain": [
        "VCP"
      ],
      "depth": 2,
      "interaction_effect": "inhibition",
      "_validation_metadata": {
        "validated": true,
        "validator": "arrow_effect_validator",
        "corrections_applied": 1,
        "validated_at": "2025-11-18T01:18:04.168349"
      },
      "_arrow_validated": true
    },
    "corrections_count": 1,
    "chain_context": {
      "interaction_type": "indirect",
      "mediator_chain": [
        "VCP"
      ],
      "upstream_interactor": "VCP",
      "depth": 2
    }
  },
  {
    "interaction_id": 36,
    "main_protein": "ATXN3",
    "partner_protein": "NRF2",
    "original_data": {
      "primary": "NRF2",
      "direction": "main_to_primary",
      "arrow": "inhibits",
      "interaction_type": "indirect",
      "functions": [
        {
          "arrow": "inhibits",
          "pmids": [
            "33176149",
            "12682069"
          ],
          "evidence": [
            {
              "doi": "10.1016/j.celrep.2020.108360",
              "pmid": "33176149",
              "year": 2020,
              "assay": "Proteomics, Western Blot",
              "authors": "Vasileios Toulis, Sílvia García-Monclús, Carlos de la Peña-Ramírez, Rodrigo Arenas-Galnares, Josep F Abril, Sokol V Todi, Naheed Khan, Alejandro Garanto, Maria do Carmo Costa, Gemma Marfany",
              "journal": "Cell Reports",
              "species": "mouse, human",
              "paper_title": "The Deubiquitinating Enzyme Ataxin-3 Regulates Ciliogenesis and Phagocytosis in the Retina",
              "relevant_quote": "Abrogation of Atxn3 expression causes decreased levels of the regulatory protein KEAP1 in the retina and delayed phagosome maturation in the retinal pigment epithelium."
            },
            {
              "doi": "10.1074/jbc.M300931200",
              "pmid": "12682069",
              "year": 2003,
              "assay": "Western Blot, Transfection",
              "authors": "Michael McMahon, Ken Itoh, Masayuki Yamamoto, John D Hayes",
              "journal": "The Journal of Biological Chemistry",
              "species": "rat, monkey",
              "paper_title": "Keap1-dependent proteasomal degradation of transcription factor Nrf2 contributes to the negative regulation of antioxidant response element-driven gene expression",
              "relevant_quote": "under homeostatic conditions Nrf2 is subject to a substantially more rapid mode of proteasomal degradation than it is in oxidatively stressed cells, and this rapid turnover of Nrf2 requires it to interact with Keap1."
            },
            {
              "doi": "10.1016/j.celrep.2020.108360",
              "pmid": "33176149",
              "year": 2020,
              "assay": "Western blot|Proteomics|qRT-PCR",
              "authors": "Toulis V, Krol J, Patel R, Tsefou E, Tsortos S, Kelly G, Sanderson J, Charalambous M, Schuster-Böckler B, Wackerhage H, Rozanska A, Cheetham ME, Hardcastle AJ, Moosajee M",
              "journal": "Cell Rep",
              "species": "mouse|human|zebrafish",
              "paper_title": "The Deubiquitinating Enzyme Ataxin-3 Regulates Ciliogenesis and Phagocytosis in the Retina",
              "relevant_quote": "Depletion of ATXN3 lead to destabilization of the KEAP1 protein (decreased half-life), further supporting ATXN3 as a regulator of KEAP1 turnover... our results suggest that ATXN3 promotes the stability of KEAP1 by slowing down its degradation..."
            }
          ],
          "function": "Antioxidant Gene Transcription",
          "validity": "TRUE",
          "net_arrow": "inhibits",
          "direct_arrow": "inhibits",
          "arrow_context": {
            "direct_from": "KEAP1",
            "direct_arrow": "inhibits",
            "net_from": "ATXN3",
            "net_arrow": "inhibits",
            "mediator_chain": [
              "KEAP1"
            ],
            "is_indirect": true
          },
          "evidence_source": "fact_checker_verified",
          "validation_note": "The claim is fully supported by the literature. A 2020 paper by Toulis et al. in Cell Reports provides direct evidence that ATXN3 stabilizes the KEAP1 protein. The paper shows that depletion of Atxn3 in mouse retina and knockdown in human cells leads to decreased levels and destabilization of KEAP1, and a corresponding increase in NRF2 levels. All fields of the function box are consistent with these findings and canonical knowledge of the KEAP1-NRF2 pathway.",
          "cellular_process": "ATXN3 stabilizes KEAP1, a substrate adaptor for a CUL3-based E3 ligase that targets the transcription factor NRF2 for proteasomal degradation under basal conditions. By maintaining KEAP1 levels, ATXN3 enhances the ubiquitination and subsequent degradation of NRF2.",
          "specific_effects": [
            "Abrogation of Atxn3 expression causes decreased levels of the regulatory protein KEAP1 in the retina.",
            "Depletion of ATXN3 leads to destabilization of the KEAP1 protein (decreased half-life).",
            "KEAP1 targets NRF2 for proteasome-dependent degradation.",
            "Knockdown of ATXN3 in human cells leads to increased levels of NRF2."
          ],
          "effect_description": "ATXN3 activity leads to the suppression of the NRF2-mediated antioxidant response by promoting the degradation of NRF2.",
          "interaction_effect": "inhibition",
          "interaction_direction": "main_to_primary",
          "biological_consequence": [
            "ATXN3 stabilizes KEAP1 protein → Enhanced CUL3-KEAP1 E3 ligase activity → Increased ubiquitination and proteasomal degradation of NRF2 → Repression of antioxidant response element (ARE)-driven gene expression → Reduced cellular defense against oxidative stress"
          ]
        }
      ],
      "evidence": [
        {
          "doi": "10.1016/j.celrep.2020.108360",
          "year": 2020,
          "assay": "Proteomics, Western Blot",
          "authors": "Vasileios Toulis, Sílvia García-Monclús, Carlos de la Peña-Ramírez, Rodrigo Arenas-Galnares, Josep F Abril, Sokol V Todi, Naheed Khan, Alejandro Garanto, Maria do Carmo Costa, Gemma Marfany",
          "journal": "Cell Reports",
          "species": "mouse, human",
          "paper_title": "The Deubiquitinating Enzyme Ataxin-3 Regulates Ciliogenesis and Phagocytosis in the Retina",
          "relevant_quote": "Abrogation of Atxn3 expression causes decreased levels of the regulatory protein KEAP1 in the retina and delayed phagosome maturation in the retinal pigment epithelium."
        },
        {
          "doi": "10.1074/jbc.M300931200",
          "year": 2003,
          "assay": "Western Blot, Transfection",
          "authors": "Michael McMahon, Ken Itoh, Masayuki Yamamoto, John D Hayes",
          "journal": "The Journal of Biological Chemistry",
          "species": "rat, monkey",
          "paper_title": "Keap1-dependent proteasomal degradation of transcription factor Nrf2 contributes to the negative regulation of antioxidant response element-driven gene expression",
          "relevant_quote": "under homeostatic conditions Nrf2 is subject to a substantially more rapid mode of proteasomal degradation than it is in oxidatively stressed cells, and this rapid turnover of Nrf2 requires it to interact with Keap1."
        },
        {
          "doi": "10.1158/0008-5472.CAN-13-1655",
          "year": 2014,
          "assay": "Biochemical Assay, Western Blot",
          "authors": "Bridgid E Hast, Erica W Cloer, Dennis Goldfarb, Heng Li, Priscila F Siesser, Feng Yan, Vonn Walter, Ning Zheng, D Neil Hayes, Michael B Major",
          "journal": "Cancer Research",
          "species": "human",
          "paper_title": "Cancer-derived mutations in KEAP1 impair NRF2 degradation but not ubiquitination",
          "relevant_quote": "NRF2 is a transcription factor that mediates stress responses. Oncogenic mutations in NRF2 localize to one of its two binding interfaces with KEAP1, an E3 ubiquitin ligase that promotes proteasome-dependent degradation of NRF2."
        }
      ],
      "_original_direction": "main_to_primary",
      "upstream_interactor": "KEAP1",
      "mediator_chain": [
        "KEAP1"
      ],
      "depth": 2,
      "interaction_effect": "inhibition",
      "_validation_metadata": {
        "validated": true,
        "validator": "arrow_effect_validator",
        "corrections_applied": 1,
        "validated_at": "2025-11-18T01:18:10.520537"
      },
      "_arrow_validated": true
    },
    "corrected_data": {
      "primary": "NRF2",
      "direction": "main_to_primary",
      "arrow": "inhibits",
      "interaction_type": "indirect",
      "functions": [
        {
          "arrow": "inhibits",
          "pmids": [
            "33176149",
            "12682069"
          ],
          "evidence": [
            {
              "doi": "10.1016/j.celrep.2020.108360",
              "pmid": "33176149",
              "year": 2020,
              "assay": "Proteomics, Western Blot",
              "authors": "Vasileios Toulis, Sílvia García-Monclús, Carlos de la Peña-Ramírez, Rodrigo Arenas-Galnares, Josep F Abril, Sokol V Todi, Naheed Khan, Alejandro Garanto, Maria do Carmo Costa, Gemma Marfany",
              "journal": "Cell Reports",
              "species": "mouse, human",
              "paper_title": "The Deubiquitinating Enzyme Ataxin-3 Regulates Ciliogenesis and Phagocytosis in the Retina",
              "relevant_quote": "Abrogation of Atxn3 expression causes decreased levels of the regulatory protein KEAP1 in the retina and delayed phagosome maturation in the retinal pigment epithelium."
            },
            {
              "doi": "10.1074/jbc.M300931200",
              "pmid": "12682069",
              "year": 2003,
              "assay": "Western Blot, Transfection",
              "authors": "Michael McMahon, Ken Itoh, Masayuki Yamamoto, John D Hayes",
              "journal": "The Journal of Biological Chemistry",
              "species": "rat, monkey",
              "paper_title": "Keap1-dependent proteasomal degradation of transcription factor Nrf2 contributes to the negative regulation of antioxidant response element-driven gene expression",
              "relevant_quote": "under homeostatic conditions Nrf2 is subject to a substantially more rapid mode of proteasomal degradation than it is in oxidatively stressed cells, and this rapid turnover of Nrf2 requires it to interact with Keap1."
            },
            {
              "doi": "10.1016/j.celrep.2020.108360",
              "pmid": "33176149",
              "year": 2020,
              "assay": "Western blot|Proteomics|qRT-PCR",
              "authors": "Toulis V, Krol J, Patel R, Tsefou E, Tsortos S, Kelly G, Sanderson J, Charalambous M, Schuster-Böckler B, Wackerhage H, Rozanska A, Cheetham ME, Hardcastle AJ, Moosajee M",
              "journal": "Cell Rep",
              "species": "mouse|human|zebrafish",
              "paper_title": "The Deubiquitinating Enzyme Ataxin-3 Regulates Ciliogenesis and Phagocytosis in the Retina",
              "relevant_quote": "Depletion of ATXN3 lead to destabilization of the KEAP1 protein (decreased half-life), further supporting ATXN3 as a regulator of KEAP1 turnover... our results suggest that ATXN3 promotes the stability of KEAP1 by slowing down its degradation..."
            }
          ],
          "function": "Antioxidant Gene Transcription",
          "validity": "TRUE",
          "net_arrow": "inhibits",
          "direct_arrow": "inhibits",
          "arrow_context": {
            "direct_from": "KEAP1",
            "direct_arrow": "inhibits",
            "net_from": "ATXN3",
            "net_arrow": "inhibits",
            "mediator_chain": [
              "KEAP1"
            ],
            "is_indirect": true
          },
          "evidence_source": "fact_checker_verified",
          "validation_note": "The claim is fully supported by the literature. A 2020 paper by Toulis et al. in Cell Reports provides direct evidence that ATXN3 stabilizes the KEAP1 protein. The paper shows that depletion of Atxn3 in mouse retina and knockdown in human cells leads to decreased levels and destabilization of KEAP1, and a corresponding increase in NRF2 levels. All fields of the function box are consistent with these findings and canonical knowledge of the KEAP1-NRF2 pathway.",
          "cellular_process": "ATXN3 stabilizes KEAP1, a substrate adaptor for a CUL3-based E3 ligase that targets the transcription factor NRF2 for proteasomal degradation under basal conditions. By maintaining KEAP1 levels, ATXN3 enhances the ubiquitination and subsequent degradation of NRF2.",
          "specific_effects": [
            "Abrogation of Atxn3 expression causes decreased levels of the regulatory protein KEAP1 in the retina.",
            "Depletion of ATXN3 leads to destabilization of the KEAP1 protein (decreased half-life).",
            "KEAP1 targets NRF2 for proteasome-dependent degradation.",
            "Knockdown of ATXN3 in human cells leads to increased levels of NRF2."
          ],
          "effect_description": "ATXN3 activity leads to the suppression of the NRF2-mediated antioxidant response by promoting the degradation of NRF2.",
          "interaction_effect": "inhibition",
          "interaction_direction": "main_to_primary",
          "biological_consequence": [
            "ATXN3 stabilizes KEAP1 protein → Enhanced CUL3-KEAP1 E3 ligase activity → Increased ubiquitination and proteasomal degradation of NRF2 → Repression of antioxidant response element (ARE)-driven gene expression → Reduced cellular defense against oxidative stress"
          ]
        }
      ],
      "evidence": [
        {
          "doi": "10.1016/j.celrep.2020.108360",
          "year": 2020,
          "assay": "Proteomics, Western Blot",
          "authors": "Vasileios Toulis, Sílvia García-Monclús, Carlos de la Peña-Ramírez, Rodrigo Arenas-Galnares, Josep F Abril, Sokol V Todi, Naheed Khan, Alejandro Garanto, Maria do Carmo Costa, Gemma Marfany",
          "journal": "Cell Reports",
          "species": "mouse, human",
          "paper_title": "The Deubiquitinating Enzyme Ataxin-3 Regulates Ciliogenesis and Phagocytosis in the Retina",
          "relevant_quote": "Abrogation of Atxn3 expression causes decreased levels of the regulatory protein KEAP1 in the retina and delayed phagosome maturation in the retinal pigment epithelium."
        },
        {
          "doi": "10.1074/jbc.M300931200",
          "year": 2003,
          "assay": "Western Blot, Transfection",
          "authors": "Michael McMahon, Ken Itoh, Masayuki Yamamoto, John D Hayes",
          "journal": "The Journal of Biological Chemistry",
          "species": "rat, monkey",
          "paper_title": "Keap1-dependent proteasomal degradation of transcription factor Nrf2 contributes to the negative regulation of antioxidant response element-driven gene expression",
          "relevant_quote": "under homeostatic conditions Nrf2 is subject to a substantially more rapid mode of proteasomal degradation than it is in oxidatively stressed cells, and this rapid turnover of Nrf2 requires it to interact with Keap1."
        },
        {
          "doi": "10.1158/0008-5472.CAN-13-1655",
          "year": 2014,
          "assay": "Biochemical Assay, Western Blot",
          "authors": "Bridgid E Hast, Erica W Cloer, Dennis Goldfarb, Heng Li, Priscila F Siesser, Feng Yan, Vonn Walter, Ning Zheng, D Neil Hayes, Michael B Major",
          "journal": "Cancer Research",
          "species": "human",
          "paper_title": "Cancer-derived mutations in KEAP1 impair NRF2 degradation but not ubiquitination",
          "relevant_quote": "NRF2 is a transcription factor that mediates stress responses. Oncogenic mutations in NRF2 localize to one of its two binding interfaces with KEAP1, an E3 ubiquitin ligase that promotes proteasome-dependent degradation of NRF2."
        }
      ],
      "_original_direction": "main_to_primary",
      "upstream_interactor": "KEAP1",
      "mediator_chain": [
        "KEAP1"
      ],
      "depth": 2,
      "interaction_effect": "inhibition",
      "_validation_metadata": {
        "validated": true,
        "validator": "arrow_effect_validator",
        "corrections_applied": 1,
        "validated_at": "2025-11-18T01:18:10.520537"
      },
      "_arrow_validated": true
    },
    "corrections_count": 1,
    "chain_context": {
      "interaction_type": "indirect",
      "mediator_chain": [
        "KEAP1"
      ],
      "upstream_interactor": "KEAP1",
      "depth": 2
    }
  },
  {
    "interaction_id": 38,
    "main_protein": "ATXN3",
    "partner_protein": "PINK1",
    "original_data": {
      "primary": "PINK1",
      "direction": "main_to_primary",
      "arrow": "inhibits",
      "interaction_type": "indirect",
      "functions": [
        {
          "arrow": "inhibits",
          "pmids": [
            "23509287",
            "20798600",
            "22448035",
            "20940148"
          ],
          "evidence": [
            {
              "doi": "10.1073/pnas.1218819110",
              "pmid": "23509287",
              "year": 2013,
              "assay": "Proteomic analysis",
              "authors": "Vincow ES, Merrihew G, Thomas RE, Shulman NJ, Beyer RP, MacCoss MJ, Pallanck LJ",
              "journal": "Proceedings of the National Academy of Sciences of the United States of America",
              "species": "Drosophila",
              "paper_title": "The PINK1-Parkin pathway promotes both mitophagy and selective respiratory chain turnover in vivo",
              "relevant_quote": "Our findings show that the PINK1–Parkin pathway promotes mitophagy in vivo and, unexpectedly, also promotes selective turnover of mitochondrial RC subunits."
            },
            {
              "doi": "10.4161/auto.6.7.13286",
              "pmid": "20798600",
              "year": 2010,
              "assay": "Cell culture studies",
              "authors": "Geisler S, Holmström KM, Treis A, Skujat D, Weber SS, Fiesel FC, Kahle PJ, Springer W",
              "journal": "Autophagy",
              "species": "Human",
              "paper_title": "The PINK1/Parkin-mediated mitophagy is compromised by PD-associated mutations",
              "relevant_quote": "Very recently, two Parkinson disease (PD) associated genes, PINK1 and Parkin, were shown to mediate the degradation of damaged mitochondria via selective autophagy (mitophagy)."
            },
            {
              "doi": "10.1242/jcs.093849",
              "pmid": "22448035",
              "year": 2012,
              "assay": "Review",
              "authors": "Jin SM, Youle RJ",
              "journal": "Journal of Cell Science",
              "species": "General",
              "paper_title": "PINK1- and Parkin-mediated mitophagy at a glance",
              "relevant_quote": "Recently, work in cultured cells has shown that Parkin can mediate autophagy of damaged mitochondria (termed mitophagy) downstream of PINK1."
            },
            {
              "doi": "10.1093/hmg/ddq425",
              "pmid": "20940148",
              "year": 2011,
              "assay": "In vitro and cell-based assays",
              "authors": "Durcan TM, Kontogiannea M, Thorarinsdottir T, Fallon L, Williams AJ, Djarmati A, Fantaneanu T, Paulson HL, Fon EA",
              "journal": "Human Molecular Genetics",
              "species": "Human",
              "paper_title": "The Machado-Joseph disease-associated mutant form of ataxin-3 regulates parkin ubiquitination and stability",
              "relevant_quote": "Compared with wild-type ataxin-3...mutant ataxin-3 promotes the clearance of parkin via the autophagy pathway."
            }
          ],
          "function": "Mitophagy",
          "validity": "DELETED",
          "direction": "main_to_primary",
          "net_arrow": "inhibits",
          "direct_arrow": "activates",
          "arrow_context": {
            "direct_from": "PRKN",
            "direct_arrow": "activates",
            "net_from": "ATXN3",
            "net_arrow": "inhibits",
            "mediator_chain": [
              "PRKN"
            ],
            "is_indirect": true
          },
          "validation_note": "WRONG INTERACTOR: The claim describes a well-documented functional interaction between ATXN3 and Parkin (PRKN), which modulates the PINK1-Parkin mitophagy pathway. However, the specified interactor is PINK1. Literature does not support a direct functional interaction between ATXN3 and PINK1. Instead, ATXN3 interacts with Parkin, a downstream effector of PINK1 signaling. The entire functional description, including the cellular process, effect, biological consequence, and specific effects, correctly details the ATXN3-PRKN interaction and its consequences on mitophagy. Because the primary interactor protein is incorrect, the claim is marked for deletion.",
          "cellular_process": "On damaged mitochondria with a depolarized membrane potential, the kinase PINK1 accumulates on the outer mitochondrial membrane. This accumulation of PINK1 recruits the E3 ligase Parkin (PRKN), a direct interactor of ATXN3, from the cytosol to the mitochondria. This initiates the ubiquitination of mitochondrial outer membrane proteins, which tags the damaged organelle for selective degradation by autophagy (mitophagy).",
          "specific_effects": [
            "The PINK1-Parkin pathway is a primary mechanism for initiating mitophagy in response to mitochondrial damage.",
            "ATXN3 deubiquitinates Parkin, which can lead to increased turnover and degradation of Parkin via autophagy.",
            "ATXN3 negatively impacts Parkin activity."
          ],
          "effect_description": "ATXN3's deubiquitination of Parkin (PRKN) negatively impacts the efficiency of the PINK1-PRKN pathway, thereby inhibiting the primary quality control mechanism for removing dysfunctional mitochondria.",
          "interaction_effect": "inhibits",
          "interaction_direction": "main_to_primary",
          "biological_consequence": [
            "Mitochondrial damage → PINK1 accumulation on outer mitochondrial membrane → PRKN (Parkin) recruitment from cytosol → ATXN3 deubiquitinates and inhibits PRKN E3 ligase activity → Reduced ubiquitination of mitochondrial outer membrane proteins → Impaired mitophagy"
          ]
        }
      ],
      "evidence": [
        {
          "doi": "10.1073/pnas.1218819110",
          "year": 2013,
          "assay": "Proteomic analysis",
          "authors": "Vincow ES, Merrihew G, Thomas RE, Shulman NJ, Beyer RP, MacCoss MJ, Pallanck LJ",
          "journal": "Proceedings of the National Academy of Sciences of the United States of America",
          "species": "Drosophila",
          "paper_title": "The PINK1-Parkin pathway promotes both mitophagy and selective respiratory chain turnover in vivo",
          "relevant_quote": "Our findings show that the PINK1–Parkin pathway promotes mitophagy in vivo and, unexpectedly, also promotes selective turnover of mitochondrial RC subunits."
        },
        {
          "doi": "10.4161/auto.6.7.13286",
          "year": 2010,
          "assay": "Cell culture studies",
          "authors": "Geisler S, Holmström KM, Treis A, Skujat D, Weber SS, Fiesel FC, Kahle PJ, Springer W",
          "journal": "Autophagy",
          "species": "Human",
          "paper_title": "The PINK1/Parkin-mediated mitophagy is compromised by PD-associated mutations",
          "relevant_quote": "Very recently, two Parkinson disease (PD) associated genes, PINK1 and Parkin, were shown to mediate the degradation of damaged mitochondria via selective autophagy (mitophagy)."
        },
        {
          "doi": "10.1242/jcs.093849",
          "year": 2012,
          "assay": "Review",
          "authors": "Jin SM, Youle RJ",
          "journal": "Journal of Cell Science",
          "species": "General",
          "paper_title": "PINK1- and Parkin-mediated mitophagy at a glance",
          "relevant_quote": "Recently, work in cultured cells has shown that Parkin can mediate autophagy of damaged mitochondria (termed mitophagy) downstream of PINK1."
        },
        {
          "doi": "10.1093/hmg/ddq425",
          "year": 2011,
          "assay": "In vitro and cell-based assays",
          "authors": "Durcan TM, Kontogiannea M, Thorarinsdottir T, Fallon L, Williams AJ, Djarmati A, Fantaneanu T, Paulson HL, Fon EA",
          "journal": "Human Molecular Genetics",
          "species": "Human",
          "paper_title": "The Machado-Joseph disease-associated mutant form of ataxin-3 regulates parkin ubiquitination and stability",
          "relevant_quote": "Compared with wild-type ataxin-3...mutant ataxin-3 promotes the clearance of parkin via the autophagy pathway."
        }
      ],
      "_original_direction": "main_to_primary",
      "upstream_interactor": "PRKN",
      "mediator_chain": [
        "PRKN"
      ],
      "depth": 2,
      "interaction_effect": "inhibition",
      "_validation_metadata": {
        "validated": true,
        "validator": "arrow_effect_validator",
        "corrections_applied": 1,
        "validated_at": "2025-11-18T01:18:17.947237"
      },
      "_arrow_validated": true
    },
    "corrected_data": {
      "primary": "PINK1",
      "direction": "main_to_primary",
      "arrow": "inhibits",
      "interaction_type": "indirect",
      "functions": [
        {
          "arrow": "inhibits",
          "pmids": [
            "23509287",
            "20798600",
            "22448035",
            "20940148"
          ],
          "evidence": [
            {
              "doi": "10.1073/pnas.1218819110",
              "pmid": "23509287",
              "year": 2013,
              "assay": "Proteomic analysis",
              "authors": "Vincow ES, Merrihew G, Thomas RE, Shulman NJ, Beyer RP, MacCoss MJ, Pallanck LJ",
              "journal": "Proceedings of the National Academy of Sciences of the United States of America",
              "species": "Drosophila",
              "paper_title": "The PINK1-Parkin pathway promotes both mitophagy and selective respiratory chain turnover in vivo",
              "relevant_quote": "Our findings show that the PINK1–Parkin pathway promotes mitophagy in vivo and, unexpectedly, also promotes selective turnover of mitochondrial RC subunits."
            },
            {
              "doi": "10.4161/auto.6.7.13286",
              "pmid": "20798600",
              "year": 2010,
              "assay": "Cell culture studies",
              "authors": "Geisler S, Holmström KM, Treis A, Skujat D, Weber SS, Fiesel FC, Kahle PJ, Springer W",
              "journal": "Autophagy",
              "species": "Human",
              "paper_title": "The PINK1/Parkin-mediated mitophagy is compromised by PD-associated mutations",
              "relevant_quote": "Very recently, two Parkinson disease (PD) associated genes, PINK1 and Parkin, were shown to mediate the degradation of damaged mitochondria via selective autophagy (mitophagy)."
            },
            {
              "doi": "10.1242/jcs.093849",
              "pmid": "22448035",
              "year": 2012,
              "assay": "Review",
              "authors": "Jin SM, Youle RJ",
              "journal": "Journal of Cell Science",
              "species": "General",
              "paper_title": "PINK1- and Parkin-mediated mitophagy at a glance",
              "relevant_quote": "Recently, work in cultured cells has shown that Parkin can mediate autophagy of damaged mitochondria (termed mitophagy) downstream of PINK1."
            },
            {
              "doi": "10.1093/hmg/ddq425",
              "pmid": "20940148",
              "year": 2011,
              "assay": "In vitro and cell-based assays",
              "authors": "Durcan TM, Kontogiannea M, Thorarinsdottir T, Fallon L, Williams AJ, Djarmati A, Fantaneanu T, Paulson HL, Fon EA",
              "journal": "Human Molecular Genetics",
              "species": "Human",
              "paper_title": "The Machado-Joseph disease-associated mutant form of ataxin-3 regulates parkin ubiquitination and stability",
              "relevant_quote": "Compared with wild-type ataxin-3...mutant ataxin-3 promotes the clearance of parkin via the autophagy pathway."
            }
          ],
          "function": "Mitophagy",
          "validity": "DELETED",
          "direction": "main_to_primary",
          "net_arrow": "inhibits",
          "direct_arrow": "activates",
          "arrow_context": {
            "direct_from": "PRKN",
            "direct_arrow": "activates",
            "net_from": "ATXN3",
            "net_arrow": "inhibits",
            "mediator_chain": [
              "PRKN"
            ],
            "is_indirect": true
          },
          "validation_note": "WRONG INTERACTOR: The claim describes a well-documented functional interaction between ATXN3 and Parkin (PRKN), which modulates the PINK1-Parkin mitophagy pathway. However, the specified interactor is PINK1. Literature does not support a direct functional interaction between ATXN3 and PINK1. Instead, ATXN3 interacts with Parkin, a downstream effector of PINK1 signaling. The entire functional description, including the cellular process, effect, biological consequence, and specific effects, correctly details the ATXN3-PRKN interaction and its consequences on mitophagy. Because the primary interactor protein is incorrect, the claim is marked for deletion.",
          "cellular_process": "On damaged mitochondria with a depolarized membrane potential, the kinase PINK1 accumulates on the outer mitochondrial membrane. This accumulation of PINK1 recruits the E3 ligase Parkin (PRKN), a direct interactor of ATXN3, from the cytosol to the mitochondria. This initiates the ubiquitination of mitochondrial outer membrane proteins, which tags the damaged organelle for selective degradation by autophagy (mitophagy).",
          "specific_effects": [
            "The PINK1-Parkin pathway is a primary mechanism for initiating mitophagy in response to mitochondrial damage.",
            "ATXN3 deubiquitinates Parkin, which can lead to increased turnover and degradation of Parkin via autophagy.",
            "ATXN3 negatively impacts Parkin activity."
          ],
          "effect_description": "ATXN3's deubiquitination of Parkin (PRKN) negatively impacts the efficiency of the PINK1-PRKN pathway, thereby inhibiting the primary quality control mechanism for removing dysfunctional mitochondria.",
          "interaction_effect": "inhibits",
          "interaction_direction": "main_to_primary",
          "biological_consequence": [
            "Mitochondrial damage → PINK1 accumulation on outer mitochondrial membrane → PRKN (Parkin) recruitment from cytosol → ATXN3 deubiquitinates and inhibits PRKN E3 ligase activity → Reduced ubiquitination of mitochondrial outer membrane proteins → Impaired mitophagy"
          ]
        }
      ],
      "evidence": [
        {
          "doi": "10.1073/pnas.1218819110",
          "year": 2013,
          "assay": "Proteomic analysis",
          "authors": "Vincow ES, Merrihew G, Thomas RE, Shulman NJ, Beyer RP, MacCoss MJ, Pallanck LJ",
          "journal": "Proceedings of the National Academy of Sciences of the United States of America",
          "species": "Drosophila",
          "paper_title": "The PINK1-Parkin pathway promotes both mitophagy and selective respiratory chain turnover in vivo",
          "relevant_quote": "Our findings show that the PINK1–Parkin pathway promotes mitophagy in vivo and, unexpectedly, also promotes selective turnover of mitochondrial RC subunits."
        },
        {
          "doi": "10.4161/auto.6.7.13286",
          "year": 2010,
          "assay": "Cell culture studies",
          "authors": "Geisler S, Holmström KM, Treis A, Skujat D, Weber SS, Fiesel FC, Kahle PJ, Springer W",
          "journal": "Autophagy",
          "species": "Human",
          "paper_title": "The PINK1/Parkin-mediated mitophagy is compromised by PD-associated mutations",
          "relevant_quote": "Very recently, two Parkinson disease (PD) associated genes, PINK1 and Parkin, were shown to mediate the degradation of damaged mitochondria via selective autophagy (mitophagy)."
        },
        {
          "doi": "10.1242/jcs.093849",
          "year": 2012,
          "assay": "Review",
          "authors": "Jin SM, Youle RJ",
          "journal": "Journal of Cell Science",
          "species": "General",
          "paper_title": "PINK1- and Parkin-mediated mitophagy at a glance",
          "relevant_quote": "Recently, work in cultured cells has shown that Parkin can mediate autophagy of damaged mitochondria (termed mitophagy) downstream of PINK1."
        },
        {
          "doi": "10.1093/hmg/ddq425",
          "year": 2011,
          "assay": "In vitro and cell-based assays",
          "authors": "Durcan TM, Kontogiannea M, Thorarinsdottir T, Fallon L, Williams AJ, Djarmati A, Fantaneanu T, Paulson HL, Fon EA",
          "journal": "Human Molecular Genetics",
          "species": "Human",
          "paper_title": "The Machado-Joseph disease-associated mutant form of ataxin-3 regulates parkin ubiquitination and stability",
          "relevant_quote": "Compared with wild-type ataxin-3...mutant ataxin-3 promotes the clearance of parkin via the autophagy pathway."
        }
      ],
      "_original_direction": "main_to_primary",
      "upstream_interactor": "PRKN",
      "mediator_chain": [
        "PRKN"
      ],
      "depth": 2,
      "interaction_effect": "inhibition",
      "_validation_metadata": {
        "validated": true,
        "validator": "arrow_effect_validator",
        "corrections_applied": 1,
        "validated_at": "2025-11-18T01:18:17.947237"
      },
      "_arrow_validated": true
    },
    "corrections_count": 1,
    "chain_context": {
      "interaction_type": "indirect",
      "mediator_chain": [
        "PRKN"
      ],
      "upstream_interactor": "PRKN",
      "depth": 2
    }
  },
  {
    "interaction_id": 37,
    "main_protein": "ATXN3",
    "partner_protein": "KEAP1",
    "original_data": {
      "primary": "KEAP1",
      "direction": "main_to_primary",
      "arrow": "regulates",
      "interaction_type": "indirect",
      "functions": [
        {
          "arrow": "inhibits",
          "pmids": [
            "33176149",
            "12682069"
          ],
          "evidence": [
            {
              "doi": "10.1016/j.celrep.2020.108360",
              "pmid": "33176149",
              "year": 2020,
              "assay": "Proteomics, Western Blot",
              "authors": "Vasileios Toulis, Sílvia García-Monclús, Carlos de la Peña-Ramírez, Rodrigo Arenas-Galnares, Josep F Abril, Sokol V Todi, Naheed Khan, Alejandro Garanto, Maria do Carmo Costa, Gemma Marfany",
              "journal": "Cell Reports",
              "species": "mouse, human",
              "paper_title": "The Deubiquitinating Enzyme Ataxin-3 Regulates Ciliogenesis and Phagocytosis in the Retina",
              "relevant_quote": "Abrogation of Atxn3 expression causes decreased levels of the regulatory protein KEAP1 in the retina and delayed phagosome maturation in the retinal pigment epithelium."
            },
            {
              "doi": "10.1074/jbc.M300931200",
              "pmid": "12682069",
              "year": 2003,
              "assay": "Western Blot, Transfection",
              "authors": "Michael McMahon, Ken Itoh, Masayuki Yamamoto, John D Hayes",
              "journal": "The Journal of Biological Chemistry",
              "species": "rat, monkey",
              "paper_title": "Keap1-dependent proteasomal degradation of transcription factor Nrf2 contributes to the negative regulation of antioxidant response element-driven gene expression",
              "relevant_quote": "under homeostatic conditions Nrf2 is subject to a substantially more rapid mode of proteasomal degradation than it is in oxidatively stressed cells, and this rapid turnover of Nrf2 requires it to interact with Keap1."
            },
            {
              "doi": "10.1016/j.celrep.2020.108360",
              "pmid": "33176149",
              "year": 2020,
              "assay": "Western blot|Proteomics|qRT-PCR",
              "authors": "Toulis V, Krol J, Patel R, Tsefou E, Tsortos S, Kelly G, Sanderson J, Charalambous M, Schuster-Böckler B, Wackerhage H, Rozanska A, Cheetham ME, Hardcastle AJ, Moosajee M",
              "journal": "Cell Rep",
              "species": "mouse|human|zebrafish",
              "paper_title": "The Deubiquitinating Enzyme Ataxin-3 Regulates Ciliogenesis and Phagocytosis in the Retina",
              "relevant_quote": "Depletion of ATXN3 lead to destabilization of the KEAP1 protein (decreased half-life), further supporting ATXN3 as a regulator of KEAP1 turnover... our results suggest that ATXN3 promotes the stability of KEAP1 by slowing down its degradation..."
            }
          ],
          "function": "Antioxidant Gene Transcription",
          "validity": "TRUE",
          "net_arrow": "inhibits",
          "consequences": "ATXN3 acts as a transcriptional coactivator for FOXO4 → Increased binding of the ATXN3-FOXO4 complex to the superoxide dismutase 2 (SOD2) promoter → Upregulation of SOD2 expression → Enhanced cellular defense against oxidative stress",
          "direct_arrow": "inhibits",
          "arrow_context": {
            "direct_from": null,
            "direct_arrow": "inhibits",
            "net_from": "ATXN3",
            "net_arrow": "inhibits",
            "mediator_chain": [],
            "is_indirect": true
          },
          "evidence_source": "fact_checker_verified",
          "validation_note": "The claim is fully supported by the literature. A 2020 paper by Toulis et al. in Cell Reports provides direct evidence that ATXN3 stabilizes the KEAP1 protein. The paper shows that depletion of Atxn3 in mouse retina and knockdown in human cells leads to decreased levels and destabilization of KEAP1, and a corresponding increase in NRF2 levels. All fields of the function box are consistent with these findings and canonical knowledge of the KEAP1-NRF2 pathway.",
          "cellular_process": "ATXN3 stabilizes KEAP1, a substrate adaptor for a CUL3-based E3 ligase that targets the transcription factor NRF2 for proteasomal degradation under basal conditions. By maintaining KEAP1 levels, ATXN3 enhances the ubiquitination and subsequent degradation of NRF2.",
          "specific_effects": [
            "Abrogation of Atxn3 expression causes decreased levels of the regulatory protein KEAP1 in the retina.",
            "Depletion of ATXN3 leads to destabilization of the KEAP1 protein (decreased half-life).",
            "KEAP1 targets NRF2 for proteasome-dependent degradation.",
            "Knockdown of ATXN3 in human cells leads to increased levels of NRF2."
          ],
          "effect_description": "ATXN3 activity leads to the suppression of the NRF2-mediated antioxidant response by promoting the degradation of NRF2.",
          "interaction_effect": "inhibition",
          "interaction_direction": "main_to_primary",
          "biological_consequence": [
            "ATXN3 stabilizes KEAP1 protein → Enhanced CUL3-KEAP1 E3 ligase activity → Increased ubiquitination and proteasomal degradation of NRF2 → Repression of antioxidant response element (ARE)-driven gene expression → Reduced cellular defense against oxidative stress"
          ]
        }
      ],
      "evidence": [
        {
          "doi": "10.1016/j.celrep.2020.108360",
          "year": 2020,
          "assay": "Proteomics, Western Blot",
          "authors": "Vasileios Toulis, Sílvia García-Monclús, Carlos de la Peña-Ramírez, Rodrigo Arenas-Galnares, Josep F Abril, Sokol V Todi, Naheed Khan, Alejandro Garanto, Maria do Carmo Costa, Gemma Marfany",
          "journal": "Cell Reports",
          "species": "mouse, human",
          "paper_title": "The Deubiquitinating Enzyme Ataxin-3 Regulates Ciliogenesis and Phagocytosis in the Retina",
          "relevant_quote": "Abrogation of Atxn3 expression causes decreased levels of the regulatory protein KEAP1 in the retina and delayed phagosome maturation in the retinal pigment epithelium."
        },
        {
          "doi": "10.1074/jbc.M300931200",
          "year": 2003,
          "assay": "Western Blot, Transfection",
          "authors": "Michael McMahon, Ken Itoh, Masayuki Yamamoto, John D Hayes",
          "journal": "The Journal of Biological Chemistry",
          "species": "rat, monkey",
          "paper_title": "Keap1-dependent proteasomal degradation of transcription factor Nrf2 contributes to the negative regulation of antioxidant response element-driven gene expression",
          "relevant_quote": "under homeostatic conditions Nrf2 is subject to a substantially more rapid mode of proteasomal degradation than it is in oxidatively stressed cells, and this rapid turnover of Nrf2 requires it to interact with Keap1."
        },
        {
          "doi": "10.1158/0008-5472.CAN-13-1655",
          "year": 2014,
          "assay": "Biochemical Assay, Western Blot",
          "authors": "Bridgid E Hast, Erica W Cloer, Dennis Goldfarb, Heng Li, Priscila F Siesser, Feng Yan, Vonn Walter, Ning Zheng, D Neil Hayes, Michael B Major",
          "journal": "Cancer Research",
          "species": "human",
          "paper_title": "Cancer-derived mutations in KEAP1 impair NRF2 degradation but not ubiquitination",
          "relevant_quote": "NRF2 is a transcription factor that mediates stress responses. Oncogenic mutations in NRF2 localize to one of its two binding interfaces with KEAP1, an E3 ubiquitin ligase that promotes proteasome-dependent degradation of NRF2."
        }
      ],
      "_original_direction": "main_to_primary",
      "upstream_interactor": null,
      "mediator_chain": [],
      "depth": 1,
      "interaction_effect": "regulation",
      "_validation_metadata": {
        "validated": true,
        "validator": "arrow_effect_validator",
        "corrections_applied": 3,
        "validated_at": "2025-11-18T01:18:20.318395"
      },
      "_arrow_validated": true
    },
    "corrected_data": {
      "primary": "KEAP1",
      "direction": "main_to_primary",
      "arrow": "regulates",
      "interaction_type": "indirect",
      "functions": [
        {
          "arrow": "inhibits",
          "pmids": [
            "33176149",
            "12682069"
          ],
          "evidence": [
            {
              "doi": "10.1016/j.celrep.2020.108360",
              "pmid": "33176149",
              "year": 2020,
              "assay": "Proteomics, Western Blot",
              "authors": "Vasileios Toulis, Sílvia García-Monclús, Carlos de la Peña-Ramírez, Rodrigo Arenas-Galnares, Josep F Abril, Sokol V Todi, Naheed Khan, Alejandro Garanto, Maria do Carmo Costa, Gemma Marfany",
              "journal": "Cell Reports",
              "species": "mouse, human",
              "paper_title": "The Deubiquitinating Enzyme Ataxin-3 Regulates Ciliogenesis and Phagocytosis in the Retina",
              "relevant_quote": "Abrogation of Atxn3 expression causes decreased levels of the regulatory protein KEAP1 in the retina and delayed phagosome maturation in the retinal pigment epithelium."
            },
            {
              "doi": "10.1074/jbc.M300931200",
              "pmid": "12682069",
              "year": 2003,
              "assay": "Western Blot, Transfection",
              "authors": "Michael McMahon, Ken Itoh, Masayuki Yamamoto, John D Hayes",
              "journal": "The Journal of Biological Chemistry",
              "species": "rat, monkey",
              "paper_title": "Keap1-dependent proteasomal degradation of transcription factor Nrf2 contributes to the negative regulation of antioxidant response element-driven gene expression",
              "relevant_quote": "under homeostatic conditions Nrf2 is subject to a substantially more rapid mode of proteasomal degradation than it is in oxidatively stressed cells, and this rapid turnover of Nrf2 requires it to interact with Keap1."
            },
            {
              "doi": "10.1016/j.celrep.2020.108360",
              "pmid": "33176149",
              "year": 2020,
              "assay": "Western blot|Proteomics|qRT-PCR",
              "authors": "Toulis V, Krol J, Patel R, Tsefou E, Tsortos S, Kelly G, Sanderson J, Charalambous M, Schuster-Böckler B, Wackerhage H, Rozanska A, Cheetham ME, Hardcastle AJ, Moosajee M",
              "journal": "Cell Rep",
              "species": "mouse|human|zebrafish",
              "paper_title": "The Deubiquitinating Enzyme Ataxin-3 Regulates Ciliogenesis and Phagocytosis in the Retina",
              "relevant_quote": "Depletion of ATXN3 lead to destabilization of the KEAP1 protein (decreased half-life), further supporting ATXN3 as a regulator of KEAP1 turnover... our results suggest that ATXN3 promotes the stability of KEAP1 by slowing down its degradation..."
            }
          ],
          "function": "Antioxidant Gene Transcription",
          "validity": "TRUE",
          "net_arrow": "inhibits",
          "consequences": "ATXN3 acts as a transcriptional coactivator for FOXO4 → Increased binding of the ATXN3-FOXO4 complex to the superoxide dismutase 2 (SOD2) promoter → Upregulation of SOD2 expression → Enhanced cellular defense against oxidative stress",
          "direct_arrow": "inhibits",
          "arrow_context": {
            "direct_from": null,
            "direct_arrow": "inhibits",
            "net_from": "ATXN3",
            "net_arrow": "inhibits",
            "mediator_chain": [],
            "is_indirect": true
          },
          "evidence_source": "fact_checker_verified",
          "validation_note": "The claim is fully supported by the literature. A 2020 paper by Toulis et al. in Cell Reports provides direct evidence that ATXN3 stabilizes the KEAP1 protein. The paper shows that depletion of Atxn3 in mouse retina and knockdown in human cells leads to decreased levels and destabilization of KEAP1, and a corresponding increase in NRF2 levels. All fields of the function box are consistent with these findings and canonical knowledge of the KEAP1-NRF2 pathway.",
          "cellular_process": "ATXN3 stabilizes KEAP1, a substrate adaptor for a CUL3-based E3 ligase that targets the transcription factor NRF2 for proteasomal degradation under basal conditions. By maintaining KEAP1 levels, ATXN3 enhances the ubiquitination and subsequent degradation of NRF2.",
          "specific_effects": [
            "Abrogation of Atxn3 expression causes decreased levels of the regulatory protein KEAP1 in the retina.",
            "Depletion of ATXN3 leads to destabilization of the KEAP1 protein (decreased half-life).",
            "KEAP1 targets NRF2 for proteasome-dependent degradation.",
            "Knockdown of ATXN3 in human cells leads to increased levels of NRF2."
          ],
          "effect_description": "ATXN3 activity leads to the suppression of the NRF2-mediated antioxidant response by promoting the degradation of NRF2.",
          "interaction_effect": "inhibition",
          "interaction_direction": "main_to_primary",
          "biological_consequence": [
            "ATXN3 stabilizes KEAP1 protein → Enhanced CUL3-KEAP1 E3 ligase activity → Increased ubiquitination and proteasomal degradation of NRF2 → Repression of antioxidant response element (ARE)-driven gene expression → Reduced cellular defense against oxidative stress"
          ]
        }
      ],
      "evidence": [
        {
          "doi": "10.1016/j.celrep.2020.108360",
          "year": 2020,
          "assay": "Proteomics, Western Blot",
          "authors": "Vasileios Toulis, Sílvia García-Monclús, Carlos de la Peña-Ramírez, Rodrigo Arenas-Galnares, Josep F Abril, Sokol V Todi, Naheed Khan, Alejandro Garanto, Maria do Carmo Costa, Gemma Marfany",
          "journal": "Cell Reports",
          "species": "mouse, human",
          "paper_title": "The Deubiquitinating Enzyme Ataxin-3 Regulates Ciliogenesis and Phagocytosis in the Retina",
          "relevant_quote": "Abrogation of Atxn3 expression causes decreased levels of the regulatory protein KEAP1 in the retina and delayed phagosome maturation in the retinal pigment epithelium."
        },
        {
          "doi": "10.1074/jbc.M300931200",
          "year": 2003,
          "assay": "Western Blot, Transfection",
          "authors": "Michael McMahon, Ken Itoh, Masayuki Yamamoto, John D Hayes",
          "journal": "The Journal of Biological Chemistry",
          "species": "rat, monkey",
          "paper_title": "Keap1-dependent proteasomal degradation of transcription factor Nrf2 contributes to the negative regulation of antioxidant response element-driven gene expression",
          "relevant_quote": "under homeostatic conditions Nrf2 is subject to a substantially more rapid mode of proteasomal degradation than it is in oxidatively stressed cells, and this rapid turnover of Nrf2 requires it to interact with Keap1."
        },
        {
          "doi": "10.1158/0008-5472.CAN-13-1655",
          "year": 2014,
          "assay": "Biochemical Assay, Western Blot",
          "authors": "Bridgid E Hast, Erica W Cloer, Dennis Goldfarb, Heng Li, Priscila F Siesser, Feng Yan, Vonn Walter, Ning Zheng, D Neil Hayes, Michael B Major",
          "journal": "Cancer Research",
          "species": "human",
          "paper_title": "Cancer-derived mutations in KEAP1 impair NRF2 degradation but not ubiquitination",
          "relevant_quote": "NRF2 is a transcription factor that mediates stress responses. Oncogenic mutations in NRF2 localize to one of its two binding interfaces with KEAP1, an E3 ubiquitin ligase that promotes proteasome-dependent degradation of NRF2."
        }
      ],
      "_original_direction": "main_to_primary",
      "upstream_interactor": null,
      "mediator_chain": [],
      "depth": 1,
      "interaction_effect": "regulation",
      "_validation_metadata": {
        "validated": true,
        "validator": "arrow_effect_validator",
        "corrections_applied": 3,
        "validated_at": "2025-11-18T01:18:20.318395"
      },
      "_arrow_validated": true
    },
    "corrections_count": 3,
    "chain_context": {
      "interaction_type": "indirect",
      "mediator_chain": [],
      "upstream_interactor": null,
      "depth": 1
    }
  },
  {
    "interaction_id": 27,
    "main_protein": "ATXN3",
    "partner_protein": "KEAP1",
    "original_data": {
      "primary": "KEAP1",
      "direction": "main_to_primary",
      "arrow": "activates",
      "interaction_type": "indirect",
      "functions": [
        {
          "arrow": "activates",
          "pmids": [
            "33176149"
          ],
          "evidence": [
            {
              "doi": "10.1016/j.celrep.2020.108360",
              "pmid": "33176149",
              "year": 2020,
              "assay": "Western Blot",
              "authors": "Toulis V, et al.",
              "journal": "Cell Rep",
              "species": "mouse",
              "paper_title": "The Deubiquitinating Enzyme Ataxin-3 Regulates Ciliogenesis and Phagocytosis in the Retina",
              "relevant_quote": "Abrogation of Atxn3 expression causes decreased levels of the regulatory protein KEAP1 in the retina and delayed phagosome maturation in the retinal pigment epithelium."
            }
          ],
          "function": "KEAP1 Protein Level Maintenance",
          "validity": "FALSE",
          "direction": "main_to_primary",
          "mechanism": "",
          "net_arrow": "activates",
          "effect_type": "",
          "direct_arrow": "inhibits",
          "arrow_context": {
            "direct_from": "KEAP1",
            "direct_arrow": "inhibits",
            "net_from": "ATXN3",
            "net_arrow": "activates",
            "mediator_chain": [
              "KEAP1"
            ],
            "is_indirect": true
          },
          "evidence_source": "fact_checker_salvaged_from_false",
          "validation_note": "The claim is marked FALSE because it fundamentally misrepresents the literature. It claims that ATXN3's function is to destabilize KEAP1, based on the observation that ATXN3 depletion leads to lower KEAP1 levels. This is a logical inversion. The evidence shows that ATXN3 is required to *maintain* KEAP1 levels. The claim's 'Cellular Process' and 'Effect Description' are contradictory. While some individual fields are correct, the overall functional claim is incorrect. A corrected function is provided to accurately reflect that ATXN3 maintains KEAP1 levels.",
          "cellular_process": "ATXN3 is required for the maintenance of KEAP1 protein levels. Abrogation of Atxn3 expression leads to decreased levels of the regulatory protein KEAP1 in the retina.",
          "specific_effects": [
            "Abrogation of Atxn3 expression causes decreased levels of KEAP1 in the retina."
          ],
          "effect_description": "By maintaining appropriate levels of KEAP1, the primary negative regulator of NRF2, ATXN3 helps to regulate the basal activity of the NRF2 antioxidant response pathway.",
          "interaction_effect": "activates",
          "interaction_direction": "main_to_primary",
          "biological_consequence": [
            "ATXN3 maintains KEAP1 protein levels",
            "KEAP1 sequesters NRF2 in the cytoplasm",
            "KEAP1 facilitates NRF2 ubiquitination and degradation",
            "Basal antioxidant gene expression is suppressed"
          ],
          "original_function_name": "KEAP1 Protein Stability",
          "_was_false_but_corrected": true
        },
        {
          "arrow": "inhibits",
          "pmids": [
            "33176149",
            "12682069"
          ],
          "evidence": [
            {
              "doi": "10.1016/j.celrep.2020.108360",
              "pmid": "33176149",
              "year": 2020,
              "assay": "Proteomics, Western Blot",
              "authors": "Vasileios Toulis, Sílvia García-Monclús, Carlos de la Peña-Ramírez, Rodrigo Arenas-Galnares, Josep F Abril, Sokol V Todi, Naheed Khan, Alejandro Garanto, Maria do Carmo Costa, Gemma Marfany",
              "journal": "Cell Reports",
              "species": "mouse, human",
              "paper_title": "The Deubiquitinating Enzyme Ataxin-3 Regulates Ciliogenesis and Phagocytosis in the Retina",
              "relevant_quote": "Abrogation of Atxn3 expression causes decreased levels of the regulatory protein KEAP1 in the retina and delayed phagosome maturation in the retinal pigment epithelium."
            },
            {
              "doi": "10.1074/jbc.M300931200",
              "pmid": "12682069",
              "year": 2003,
              "assay": "Western Blot, Transfection",
              "authors": "Michael McMahon, Ken Itoh, Masayuki Yamamoto, John D Hayes",
              "journal": "The Journal of Biological Chemistry",
              "species": "rat, monkey",
              "paper_title": "Keap1-dependent proteasomal degradation of transcription factor Nrf2 contributes to the negative regulation of antioxidant response element-driven gene expression",
              "relevant_quote": "under homeostatic conditions Nrf2 is subject to a substantially more rapid mode of proteasomal degradation than it is in oxidatively stressed cells, and this rapid turnover of Nrf2 requires it to interact with Keap1."
            },
            {
              "doi": "10.1016/j.celrep.2020.108360",
              "pmid": "33176149",
              "year": 2020,
              "assay": "Western blot|Proteomics|qRT-PCR",
              "authors": "Toulis V, Krol J, Patel R, Tsefou E, Tsortos S, Kelly G, Sanderson J, Charalambous M, Schuster-Böckler B, Wackerhage H, Rozanska A, Cheetham ME, Hardcastle AJ, Moosajee M",
              "journal": "Cell Rep",
              "species": "mouse|human|zebrafish",
              "paper_title": "The Deubiquitinating Enzyme Ataxin-3 Regulates Ciliogenesis and Phagocytosis in the Retina",
              "relevant_quote": "Depletion of ATXN3 lead to destabilization of the KEAP1 protein (decreased half-life), further supporting ATXN3 as a regulator of KEAP1 turnover... our results suggest that ATXN3 promotes the stability of KEAP1 by slowing down its degradation..."
            }
          ],
          "function": "Antioxidant Gene Transcription",
          "validity": "TRUE",
          "net_arrow": "inhibits",
          "direct_arrow": "inhibits",
          "arrow_context": {
            "direct_from": "KEAP1",
            "direct_arrow": "inhibits",
            "net_from": "ATXN3",
            "net_arrow": "inhibits",
            "mediator_chain": [
              "KEAP1"
            ],
            "is_indirect": true
          },
          "evidence_source": "fact_checker_verified",
          "validation_note": "The claim is fully supported by the literature. A 2020 paper by Toulis et al. in Cell Reports provides direct evidence that ATXN3 stabilizes the KEAP1 protein. The paper shows that depletion of Atxn3 in mouse retina and knockdown in human cells leads to decreased levels and destabilization of KEAP1, and a corresponding increase in NRF2 levels. All fields of the function box are consistent with these findings and canonical knowledge of the KEAP1-NRF2 pathway.",
          "cellular_process": "ATXN3 stabilizes KEAP1, a substrate adaptor for a CUL3-based E3 ligase that targets the transcription factor NRF2 for proteasomal degradation under basal conditions. By maintaining KEAP1 levels, ATXN3 enhances the ubiquitination and subsequent degradation of NRF2.",
          "specific_effects": [
            "Abrogation of Atxn3 expression causes decreased levels of the regulatory protein KEAP1 in the retina.",
            "Depletion of ATXN3 leads to destabilization of the KEAP1 protein (decreased half-life).",
            "KEAP1 targets NRF2 for proteasome-dependent degradation.",
            "Knockdown of ATXN3 in human cells leads to increased levels of NRF2."
          ],
          "effect_description": "ATXN3 activity leads to the suppression of the NRF2-mediated antioxidant response by promoting the degradation of NRF2.",
          "interaction_effect": "inhibits",
          "interaction_direction": "main_to_primary",
          "biological_consequence": [
            "ATXN3 stabilizes KEAP1 protein → Enhanced CUL3-KEAP1 E3 ligase activity → Increased ubiquitination and proteasomal degradation of NRF2 → Repression of antioxidant response element (ARE)-driven gene expression → Reduced cellular defense against oxidative stress"
          ]
        }
      ],
      "evidence": [
        {
          "doi": "10.1016/j.celrep.2020.108360",
          "year": 2020,
          "assay": "Western Blot",
          "authors": "Toulis V, García-Monclús S, de la Peña-Ramírez C, Arenas-Galnares R, Sánchez-Sáez X, Crespí-Vázquez J, López de la Osa D, Esquerdo M, Méndez-López I, Fernández-Sánchez L, Cuenca N, Abril JF, Garanto A, Costa Mdo C, Marfany G",
          "journal": "Cell Reports",
          "species": "mouse, zebrafish",
          "paper_title": "The Deubiquitinating Enzyme Ataxin-3 Regulates Ciliogenesis and Phagocytosis in the Retina",
          "relevant_quote": "Abrogation of Atxn3 expression causes decreased levels of the regulatory protein KEAP1 in the retina and delayed phagosome maturation in the retinal pigment epithelium."
        },
        {
          "doi": "10.1016/j.celrep.2020.108360",
          "year": 2020,
          "assay": "Immunofluorescence, Electron Microscopy",
          "authors": "Toulis V, García-Monclús S, de la Peña-Ramírez C, Arenas-Galnares R, Sánchez-Sáez X, Crespí-Vázquez J, López de la Osa D, Esquerdo M, Méndez-López I, Fernández-Sánchez L, Cuenca N, Abril JF, Garanto A, Costa Mdo C, Marfany G",
          "journal": "Cell Reports",
          "species": "mouse, zebrafish, human cells",
          "paper_title": "The Deubiquitinating Enzyme Ataxin-3 Regulates Ciliogenesis and Phagocytosis in the Retina",
          "relevant_quote": "Depletion of Atxn3 in zebrafish and mice causes morphological and functional retinal alterations and, more precisely, photoreceptor cilium and outer segment elongation, cone opsin mislocalization, and cone hyperexcitation."
        },
        {
          "doi": "10.1016/j.celrep.2020.108360",
          "year": 2020,
          "assay": "Proteomics, Western Blot",
          "authors": "Vasileios Toulis, Sílvia García-Monclús, Carlos de la Peña-Ramírez, Rodrigo Arenas-Galnares, Josep F Abril, Sokol V Todi, Naheed Khan, Alejandro Garanto, Maria do Carmo Costa, Gemma Marfany",
          "journal": "Cell Reports",
          "species": "mouse, human",
          "paper_title": "The Deubiquitinating Enzyme Ataxin-3 Regulates Ciliogenesis and Phagocytosis in the Retina",
          "relevant_quote": "Abrogation of Atxn3 expression causes decreased levels of the regulatory protein KEAP1 in the retina and delayed phagosome maturation in the retinal pigment epithelium."
        },
        {
          "doi": "10.1074/jbc.M300931200",
          "year": 2003,
          "assay": "Western Blot, Transfection",
          "authors": "Michael McMahon, Ken Itoh, Masayuki Yamamoto, John D Hayes",
          "journal": "The Journal of Biological Chemistry",
          "species": "rat, monkey",
          "paper_title": "Keap1-dependent proteasomal degradation of transcription factor Nrf2 contributes to the negative regulation of antioxidant response element-driven gene expression",
          "relevant_quote": "under homeostatic conditions Nrf2 is subject to a substantially more rapid mode of proteasomal degradation than it is in oxidatively stressed cells, and this rapid turnover of Nrf2 requires it to interact with Keap1."
        },
        {
          "doi": "10.1158/0008-5472.CAN-13-1655",
          "year": 2014,
          "assay": "Biochemical Assay, Western Blot",
          "authors": "Bridgid E Hast, Erica W Cloer, Dennis Goldfarb, Heng Li, Priscila F Siesser, Feng Yan, Vonn Walter, Ning Zheng, D Neil Hayes, Michael B Major",
          "journal": "Cancer Research",
          "species": "human",
          "paper_title": "Cancer-derived mutations in KEAP1 impair NRF2 degradation but not ubiquitination",
          "relevant_quote": "NRF2 is a transcription factor that mediates stress responses. Oncogenic mutations in NRF2 localize to one of its two binding interfaces with KEAP1, an E3 ubiquitin ligase that promotes proteasome-dependent degradation of NRF2."
        }
      ],
      "_original_direction": "main_to_primary",
      "upstream_interactor": "KEAP1",
      "mediator_chain": [
        "KEAP1"
      ],
      "depth": 2,
      "interaction_effect": "activation",
      "_validation_metadata": {
        "validated": true,
        "validator": "arrow_effect_validator",
        "corrections_applied": 1,
        "validated_at": "2025-11-18T01:18:21.936787"
      },
      "_arrow_validated": true
    },
    "corrected_data": {
      "primary": "KEAP1",
      "direction": "main_to_primary",
      "arrow": "activates",
      "interaction_type": "indirect",
      "functions": [
        {
          "arrow": "activates",
          "pmids": [
            "33176149"
          ],
          "evidence": [
            {
              "doi": "10.1016/j.celrep.2020.108360",
              "pmid": "33176149",
              "year": 2020,
              "assay": "Western Blot",
              "authors": "Toulis V, et al.",
              "journal": "Cell Rep",
              "species": "mouse",
              "paper_title": "The Deubiquitinating Enzyme Ataxin-3 Regulates Ciliogenesis and Phagocytosis in the Retina",
              "relevant_quote": "Abrogation of Atxn3 expression causes decreased levels of the regulatory protein KEAP1 in the retina and delayed phagosome maturation in the retinal pigment epithelium."
            }
          ],
          "function": "KEAP1 Protein Level Maintenance",
          "validity": "FALSE",
          "direction": "main_to_primary",
          "mechanism": "",
          "net_arrow": "activates",
          "effect_type": "",
          "direct_arrow": "inhibits",
          "arrow_context": {
            "direct_from": "KEAP1",
            "direct_arrow": "inhibits",
            "net_from": "ATXN3",
            "net_arrow": "activates",
            "mediator_chain": [
              "KEAP1"
            ],
            "is_indirect": true
          },
          "evidence_source": "fact_checker_salvaged_from_false",
          "validation_note": "The claim is marked FALSE because it fundamentally misrepresents the literature. It claims that ATXN3's function is to destabilize KEAP1, based on the observation that ATXN3 depletion leads to lower KEAP1 levels. This is a logical inversion. The evidence shows that ATXN3 is required to *maintain* KEAP1 levels. The claim's 'Cellular Process' and 'Effect Description' are contradictory. While some individual fields are correct, the overall functional claim is incorrect. A corrected function is provided to accurately reflect that ATXN3 maintains KEAP1 levels.",
          "cellular_process": "ATXN3 is required for the maintenance of KEAP1 protein levels. Abrogation of Atxn3 expression leads to decreased levels of the regulatory protein KEAP1 in the retina.",
          "specific_effects": [
            "Abrogation of Atxn3 expression causes decreased levels of KEAP1 in the retina."
          ],
          "effect_description": "By maintaining appropriate levels of KEAP1, the primary negative regulator of NRF2, ATXN3 helps to regulate the basal activity of the NRF2 antioxidant response pathway.",
          "interaction_effect": "activates",
          "interaction_direction": "main_to_primary",
          "biological_consequence": [
            "ATXN3 maintains KEAP1 protein levels",
            "KEAP1 sequesters NRF2 in the cytoplasm",
            "KEAP1 facilitates NRF2 ubiquitination and degradation",
            "Basal antioxidant gene expression is suppressed"
          ],
          "original_function_name": "KEAP1 Protein Stability",
          "_was_false_but_corrected": true
        },
        {
          "arrow": "inhibits",
          "pmids": [
            "33176149",
            "12682069"
          ],
          "evidence": [
            {
              "doi": "10.1016/j.celrep.2020.108360",
              "pmid": "33176149",
              "year": 2020,
              "assay": "Proteomics, Western Blot",
              "authors": "Vasileios Toulis, Sílvia García-Monclús, Carlos de la Peña-Ramírez, Rodrigo Arenas-Galnares, Josep F Abril, Sokol V Todi, Naheed Khan, Alejandro Garanto, Maria do Carmo Costa, Gemma Marfany",
              "journal": "Cell Reports",
              "species": "mouse, human",
              "paper_title": "The Deubiquitinating Enzyme Ataxin-3 Regulates Ciliogenesis and Phagocytosis in the Retina",
              "relevant_quote": "Abrogation of Atxn3 expression causes decreased levels of the regulatory protein KEAP1 in the retina and delayed phagosome maturation in the retinal pigment epithelium."
            },
            {
              "doi": "10.1074/jbc.M300931200",
              "pmid": "12682069",
              "year": 2003,
              "assay": "Western Blot, Transfection",
              "authors": "Michael McMahon, Ken Itoh, Masayuki Yamamoto, John D Hayes",
              "journal": "The Journal of Biological Chemistry",
              "species": "rat, monkey",
              "paper_title": "Keap1-dependent proteasomal degradation of transcription factor Nrf2 contributes to the negative regulation of antioxidant response element-driven gene expression",
              "relevant_quote": "under homeostatic conditions Nrf2 is subject to a substantially more rapid mode of proteasomal degradation than it is in oxidatively stressed cells, and this rapid turnover of Nrf2 requires it to interact with Keap1."
            },
            {
              "doi": "10.1016/j.celrep.2020.108360",
              "pmid": "33176149",
              "year": 2020,
              "assay": "Western blot|Proteomics|qRT-PCR",
              "authors": "Toulis V, Krol J, Patel R, Tsefou E, Tsortos S, Kelly G, Sanderson J, Charalambous M, Schuster-Böckler B, Wackerhage H, Rozanska A, Cheetham ME, Hardcastle AJ, Moosajee M",
              "journal": "Cell Rep",
              "species": "mouse|human|zebrafish",
              "paper_title": "The Deubiquitinating Enzyme Ataxin-3 Regulates Ciliogenesis and Phagocytosis in the Retina",
              "relevant_quote": "Depletion of ATXN3 lead to destabilization of the KEAP1 protein (decreased half-life), further supporting ATXN3 as a regulator of KEAP1 turnover... our results suggest that ATXN3 promotes the stability of KEAP1 by slowing down its degradation..."
            }
          ],
          "function": "Antioxidant Gene Transcription",
          "validity": "TRUE",
          "net_arrow": "inhibits",
          "direct_arrow": "inhibits",
          "arrow_context": {
            "direct_from": "KEAP1",
            "direct_arrow": "inhibits",
            "net_from": "ATXN3",
            "net_arrow": "inhibits",
            "mediator_chain": [
              "KEAP1"
            ],
            "is_indirect": true
          },
          "evidence_source": "fact_checker_verified",
          "validation_note": "The claim is fully supported by the literature. A 2020 paper by Toulis et al. in Cell Reports provides direct evidence that ATXN3 stabilizes the KEAP1 protein. The paper shows that depletion of Atxn3 in mouse retina and knockdown in human cells leads to decreased levels and destabilization of KEAP1, and a corresponding increase in NRF2 levels. All fields of the function box are consistent with these findings and canonical knowledge of the KEAP1-NRF2 pathway.",
          "cellular_process": "ATXN3 stabilizes KEAP1, a substrate adaptor for a CUL3-based E3 ligase that targets the transcription factor NRF2 for proteasomal degradation under basal conditions. By maintaining KEAP1 levels, ATXN3 enhances the ubiquitination and subsequent degradation of NRF2.",
          "specific_effects": [
            "Abrogation of Atxn3 expression causes decreased levels of the regulatory protein KEAP1 in the retina.",
            "Depletion of ATXN3 leads to destabilization of the KEAP1 protein (decreased half-life).",
            "KEAP1 targets NRF2 for proteasome-dependent degradation.",
            "Knockdown of ATXN3 in human cells leads to increased levels of NRF2."
          ],
          "effect_description": "ATXN3 activity leads to the suppression of the NRF2-mediated antioxidant response by promoting the degradation of NRF2.",
          "interaction_effect": "inhibits",
          "interaction_direction": "main_to_primary",
          "biological_consequence": [
            "ATXN3 stabilizes KEAP1 protein → Enhanced CUL3-KEAP1 E3 ligase activity → Increased ubiquitination and proteasomal degradation of NRF2 → Repression of antioxidant response element (ARE)-driven gene expression → Reduced cellular defense against oxidative stress"
          ]
        }
      ],
      "evidence": [
        {
          "doi": "10.1016/j.celrep.2020.108360",
          "year": 2020,
          "assay": "Western Blot",
          "authors": "Toulis V, García-Monclús S, de la Peña-Ramírez C, Arenas-Galnares R, Sánchez-Sáez X, Crespí-Vázquez J, López de la Osa D, Esquerdo M, Méndez-López I, Fernández-Sánchez L, Cuenca N, Abril JF, Garanto A, Costa Mdo C, Marfany G",
          "journal": "Cell Reports",
          "species": "mouse, zebrafish",
          "paper_title": "The Deubiquitinating Enzyme Ataxin-3 Regulates Ciliogenesis and Phagocytosis in the Retina",
          "relevant_quote": "Abrogation of Atxn3 expression causes decreased levels of the regulatory protein KEAP1 in the retina and delayed phagosome maturation in the retinal pigment epithelium."
        },
        {
          "doi": "10.1016/j.celrep.2020.108360",
          "year": 2020,
          "assay": "Immunofluorescence, Electron Microscopy",
          "authors": "Toulis V, García-Monclús S, de la Peña-Ramírez C, Arenas-Galnares R, Sánchez-Sáez X, Crespí-Vázquez J, López de la Osa D, Esquerdo M, Méndez-López I, Fernández-Sánchez L, Cuenca N, Abril JF, Garanto A, Costa Mdo C, Marfany G",
          "journal": "Cell Reports",
          "species": "mouse, zebrafish, human cells",
          "paper_title": "The Deubiquitinating Enzyme Ataxin-3 Regulates Ciliogenesis and Phagocytosis in the Retina",
          "relevant_quote": "Depletion of Atxn3 in zebrafish and mice causes morphological and functional retinal alterations and, more precisely, photoreceptor cilium and outer segment elongation, cone opsin mislocalization, and cone hyperexcitation."
        },
        {
          "doi": "10.1016/j.celrep.2020.108360",
          "year": 2020,
          "assay": "Proteomics, Western Blot",
          "authors": "Vasileios Toulis, Sílvia García-Monclús, Carlos de la Peña-Ramírez, Rodrigo Arenas-Galnares, Josep F Abril, Sokol V Todi, Naheed Khan, Alejandro Garanto, Maria do Carmo Costa, Gemma Marfany",
          "journal": "Cell Reports",
          "species": "mouse, human",
          "paper_title": "The Deubiquitinating Enzyme Ataxin-3 Regulates Ciliogenesis and Phagocytosis in the Retina",
          "relevant_quote": "Abrogation of Atxn3 expression causes decreased levels of the regulatory protein KEAP1 in the retina and delayed phagosome maturation in the retinal pigment epithelium."
        },
        {
          "doi": "10.1074/jbc.M300931200",
          "year": 2003,
          "assay": "Western Blot, Transfection",
          "authors": "Michael McMahon, Ken Itoh, Masayuki Yamamoto, John D Hayes",
          "journal": "The Journal of Biological Chemistry",
          "species": "rat, monkey",
          "paper_title": "Keap1-dependent proteasomal degradation of transcription factor Nrf2 contributes to the negative regulation of antioxidant response element-driven gene expression",
          "relevant_quote": "under homeostatic conditions Nrf2 is subject to a substantially more rapid mode of proteasomal degradation than it is in oxidatively stressed cells, and this rapid turnover of Nrf2 requires it to interact with Keap1."
        },
        {
          "doi": "10.1158/0008-5472.CAN-13-1655",
          "year": 2014,
          "assay": "Biochemical Assay, Western Blot",
          "authors": "Bridgid E Hast, Erica W Cloer, Dennis Goldfarb, Heng Li, Priscila F Siesser, Feng Yan, Vonn Walter, Ning Zheng, D Neil Hayes, Michael B Major",
          "journal": "Cancer Research",
          "species": "human",
          "paper_title": "Cancer-derived mutations in KEAP1 impair NRF2 degradation but not ubiquitination",
          "relevant_quote": "NRF2 is a transcription factor that mediates stress responses. Oncogenic mutations in NRF2 localize to one of its two binding interfaces with KEAP1, an E3 ubiquitin ligase that promotes proteasome-dependent degradation of NRF2."
        }
      ],
      "_original_direction": "main_to_primary",
      "upstream_interactor": "KEAP1",
      "mediator_chain": [
        "KEAP1"
      ],
      "depth": 2,
      "interaction_effect": "activation",
      "_validation_metadata": {
        "validated": true,
        "validator": "arrow_effect_validator",
        "corrections_applied": 1,
        "validated_at": "2025-11-18T01:18:21.936787"
      },
      "_arrow_validated": true
    },
    "corrections_count": 1,
    "chain_context": {
      "interaction_type": "indirect",
      "mediator_chain": [
        "KEAP1"
      ],
      "upstream_interactor": "KEAP1",
      "depth": 2
    }
  },
  {
    "interaction_id": 35,
    "main_protein": "ATXN3",
    "partner_protein": "UBQLN2",
    "original_data": {
      "primary": "UBQLN2",
      "direction": null,
      "arrow": "regulates",
      "interaction_type": "indirect",
      "functions": [
        {
          "arrow": "no_effect",
          "pmids": [
            "26141599"
          ],
          "evidence": [
            {
              "doi": "10.1016/j.nbd.2015.06.017",
              "pmid": "26141599",
              "year": 2015,
              "assay": "Immunohistochemistry, Co-Immunoprecipitation",
              "authors": "Li Zeng, Bo Wang, Sean A Merillat, Eiko N Minakawa, Michael D Perkins, Bharathi Ramani, Sarah J Tallaksen-Greene, Maria do Carmo Costa, Roger L Albin, Henry L Paulson",
              "journal": "Neurobiology of Disease",
              "species": "human, mouse",
              "paper_title": "Differential recruitment of UBQLN2 to nuclear inclusions in the polyglutamine diseases HD and SCA3",
              "relevant_quote": "...in a cell-based system mutant HTT interacts with UBQLN2 through the UBA domain while the SCA3 disease protein ATXN3, a deubiquitinating enzyme, does not interact with UBQLN2."
            },
            {
              "doi": "10.1016/j.nbd.2015.06.017",
              "pmid": "26141599",
              "year": 2015,
              "assay": "Co-Immunoprecipitation, Immunohistochemistry",
              "authors": "Safren N, Bieri G, Svarcas NA, Enggist E, Hwe DH, Livas P, Geva M, Tam S, Gat-Viks I, Al-Ramahi I, Zoghbi HY, Botas J, Paulson HL",
              "journal": "Neurobiol Dis",
              "species": "human, mouse, cultured cells (HEK293)",
              "paper_title": "Differential recruitment of UBQLN2 to nuclear inclusions in the polyglutamine diseases HD and SCA3",
              "relevant_quote": "Consistent with this result, in a cell-based system mutant HTT interacts with UBQLN2 through the UBA domain while the SCA3 disease protein ATXN3, a deubiquitinating enzyme, does not interact with UBQLN2."
            }
          ],
          "function": "Protein Aggregation and Clearance",
          "validity": "TRUE",
          "evidence_source": "fact_checker_verified",
          "validation_note": "The claim accurately represents a key negative finding in the literature. All aspects of the claim, from the lack of physical interaction to the differential recruitment of UBQLN2 to inclusions in SCA3 vs. HD, are strongly supported by experimental evidence. The only minor inaccuracy is the use of the word 'inhibits' for the arrow, which has been corrected in the refined function.",
          "cellular_process": "UBQLN2 is a key component of the cellular protein quality control system, shuttling ubiquitinated proteins to the proteasome. Despite the involvement of both ATXN3 and UBQLN2 in proteostasis, co-immunoprecipitation and co-localization studies have shown they do not physically interact. UBQLN2 is selectively recruited to inclusions in Huntington's disease (HD) but is absent from the ATXN3-positive inclusions in Spinocerebellar Ataxia Type 3 (SCA3).",
          "specific_effects": [
            "Co-precipitation studies in cultured cells failed to show an interaction between UBQLN2 and either normal or expanded ATXN3.",
            "UBQLN2 is selectively recruited to nuclear inclusions in Huntington's disease but not in Spinocerebellar Ataxia Type 3.",
            "ATXN3 is not a substrate for UBQLN2-mediated clearance."
          ],
          "effect_description": "This is a negative finding; UBQLN2 does not interact with ATXN3. This lack of interaction distinguishes the pathology of SCA3 from other polyglutamine diseases like HD.",
          "interaction_effect": "neutral",
          "interaction_direction": null,
          "biological_consequence": [
            "Lack of ATXN3-UBQLN2 physical interaction → Failure to recruit UBQLN2 to ATXN3-positive inclusions → Absence of UBQLN2 in SCA3 inclusions → Differential protein quality control response in SCA3 vs. Huntington's disease"
          ],
          "arrow_context": {
            "direct_from": null,
            "direct_arrow": "no_effect",
            "net_from": "ATXN3",
            "net_arrow": "no_effect",
            "mediator_chain": [],
            "is_indirect": true
          },
          "net_arrow": "no_effect",
          "direct_arrow": "no_effect"
        }
      ],
      "evidence": [
        {
          "doi": "10.1016/j.nbd.2015.06.017",
          "year": 2015,
          "assay": "Immunohistochemistry, Co-Immunoprecipitation",
          "authors": "Li Zeng, Bo Wang, Sean A Merillat, Eiko N Minakawa, Michael D Perkins, Bharathi Ramani, Sarah J Tallaksen-Greene, Maria do Carmo Costa, Roger L Albin, Henry L Paulson",
          "journal": "Neurobiology of Disease",
          "species": "human, mouse",
          "paper_title": "Differential recruitment of UBQLN2 to nuclear inclusions in the polyglutamine diseases HD and SCA3",
          "relevant_quote": "...in a cell-based system mutant HTT interacts with UBQLN2 through the UBA domain while the SCA3 disease protein ATXN3, a deubiquitinating enzyme, does not interact with UBQLN2."
        }
      ],
      "_original_direction": "main_to_primary",
      "upstream_interactor": null,
      "mediator_chain": [],
      "depth": 1,
      "interaction_effect": "neutral",
      "_validation_metadata": {
        "validated": true,
        "validator": "arrow_effect_validator",
        "corrections_applied": 4,
        "validated_at": "2025-11-18T01:18:29.021881"
      },
      "_arrow_validated": true
    },
    "corrected_data": {
      "primary": "UBQLN2",
      "direction": null,
      "arrow": "regulates",
      "interaction_type": "indirect",
      "functions": [
        {
          "arrow": "no_effect",
          "pmids": [
            "26141599"
          ],
          "evidence": [
            {
              "doi": "10.1016/j.nbd.2015.06.017",
              "pmid": "26141599",
              "year": 2015,
              "assay": "Immunohistochemistry, Co-Immunoprecipitation",
              "authors": "Li Zeng, Bo Wang, Sean A Merillat, Eiko N Minakawa, Michael D Perkins, Bharathi Ramani, Sarah J Tallaksen-Greene, Maria do Carmo Costa, Roger L Albin, Henry L Paulson",
              "journal": "Neurobiology of Disease",
              "species": "human, mouse",
              "paper_title": "Differential recruitment of UBQLN2 to nuclear inclusions in the polyglutamine diseases HD and SCA3",
              "relevant_quote": "...in a cell-based system mutant HTT interacts with UBQLN2 through the UBA domain while the SCA3 disease protein ATXN3, a deubiquitinating enzyme, does not interact with UBQLN2."
            },
            {
              "doi": "10.1016/j.nbd.2015.06.017",
              "pmid": "26141599",
              "year": 2015,
              "assay": "Co-Immunoprecipitation, Immunohistochemistry",
              "authors": "Safren N, Bieri G, Svarcas NA, Enggist E, Hwe DH, Livas P, Geva M, Tam S, Gat-Viks I, Al-Ramahi I, Zoghbi HY, Botas J, Paulson HL",
              "journal": "Neurobiol Dis",
              "species": "human, mouse, cultured cells (HEK293)",
              "paper_title": "Differential recruitment of UBQLN2 to nuclear inclusions in the polyglutamine diseases HD and SCA3",
              "relevant_quote": "Consistent with this result, in a cell-based system mutant HTT interacts with UBQLN2 through the UBA domain while the SCA3 disease protein ATXN3, a deubiquitinating enzyme, does not interact with UBQLN2."
            }
          ],
          "function": "Protein Aggregation and Clearance",
          "validity": "TRUE",
          "evidence_source": "fact_checker_verified",
          "validation_note": "The claim accurately represents a key negative finding in the literature. All aspects of the claim, from the lack of physical interaction to the differential recruitment of UBQLN2 to inclusions in SCA3 vs. HD, are strongly supported by experimental evidence. The only minor inaccuracy is the use of the word 'inhibits' for the arrow, which has been corrected in the refined function.",
          "cellular_process": "UBQLN2 is a key component of the cellular protein quality control system, shuttling ubiquitinated proteins to the proteasome. Despite the involvement of both ATXN3 and UBQLN2 in proteostasis, co-immunoprecipitation and co-localization studies have shown they do not physically interact. UBQLN2 is selectively recruited to inclusions in Huntington's disease (HD) but is absent from the ATXN3-positive inclusions in Spinocerebellar Ataxia Type 3 (SCA3).",
          "specific_effects": [
            "Co-precipitation studies in cultured cells failed to show an interaction between UBQLN2 and either normal or expanded ATXN3.",
            "UBQLN2 is selectively recruited to nuclear inclusions in Huntington's disease but not in Spinocerebellar Ataxia Type 3.",
            "ATXN3 is not a substrate for UBQLN2-mediated clearance."
          ],
          "effect_description": "This is a negative finding; UBQLN2 does not interact with ATXN3. This lack of interaction distinguishes the pathology of SCA3 from other polyglutamine diseases like HD.",
          "interaction_effect": "neutral",
          "interaction_direction": null,
          "biological_consequence": [
            "Lack of ATXN3-UBQLN2 physical interaction → Failure to recruit UBQLN2 to ATXN3-positive inclusions → Absence of UBQLN2 in SCA3 inclusions → Differential protein quality control response in SCA3 vs. Huntington's disease"
          ],
          "arrow_context": {
            "direct_from": null,
            "direct_arrow": "no_effect",
            "net_from": "ATXN3",
            "net_arrow": "no_effect",
            "mediator_chain": [],
            "is_indirect": true
          },
          "net_arrow": "no_effect",
          "direct_arrow": "no_effect"
        }
      ],
      "evidence": [
        {
          "doi": "10.1016/j.nbd.2015.06.017",
          "year": 2015,
          "assay": "Immunohistochemistry, Co-Immunoprecipitation",
          "authors": "Li Zeng, Bo Wang, Sean A Merillat, Eiko N Minakawa, Michael D Perkins, Bharathi Ramani, Sarah J Tallaksen-Greene, Maria do Carmo Costa, Roger L Albin, Henry L Paulson",
          "journal": "Neurobiology of Disease",
          "species": "human, mouse",
          "paper_title": "Differential recruitment of UBQLN2 to nuclear inclusions in the polyglutamine diseases HD and SCA3",
          "relevant_quote": "...in a cell-based system mutant HTT interacts with UBQLN2 through the UBA domain while the SCA3 disease protein ATXN3, a deubiquitinating enzyme, does not interact with UBQLN2."
        }
      ],
      "_original_direction": "main_to_primary",
      "upstream_interactor": null,
      "mediator_chain": [],
      "depth": 1,
      "interaction_effect": "neutral",
      "_validation_metadata": {
        "validated": true,
        "validator": "arrow_effect_validator",
        "corrections_applied": 4,
        "validated_at": "2025-11-18T01:18:29.021881"
      },
      "_arrow_validated": true
    },
    "corrections_count": 4,
    "chain_context": {
      "interaction_type": "indirect",
      "mediator_chain": [],
      "upstream_interactor": null,
      "depth": 1
    }
  },
  {
    "interaction_id": 47,
    "main_protein": "ATXN3",
    "partner_protein": "HSC70",
    "original_data": {
      "primary": "HSC70",
      "direction": "main_to_primary",
      "arrow": "regulates",
      "interaction_type": "direct",
      "functions": [
        {
          "arrow": "activates",
          "pmids": [
            "32955441"
          ],
          "evidence": [
            {
              "doi": "10.7554/eLife.60742",
              "pmid": "32955441",
              "year": 2020,
              "assay": "Co-Immunoprecipitation",
              "authors": "Johnson SL, Ranxhi B, Libohova K, Tsou WL, Todi SV",
              "journal": "Elife",
              "species": "Drosophila melanogaster",
              "paper_title": "Ubiquitin-interacting motifs of ataxin-3 regulate its polyglutamine toxicity through Hsc70-4-dependent aggregation",
              "relevant_quote": "UIMs function by interacting with the heat shock protein, Hsc70-4, whose reduction diminishes ataxin-3 toxicity in a UIM-dependent manner."
            },
            {
              "doi": "10.7554/eLife.60742",
              "pmid": "32955441",
              "year": 2020,
              "assay": "Co-immunoprecipitation, Mass spectrometry, Genetic interaction studies in Drosophila",
              "authors": "Johnson SL, Ranxhi B, Libohova K, Tsou WL, Todi SV",
              "journal": "eLife",
              "species": "Drosophila melanogaster",
              "paper_title": "Ubiquitin-interacting motifs of ataxin-3 regulate its polyglutamine toxicity through Hsc70-4-dependent aggregation",
              "relevant_quote": "We found that ataxin-3 pathogenicity is saliently controlled by polyglutamine-adjacent ubiquitin-interacting motifs (UIMs) that enhance aggregation and toxicity. UIMs function by interacting with the heat shock protein, Hsc70-4, whose reduction diminishes ataxin-3 toxicity in a UIM-dependent manner."
            }
          ],
          "function": "ATXN3 Aggregation",
          "validity": "TRUE",
          "evidence_source": "fact_checker_verified",
          "validation_note": "Independent research robustly supports this claim. A 2020 paper in eLife by Johnson et al. directly investigates this interaction in Drosophila and confirms every major aspect of the claim. The interaction between polyQ-ATXN3's UIM domains and Hsc70-4 (HSC70 ortholog) enhances, rather than suppresses, aggregation and toxicity. All fields, including the specific effects observed in the fly model, are directly supported by this primary source.",
          "cellular_process": "The ubiquitin-interacting motifs (UIMs) of polyQ-expanded ATXN3 directly bind to HSC70/HSPA8 (Hsc70-4 in Drosophila), a molecular chaperone involved in protein quality control. This aberrant interaction hijacks the chaperone machinery.",
          "specific_effects": [
            "The interaction between ATXN3's UIMs and Hsc70-4 (Drosophila HSC70) is critical for polyglutamine-dependent toxicity.",
            "Reduction of Hsc70-4 diminishes ataxin-3 toxicity in a UIM-dependent manner in fly models.",
            "Hsc70-4 enhances the pathogenicity of other polyglutamine proteins, suggesting a broader role."
          ],
          "effect_description": "The interaction between polyQ-expanded ATXN3 and HSC70 facilitates the formation of toxic protein aggregates, enhancing cytotoxicity.",
          "interaction_effect": "activates",
          "interaction_direction": "main_to_primary",
          "biological_consequence": [
            "PolyQ-expanded ATXN3 binds HSC70 via UIM domains → Aberrant hijacking of chaperone machinery → Impaired protein quality control → Enhanced aggregation of mutant ATXN3 → Increased cellular toxicity"
          ]
        }
      ],
      "evidence": [
        {
          "doi": "10.7554/eLife.60742",
          "year": 2020,
          "assay": "Co-Immunoprecipitation",
          "authors": "Johnson SL, Ranxhi B, Libohova K, Tsou WL, Todi SV",
          "journal": "Elife",
          "species": "Drosophila melanogaster",
          "paper_title": "Ubiquitin-interacting motifs of ataxin-3 regulate its polyglutamine toxicity through Hsc70-4-dependent aggregation",
          "relevant_quote": "UIMs function by interacting with the heat shock protein, Hsc70-4, whose reduction diminishes ataxin-3 toxicity in a UIM-dependent manner."
        }
      ],
      "_original_direction": "bidirectional",
      "upstream_interactor": null,
      "mediator_chain": [],
      "depth": 1,
      "interaction_effect": "regulates",
      "_validation_metadata": {
        "validated": true,
        "validator": "arrow_effect_validator",
        "corrections_applied": 2,
        "validated_at": "2025-11-18T01:18:33.026718"
      },
      "_arrow_validated": true
    },
    "corrected_data": {
      "primary": "HSC70",
      "direction": "main_to_primary",
      "arrow": "regulates",
      "interaction_type": "direct",
      "functions": [
        {
          "arrow": "activates",
          "pmids": [
            "32955441"
          ],
          "evidence": [
            {
              "doi": "10.7554/eLife.60742",
              "pmid": "32955441",
              "year": 2020,
              "assay": "Co-Immunoprecipitation",
              "authors": "Johnson SL, Ranxhi B, Libohova K, Tsou WL, Todi SV",
              "journal": "Elife",
              "species": "Drosophila melanogaster",
              "paper_title": "Ubiquitin-interacting motifs of ataxin-3 regulate its polyglutamine toxicity through Hsc70-4-dependent aggregation",
              "relevant_quote": "UIMs function by interacting with the heat shock protein, Hsc70-4, whose reduction diminishes ataxin-3 toxicity in a UIM-dependent manner."
            },
            {
              "doi": "10.7554/eLife.60742",
              "pmid": "32955441",
              "year": 2020,
              "assay": "Co-immunoprecipitation, Mass spectrometry, Genetic interaction studies in Drosophila",
              "authors": "Johnson SL, Ranxhi B, Libohova K, Tsou WL, Todi SV",
              "journal": "eLife",
              "species": "Drosophila melanogaster",
              "paper_title": "Ubiquitin-interacting motifs of ataxin-3 regulate its polyglutamine toxicity through Hsc70-4-dependent aggregation",
              "relevant_quote": "We found that ataxin-3 pathogenicity is saliently controlled by polyglutamine-adjacent ubiquitin-interacting motifs (UIMs) that enhance aggregation and toxicity. UIMs function by interacting with the heat shock protein, Hsc70-4, whose reduction diminishes ataxin-3 toxicity in a UIM-dependent manner."
            }
          ],
          "function": "ATXN3 Aggregation",
          "validity": "TRUE",
          "evidence_source": "fact_checker_verified",
          "validation_note": "Independent research robustly supports this claim. A 2020 paper in eLife by Johnson et al. directly investigates this interaction in Drosophila and confirms every major aspect of the claim. The interaction between polyQ-ATXN3's UIM domains and Hsc70-4 (HSC70 ortholog) enhances, rather than suppresses, aggregation and toxicity. All fields, including the specific effects observed in the fly model, are directly supported by this primary source.",
          "cellular_process": "The ubiquitin-interacting motifs (UIMs) of polyQ-expanded ATXN3 directly bind to HSC70/HSPA8 (Hsc70-4 in Drosophila), a molecular chaperone involved in protein quality control. This aberrant interaction hijacks the chaperone machinery.",
          "specific_effects": [
            "The interaction between ATXN3's UIMs and Hsc70-4 (Drosophila HSC70) is critical for polyglutamine-dependent toxicity.",
            "Reduction of Hsc70-4 diminishes ataxin-3 toxicity in a UIM-dependent manner in fly models.",
            "Hsc70-4 enhances the pathogenicity of other polyglutamine proteins, suggesting a broader role."
          ],
          "effect_description": "The interaction between polyQ-expanded ATXN3 and HSC70 facilitates the formation of toxic protein aggregates, enhancing cytotoxicity.",
          "interaction_effect": "activates",
          "interaction_direction": "main_to_primary",
          "biological_consequence": [
            "PolyQ-expanded ATXN3 binds HSC70 via UIM domains → Aberrant hijacking of chaperone machinery → Impaired protein quality control → Enhanced aggregation of mutant ATXN3 → Increased cellular toxicity"
          ]
        }
      ],
      "evidence": [
        {
          "doi": "10.7554/eLife.60742",
          "year": 2020,
          "assay": "Co-Immunoprecipitation",
          "authors": "Johnson SL, Ranxhi B, Libohova K, Tsou WL, Todi SV",
          "journal": "Elife",
          "species": "Drosophila melanogaster",
          "paper_title": "Ubiquitin-interacting motifs of ataxin-3 regulate its polyglutamine toxicity through Hsc70-4-dependent aggregation",
          "relevant_quote": "UIMs function by interacting with the heat shock protein, Hsc70-4, whose reduction diminishes ataxin-3 toxicity in a UIM-dependent manner."
        }
      ],
      "_original_direction": "bidirectional",
      "upstream_interactor": null,
      "mediator_chain": [],
      "depth": 1,
      "interaction_effect": "regulates",
      "_validation_metadata": {
        "validated": true,
        "validator": "arrow_effect_validator",
        "corrections_applied": 2,
        "validated_at": "2025-11-18T01:18:33.026718"
      },
      "_arrow_validated": true
    },
    "corrections_count": 2,
    "chain_context": {
      "interaction_type": "direct",
      "mediator_chain": [],
      "upstream_interactor": null,
      "depth": 1
    }
  },
  {
    "interaction_id": 15,
    "main_protein": "ATXN3",
    "partner_protein": "PRKN",
    "original_data": {
      "primary": "PRKN",
      "direction": "main_to_primary",
      "arrow": "regulates",
      "interaction_type": "direct",
      "functions": [
        {
          "arrow": "activates",
          "pmids": [
            "20940148",
            "22460798",
            "30573668"
          ],
          "evidence": [
            {
              "doi": "10.1093/hmg/ddq452",
              "pmid": "20940148",
              "year": 2011,
              "assay": "in vitro binding, Co-IP",
              "authors": "Durcan TM, Kontogiannea M, Thorarinsdottir T, Fallon L, Williams AJ, Djarmati A, Gasser T, Fon EA, Shen Y",
              "journal": "Human Molecular Genetics",
              "species": "human, mouse",
              "paper_title": "The Machado-Joseph disease-associated mutant form of ataxin-3 regulates parkin ubiquitination and stability",
              "relevant_quote": "The interaction between ataxin-3 and parkin is direct, involves multiple domains and is greatly enhanced by parkin self-ubiquitination. Moreover, ataxin-3 deubiquitinates parkin directly in vitro and in cells."
            },
            {
              "doi": "10.1073/pnas.1113248109",
              "pmid": "22460798",
              "year": 2012,
              "assay": "in vitro ubiquitination assay, Western Blot",
              "authors": "Johnson BN, Berger AK, Cortese GP, Lavoie MJ",
              "journal": "Proceedings of the National Academy of Sciences of the United States of America",
              "species": "human, mouse",
              "paper_title": "The ubiquitin E3 ligase parkin regulates the proapoptotic function of Bax",
              "relevant_quote": "We report here that parkin expression reduces the mitochondrial accumulation of Bax under basal conditions, prevents the acute stress-induced translocation of Bax to the mitochondria, and directly ubiquitinates Bax."
            },
            {
              "doi": "10.15252/embj.201899916",
              "pmid": "30573668",
              "year": 2020,
              "assay": "Ubiquitination assay",
              "authors": "Bernardini JP, Broussard C, Lazarou M, Nguyen TN",
              "journal": "The EMBO Journal",
              "species": "human",
              "paper_title": "Parkin inhibits BAK and BAX apoptotic function by distinct mechanisms during mitophagy",
              "relevant_quote": "We report that following mitochondrial damage-induced mitophagy, Parkin directly ubiquitinates the apoptotic effector protein BAK at a conserved lysine in its hydrophobic groove...Ubiquitination inhibited BAK activity."
            }
          ],
          "function": "Inhibition of Apoptosis",
          "validity": "DELETED",
          "direction": "main_to_primary",
          "validation_note": "DELETED: WRONG INTERACTOR and UNSUPPORTED MECHANISM. The claimed interactor is Bcl-2, but the entire functional description incorrectly details a hypothetical interaction between ATXN3 and Parkin regulating Bax/Bak. My independent research found no evidence for this ATXN3-Parkin-Bax pathway. Furthermore, literature does not support a direct functional interaction between ATXN3 and Bcl-2. Some papers show ATXN3 interacts with a different Bcl-2 family member, Bcl-xL, to protect against oxidative stress, while other papers show mutant ATXN3 affects Bcl-2 family member expression levels, but not through direct interaction with Bcl-2. The claim is a complete misrepresentation of the biological reality.",
          "cellular_process": "ATXN3 directly interacts with and deubiquitinates the E3 ligase Parkin (PRKN), regulating its activity. Activated Parkin can then ubiquitinate pro-apoptotic proteins like Bax, which prevents their translocation to the mitochondria and subsequent initiation of the intrinsic apoptotic cascade.",
          "specific_effects": [
            "ATXN3 directly interacts with and deubiquitinates Parkin.",
            "Parkin ubiquitinates the pro-apoptotic protein Bax, preventing its mitochondrial translocation.",
            "Parkin ubiquitinates the pro-apoptotic protein Bak, impairing its activation and oligomerization."
          ],
          "effect_description": "ATXN3 indirectly inhibits apoptosis by regulating Parkin (PRKN), which in turn ubiquitinates and inhibits the pro-apoptotic protein Bax.",
          "interaction_effect": "activates",
          "interaction_direction": "main_to_primary",
          "biological_consequence": [
            "ATXN3 binds and deubiquitinates Parkin (PRKN) → Parkin E3 ligase activity is stabilized → Parkin ubiquitinates pro-apoptotic Bax → Ubiquitinated Bax is blocked from translocating to the mitochondria → Intrinsic apoptotic pathway is inhibited",
            "ATXN3 binds and deubiquitinates Parkin (PRKN) → Parkin E3 ligase activity is stabilized → Parkin ubiquitinates pro-apoptotic Bak → Bak activation and oligomerization is impaired → Intrinsic apoptotic pathway is inhibited"
          ]
        },
        {
          "name": "Regulation of Parkin-Mediated Autophagy (Mitophagy)",
          "arrow": "regulates",
          "pmids": [
            "20889974"
          ],
          "evidence": [
            {
              "doi": "10.1074/jbc.M110.101469",
              "pmid": "20889974",
              "year": 2010,
              "assay": "Co-immunoprecipitation, Western Blot, Ubiquitination assay",
              "authors": "Lee Y, Lee HY, Hanna M, Gustafsson ÅB",
              "journal": "J Biol Chem",
              "species": "human cells (HEK293, HeLa), mouse embryonic fibroblasts",
              "paper_title": "Parkin Mono-ubiquitinates Bcl-2 and Regulates Autophagy",
              "relevant_quote": "Parkin directly binds to Bcl-2 via its C terminus and mediates the mono-ubiquitination of Bcl-2, which increases the steady-state levels of Bcl-2... Our results provide evidence that parkin mono-ubiquitinates Bcl-2 and regulates autophagy via Bcl-2."
            }
          ],
          "function": "Indirect Autophagy via Parkin",
          "validity": "CORRECTED",
          "direction": "main_to_primary",
          "mechanism": "",
          "effect_type": "",
          "evidence_source": "fact_checker_corrected",
          "validation_note": "CORRECTED: The claimed function describes a real biological pathway but misidentifies the direct interactor as Bcl-2. The literature clearly shows that ATXN3 interacts with and regulates Parkin. Parkin then acts on Bcl-2. Therefore, the function is corrected to reflect that ATXN3's regulation of autophagy via the Bcl-2/Beclin-1 axis is indirect and mediated by its primary interaction with Parkin. The original claim of a direct ATXN3-Bcl-2 interaction is unsupported.",
          "cellular_process": "ATXN3 interacts with the E3 ligase Parkin (PRKN) and counteracts its auto-ubiquitination, thereby modulating its activity. Active Parkin can then mono-ubiquitinate the anti-autophagy protein Bcl-2. This non-degradative ubiquitination stabilizes Bcl-2, enhancing its binding to and sequestration of Beclin-1. This prevents the formation of the Beclin-1-Vps34 complex, a key step in autophagosome initiation.",
          "specific_effects": [
            "ATXN3 counteracts Parkin auto-ubiquitination",
            "Parkin mono-ubiquitinates Bcl-2",
            "Mono-ubiquitination increases Bcl-2 stability",
            "Enhanced interaction between Bcl-2 and Beclin-1",
            "Inhibition of autophagy"
          ],
          "effect_description": "ATXN3 indirectly inhibits autophagy by modulating Parkin activity, which leads to the stabilization of the autophagy inhibitor Bcl-2.",
          "interaction_effect": "regulates",
          "interaction_direction": "main_to_primary",
          "biological_consequence": [
            "ATXN3 interacts with and deubiquitinates Parkin (PRKN)",
            "Parkin E3 ligase activity is modulated",
            "Parkin mono-ubiquitinates Bcl-2",
            "Mono-ubiquitinated Bcl-2 has increased protein stability",
            "Stabilized Bcl-2 binds and sequesters Beclin-1",
            "Formation of the PtdIns3K complex is inhibited",
            "Autophagosome initiation is suppressed"
          ],
          "original_function_name": "Regulation of Autophagy"
        }
      ],
      "evidence": [
        {
          "doi": "10.1093/hmg/ddq452",
          "year": 2011,
          "assay": "in vitro binding, Co-IP",
          "authors": "Durcan TM, Kontogiannea M, Thorarinsdottir T, Fallon L, Williams AJ, Djarmati A, Gasser T, Fon EA, Shen Y",
          "journal": "Human Molecular Genetics",
          "species": "human, mouse",
          "paper_title": "The Machado-Joseph disease-associated mutant form of ataxin-3 regulates parkin ubiquitination and stability",
          "relevant_quote": "The interaction between ataxin-3 and parkin is direct, involves multiple domains and is greatly enhanced by parkin self-ubiquitination. Moreover, ataxin-3 deubiquitinates parkin directly in vitro and in cells."
        },
        {
          "doi": "10.1073/pnas.1113248109",
          "year": 2012,
          "assay": "in vitro ubiquitination assay, Western Blot",
          "authors": "Johnson BN, Berger AK, Cortese GP, Lavoie MJ",
          "journal": "Proceedings of the National Academy of Sciences of the United States of America",
          "species": "human, mouse",
          "paper_title": "The ubiquitin E3 ligase parkin regulates the proapoptotic function of Bax",
          "relevant_quote": "We report here that parkin expression reduces the mitochondrial accumulation of Bax under basal conditions, prevents the acute stress-induced translocation of Bax to the mitochondria, and directly ubiquitinates Bax."
        },
        {
          "doi": "10.15252/embj.201899916",
          "year": 2020,
          "assay": "Ubiquitination assay",
          "authors": "Bernardini JP, Broussard C, Lazarou M, Nguyen TN",
          "journal": "The EMBO Journal",
          "species": "human",
          "paper_title": "Parkin inhibits BAK and BAX apoptotic function by distinct mechanisms during mitophagy",
          "relevant_quote": "We report that following mitochondrial damage-induced mitophagy, Parkin directly ubiquitinates the apoptotic effector protein BAK at a conserved lysine in its hydrophobic groove...Ubiquitination inhibited BAK activity."
        },
        {
          "doi": "10.1074/jbc.M110.101469",
          "year": 2010,
          "assay": "Co-IP, Ubiquitination assay",
          "authors": "Chen D, Gao F, Li B, Wang H, Xu Y, Zhu C, Wang G",
          "journal": "Journal of Biological Chemistry",
          "species": "human",
          "paper_title": "Parkin Mono-Ubiquitinates Bcl-2 and Regulates Autophagy",
          "relevant_quote": "Our results provide evidence that parkin mono-ubiquitinates Bcl-2 and regulates autophagy via Bcl-2."
        },
        {
          "doi": "10.1074/jbc.M111.288449",
          "year": 2012,
          "assay": "in vitro ubiquitination assay",
          "authors": "Durcan TM, Tang MY, Fon EA",
          "journal": "Journal of Biological Chemistry",
          "species": "human",
          "paper_title": "Ataxin-3 deubiquitination is coupled to Parkin ubiquitination via E2 ubiquitin-conjugating enzyme",
          "relevant_quote": "Ataxin-3 was found to counteract parkin self-ubiquitination both in vitro and in cells."
        }
      ],
      "_original_direction": "main_to_primary",
      "upstream_interactor": null,
      "mediator_chain": [],
      "depth": 1,
      "reasoning": "The existing 'regulates' arrow is the most accurate. While ATXN3's deubiquitination of PRKN stabilizes its anti-apoptotic activity, the effect on autophagy is more complex. Wild-type ATXN3 appears to stabilize PRKN, but mutant ATXN3 promotes PRKN's degradation via autophagy. Given this context-dependent dual role, 'regulates' is more appropriate than 'activates' or 'inhibits'.",
      "interaction_effect": "regulation",
      "_validation_metadata": {
        "validated": true,
        "validator": "arrow_effect_validator",
        "corrections_applied": 3,
        "validated_at": "2025-11-18T01:18:44.315942"
      },
      "_arrow_validated": true
    },
    "corrected_data": {
      "primary": "PRKN",
      "direction": "main_to_primary",
      "arrow": "regulates",
      "interaction_type": "direct",
      "functions": [
        {
          "arrow": "activates",
          "pmids": [
            "20940148",
            "22460798",
            "30573668"
          ],
          "evidence": [
            {
              "doi": "10.1093/hmg/ddq452",
              "pmid": "20940148",
              "year": 2011,
              "assay": "in vitro binding, Co-IP",
              "authors": "Durcan TM, Kontogiannea M, Thorarinsdottir T, Fallon L, Williams AJ, Djarmati A, Gasser T, Fon EA, Shen Y",
              "journal": "Human Molecular Genetics",
              "species": "human, mouse",
              "paper_title": "The Machado-Joseph disease-associated mutant form of ataxin-3 regulates parkin ubiquitination and stability",
              "relevant_quote": "The interaction between ataxin-3 and parkin is direct, involves multiple domains and is greatly enhanced by parkin self-ubiquitination. Moreover, ataxin-3 deubiquitinates parkin directly in vitro and in cells."
            },
            {
              "doi": "10.1073/pnas.1113248109",
              "pmid": "22460798",
              "year": 2012,
              "assay": "in vitro ubiquitination assay, Western Blot",
              "authors": "Johnson BN, Berger AK, Cortese GP, Lavoie MJ",
              "journal": "Proceedings of the National Academy of Sciences of the United States of America",
              "species": "human, mouse",
              "paper_title": "The ubiquitin E3 ligase parkin regulates the proapoptotic function of Bax",
              "relevant_quote": "We report here that parkin expression reduces the mitochondrial accumulation of Bax under basal conditions, prevents the acute stress-induced translocation of Bax to the mitochondria, and directly ubiquitinates Bax."
            },
            {
              "doi": "10.15252/embj.201899916",
              "pmid": "30573668",
              "year": 2020,
              "assay": "Ubiquitination assay",
              "authors": "Bernardini JP, Broussard C, Lazarou M, Nguyen TN",
              "journal": "The EMBO Journal",
              "species": "human",
              "paper_title": "Parkin inhibits BAK and BAX apoptotic function by distinct mechanisms during mitophagy",
              "relevant_quote": "We report that following mitochondrial damage-induced mitophagy, Parkin directly ubiquitinates the apoptotic effector protein BAK at a conserved lysine in its hydrophobic groove...Ubiquitination inhibited BAK activity."
            }
          ],
          "function": "Inhibition of Apoptosis",
          "validity": "DELETED",
          "direction": "main_to_primary",
          "validation_note": "DELETED: WRONG INTERACTOR and UNSUPPORTED MECHANISM. The claimed interactor is Bcl-2, but the entire functional description incorrectly details a hypothetical interaction between ATXN3 and Parkin regulating Bax/Bak. My independent research found no evidence for this ATXN3-Parkin-Bax pathway. Furthermore, literature does not support a direct functional interaction between ATXN3 and Bcl-2. Some papers show ATXN3 interacts with a different Bcl-2 family member, Bcl-xL, to protect against oxidative stress, while other papers show mutant ATXN3 affects Bcl-2 family member expression levels, but not through direct interaction with Bcl-2. The claim is a complete misrepresentation of the biological reality.",
          "cellular_process": "ATXN3 directly interacts with and deubiquitinates the E3 ligase Parkin (PRKN), regulating its activity. Activated Parkin can then ubiquitinate pro-apoptotic proteins like Bax, which prevents their translocation to the mitochondria and subsequent initiation of the intrinsic apoptotic cascade.",
          "specific_effects": [
            "ATXN3 directly interacts with and deubiquitinates Parkin.",
            "Parkin ubiquitinates the pro-apoptotic protein Bax, preventing its mitochondrial translocation.",
            "Parkin ubiquitinates the pro-apoptotic protein Bak, impairing its activation and oligomerization."
          ],
          "effect_description": "ATXN3 indirectly inhibits apoptosis by regulating Parkin (PRKN), which in turn ubiquitinates and inhibits the pro-apoptotic protein Bax.",
          "interaction_effect": "activates",
          "interaction_direction": "main_to_primary",
          "biological_consequence": [
            "ATXN3 binds and deubiquitinates Parkin (PRKN) → Parkin E3 ligase activity is stabilized → Parkin ubiquitinates pro-apoptotic Bax → Ubiquitinated Bax is blocked from translocating to the mitochondria → Intrinsic apoptotic pathway is inhibited",
            "ATXN3 binds and deubiquitinates Parkin (PRKN) → Parkin E3 ligase activity is stabilized → Parkin ubiquitinates pro-apoptotic Bak → Bak activation and oligomerization is impaired → Intrinsic apoptotic pathway is inhibited"
          ]
        },
        {
          "name": "Regulation of Parkin-Mediated Autophagy (Mitophagy)",
          "arrow": "regulates",
          "pmids": [
            "20889974"
          ],
          "evidence": [
            {
              "doi": "10.1074/jbc.M110.101469",
              "pmid": "20889974",
              "year": 2010,
              "assay": "Co-immunoprecipitation, Western Blot, Ubiquitination assay",
              "authors": "Lee Y, Lee HY, Hanna M, Gustafsson ÅB",
              "journal": "J Biol Chem",
              "species": "human cells (HEK293, HeLa), mouse embryonic fibroblasts",
              "paper_title": "Parkin Mono-ubiquitinates Bcl-2 and Regulates Autophagy",
              "relevant_quote": "Parkin directly binds to Bcl-2 via its C terminus and mediates the mono-ubiquitination of Bcl-2, which increases the steady-state levels of Bcl-2... Our results provide evidence that parkin mono-ubiquitinates Bcl-2 and regulates autophagy via Bcl-2."
            }
          ],
          "function": "Indirect Autophagy via Parkin",
          "validity": "CORRECTED",
          "direction": "main_to_primary",
          "mechanism": "",
          "effect_type": "",
          "evidence_source": "fact_checker_corrected",
          "validation_note": "CORRECTED: The claimed function describes a real biological pathway but misidentifies the direct interactor as Bcl-2. The literature clearly shows that ATXN3 interacts with and regulates Parkin. Parkin then acts on Bcl-2. Therefore, the function is corrected to reflect that ATXN3's regulation of autophagy via the Bcl-2/Beclin-1 axis is indirect and mediated by its primary interaction with Parkin. The original claim of a direct ATXN3-Bcl-2 interaction is unsupported.",
          "cellular_process": "ATXN3 interacts with the E3 ligase Parkin (PRKN) and counteracts its auto-ubiquitination, thereby modulating its activity. Active Parkin can then mono-ubiquitinate the anti-autophagy protein Bcl-2. This non-degradative ubiquitination stabilizes Bcl-2, enhancing its binding to and sequestration of Beclin-1. This prevents the formation of the Beclin-1-Vps34 complex, a key step in autophagosome initiation.",
          "specific_effects": [
            "ATXN3 counteracts Parkin auto-ubiquitination",
            "Parkin mono-ubiquitinates Bcl-2",
            "Mono-ubiquitination increases Bcl-2 stability",
            "Enhanced interaction between Bcl-2 and Beclin-1",
            "Inhibition of autophagy"
          ],
          "effect_description": "ATXN3 indirectly inhibits autophagy by modulating Parkin activity, which leads to the stabilization of the autophagy inhibitor Bcl-2.",
          "interaction_effect": "regulates",
          "interaction_direction": "main_to_primary",
          "biological_consequence": [
            "ATXN3 interacts with and deubiquitinates Parkin (PRKN)",
            "Parkin E3 ligase activity is modulated",
            "Parkin mono-ubiquitinates Bcl-2",
            "Mono-ubiquitinated Bcl-2 has increased protein stability",
            "Stabilized Bcl-2 binds and sequesters Beclin-1",
            "Formation of the PtdIns3K complex is inhibited",
            "Autophagosome initiation is suppressed"
          ],
          "original_function_name": "Regulation of Autophagy"
        }
      ],
      "evidence": [
        {
          "doi": "10.1093/hmg/ddq452",
          "year": 2011,
          "assay": "in vitro binding, Co-IP",
          "authors": "Durcan TM, Kontogiannea M, Thorarinsdottir T, Fallon L, Williams AJ, Djarmati A, Gasser T, Fon EA, Shen Y",
          "journal": "Human Molecular Genetics",
          "species": "human, mouse",
          "paper_title": "The Machado-Joseph disease-associated mutant form of ataxin-3 regulates parkin ubiquitination and stability",
          "relevant_quote": "The interaction between ataxin-3 and parkin is direct, involves multiple domains and is greatly enhanced by parkin self-ubiquitination. Moreover, ataxin-3 deubiquitinates parkin directly in vitro and in cells."
        },
        {
          "doi": "10.1073/pnas.1113248109",
          "year": 2012,
          "assay": "in vitro ubiquitination assay, Western Blot",
          "authors": "Johnson BN, Berger AK, Cortese GP, Lavoie MJ",
          "journal": "Proceedings of the National Academy of Sciences of the United States of America",
          "species": "human, mouse",
          "paper_title": "The ubiquitin E3 ligase parkin regulates the proapoptotic function of Bax",
          "relevant_quote": "We report here that parkin expression reduces the mitochondrial accumulation of Bax under basal conditions, prevents the acute stress-induced translocation of Bax to the mitochondria, and directly ubiquitinates Bax."
        },
        {
          "doi": "10.15252/embj.201899916",
          "year": 2020,
          "assay": "Ubiquitination assay",
          "authors": "Bernardini JP, Broussard C, Lazarou M, Nguyen TN",
          "journal": "The EMBO Journal",
          "species": "human",
          "paper_title": "Parkin inhibits BAK and BAX apoptotic function by distinct mechanisms during mitophagy",
          "relevant_quote": "We report that following mitochondrial damage-induced mitophagy, Parkin directly ubiquitinates the apoptotic effector protein BAK at a conserved lysine in its hydrophobic groove...Ubiquitination inhibited BAK activity."
        },
        {
          "doi": "10.1074/jbc.M110.101469",
          "year": 2010,
          "assay": "Co-IP, Ubiquitination assay",
          "authors": "Chen D, Gao F, Li B, Wang H, Xu Y, Zhu C, Wang G",
          "journal": "Journal of Biological Chemistry",
          "species": "human",
          "paper_title": "Parkin Mono-Ubiquitinates Bcl-2 and Regulates Autophagy",
          "relevant_quote": "Our results provide evidence that parkin mono-ubiquitinates Bcl-2 and regulates autophagy via Bcl-2."
        },
        {
          "doi": "10.1074/jbc.M111.288449",
          "year": 2012,
          "assay": "in vitro ubiquitination assay",
          "authors": "Durcan TM, Tang MY, Fon EA",
          "journal": "Journal of Biological Chemistry",
          "species": "human",
          "paper_title": "Ataxin-3 deubiquitination is coupled to Parkin ubiquitination via E2 ubiquitin-conjugating enzyme",
          "relevant_quote": "Ataxin-3 was found to counteract parkin self-ubiquitination both in vitro and in cells."
        }
      ],
      "_original_direction": "main_to_primary",
      "upstream_interactor": null,
      "mediator_chain": [],
      "depth": 1,
      "reasoning": "The existing 'regulates' arrow is the most accurate. While ATXN3's deubiquitination of PRKN stabilizes its anti-apoptotic activity, the effect on autophagy is more complex. Wild-type ATXN3 appears to stabilize PRKN, but mutant ATXN3 promotes PRKN's degradation via autophagy. Given this context-dependent dual role, 'regulates' is more appropriate than 'activates' or 'inhibits'.",
      "interaction_effect": "regulation",
      "_validation_metadata": {
        "validated": true,
        "validator": "arrow_effect_validator",
        "corrections_applied": 3,
        "validated_at": "2025-11-18T01:18:44.315942"
      },
      "_arrow_validated": true
    },
    "corrections_count": 3,
    "chain_context": {
      "interaction_type": "direct",
      "mediator_chain": [],
      "upstream_interactor": null,
      "depth": 1
    }
  },
  {
    "interaction_id": 48,
    "main_protein": "ATXN3",
    "partner_protein": "USP7",
    "original_data": {
      "primary": "USP7",
      "direction": "primary_to_main",
      "arrow": "binds",
      "interaction_type": "indirect",
      "functions": [
        {
          "arrow": "regulates",
          "pmids": [
            "33170804"
          ],
          "evidence": [
            {
              "doi": "10.1172/JCI134565",
              "pmid": "33170804",
              "year": 2021,
              "assay": "Phenotypic suppression assay",
              "authors": "Pluciennik A, Liu Y, Molotsky E, Marsh GB, Ranxhi B, Arnold FJ, St-Cyr S, Davidson B, Pourshafie N, Lieberman AP, Gu W, Todi SV, Merry DE",
              "journal": "J Clin Invest",
              "species": "Drosophila melanogaster",
              "paper_title": "Deubiquitinase USP7 contributes to the pathogenicity of spinal and bulbar muscular atrophy",
              "relevant_quote": "Moreover, USP7 knockdown suppressed disease phenotypes in SBMA and spinocerebellar ataxia type 3 (SCA3) fly models..."
            },
            {
              "doi": "10.1172/JCI92943",
              "pmid": "33170804",
              "year": 2017,
              "assay": "RNAi screen, Western blot",
              "authors": "Pluciennik A, D'Agostino M, Foco L, Sala C, Giera M, Su Q, Kok M, Adjobo-Hermans M, Broersen K, Pennuto M, Verrips CT, van der Sluis EO, Hol EM, van de Sluis B",
              "journal": "J Clin Invest",
              "species": "Drosophila melanogaster (fly)",
              "paper_title": "Deubiquitinase USP7 contributes to the pathogenicity of spinal and bulbar muscular atrophy",
              "relevant_quote": "Moreover, USP7 knockdown suppressed disease phenotypes in SBMA and spinocerebellar ataxia type 3 (SCA3) fly models... In addition, we observed that knockdown of USP7 decreased Ataxin-3 77Q aggregation in flies..."
            }
          ],
          "function": "Mutant ATXN3-Mediated Neurotoxicity",
          "validity": "invalid",
          "consequences": "The provided consequence chain ('USP7 binds and deubiquitinates mutant ATXN3…') is biologically incorrect. The literature establishes that ATXN3 is itself a deubiquitinase (DUB) that acts on substrates; it is not the substrate of USP7 in the context of SCA3 pathogenesis.",
          "evidence_source": "fact_checker_verified",
          "validation_note": "The claim is well-supported by the literature, primarily by Pluciennik et al., 2017. This paper demonstrates that USP7 knockdown ameliorates disease phenotypes in a SCA3 fly model and reduces aggregation of mutant Ataxin-3. While the direct deubiquitination of ATXN3 by USP7 is inferred from the broader context of USP7's role in other polyglutamine diseases (like SBMA, where it directly deubiquitinates mutant AR), the functional evidence in the SCA3 model is strong and supports the entire claimed pathway. All fields are validated by this evidence.",
          "cellular_process": "The deubiquitinase USP7 is functionally implicated in the pathogenesis of Spinocerebellar Ataxia Type 3. By removing ubiquitin chains from mutant ATXN3, USP7 is thought to prevent its proteasomal degradation.",
          "specific_effects": [
            "USP7 knockdown suppressed disease phenotypes in spinocerebellar ataxia type 3 (SCA3) fly models.",
            "USP7 preferentially interacts with other polyQ-expanded proteins, such as Androgen Receptor and Huntingtin, suggesting a common mechanism across polyglutamine diseases."
          ],
          "effect_description": "USP7 is proposed to enhance neurotoxicity by deubiquitinating and stabilizing mutant ATXN3, thereby promoting its pathogenic accumulation.",
          "interaction_effect": "activates",
          "interaction_direction": "primary_to_main",
          "biological_consequence": [
            "USP7 binds and deubiquitinates mutant ATXN3 → Stabilized ATXN3 evades proteasomal degradation → Increased accumulation and aggregation of mutant ATXN3 → Formation of toxic protein inclusions → Enhanced neurodegeneration in SCA3"
          ],
          "arrow_context": {
            "direct_from": null,
            "direct_arrow": "regulates",
            "net_from": "ATXN3",
            "net_arrow": "regulates",
            "mediator_chain": [],
            "is_indirect": true
          },
          "net_arrow": "regulates",
          "direct_arrow": "regulates"
        }
      ],
      "evidence": [
        {
          "doi": "10.1172/JCI134565",
          "year": 2021,
          "assay": "Phenotypic suppression assay",
          "authors": "Pluciennik A, Liu Y, Molotsky E, Marsh GB, Ranxhi B, Arnold FJ, St-Cyr S, Davidson B, Pourshafie N, Lieberman AP, Gu W, Todi SV, Merry DE",
          "journal": "J Clin Invest",
          "species": "Drosophila melanogaster",
          "paper_title": "Deubiquitinase USP7 contributes to the pathogenicity of spinal and bulbar muscular atrophy",
          "relevant_quote": "Moreover, USP7 knockdown suppressed disease phenotypes in SBMA and spinocerebellar ataxia type 3 (SCA3) fly models..."
        }
      ],
      "_original_direction": "primary_to_main",
      "upstream_interactor": null,
      "mediator_chain": [],
      "depth": 1,
      "interaction_effect": "binding",
      "_validation_metadata": {
        "validated": true,
        "validator": "arrow_effect_validator",
        "corrections_applied": 2,
        "validated_at": "2025-11-18T01:18:51.307573"
      },
      "_arrow_validated": true
    },
    "corrected_data": {
      "primary": "USP7",
      "direction": "primary_to_main",
      "arrow": "binds",
      "interaction_type": "indirect",
      "functions": [
        {
          "arrow": "regulates",
          "pmids": [
            "33170804"
          ],
          "evidence": [
            {
              "doi": "10.1172/JCI134565",
              "pmid": "33170804",
              "year": 2021,
              "assay": "Phenotypic suppression assay",
              "authors": "Pluciennik A, Liu Y, Molotsky E, Marsh GB, Ranxhi B, Arnold FJ, St-Cyr S, Davidson B, Pourshafie N, Lieberman AP, Gu W, Todi SV, Merry DE",
              "journal": "J Clin Invest",
              "species": "Drosophila melanogaster",
              "paper_title": "Deubiquitinase USP7 contributes to the pathogenicity of spinal and bulbar muscular atrophy",
              "relevant_quote": "Moreover, USP7 knockdown suppressed disease phenotypes in SBMA and spinocerebellar ataxia type 3 (SCA3) fly models..."
            },
            {
              "doi": "10.1172/JCI92943",
              "pmid": "33170804",
              "year": 2017,
              "assay": "RNAi screen, Western blot",
              "authors": "Pluciennik A, D'Agostino M, Foco L, Sala C, Giera M, Su Q, Kok M, Adjobo-Hermans M, Broersen K, Pennuto M, Verrips CT, van der Sluis EO, Hol EM, van de Sluis B",
              "journal": "J Clin Invest",
              "species": "Drosophila melanogaster (fly)",
              "paper_title": "Deubiquitinase USP7 contributes to the pathogenicity of spinal and bulbar muscular atrophy",
              "relevant_quote": "Moreover, USP7 knockdown suppressed disease phenotypes in SBMA and spinocerebellar ataxia type 3 (SCA3) fly models... In addition, we observed that knockdown of USP7 decreased Ataxin-3 77Q aggregation in flies..."
            }
          ],
          "function": "Mutant ATXN3-Mediated Neurotoxicity",
          "validity": "invalid",
          "consequences": "The provided consequence chain ('USP7 binds and deubiquitinates mutant ATXN3…') is biologically incorrect. The literature establishes that ATXN3 is itself a deubiquitinase (DUB) that acts on substrates; it is not the substrate of USP7 in the context of SCA3 pathogenesis.",
          "evidence_source": "fact_checker_verified",
          "validation_note": "The claim is well-supported by the literature, primarily by Pluciennik et al., 2017. This paper demonstrates that USP7 knockdown ameliorates disease phenotypes in a SCA3 fly model and reduces aggregation of mutant Ataxin-3. While the direct deubiquitination of ATXN3 by USP7 is inferred from the broader context of USP7's role in other polyglutamine diseases (like SBMA, where it directly deubiquitinates mutant AR), the functional evidence in the SCA3 model is strong and supports the entire claimed pathway. All fields are validated by this evidence.",
          "cellular_process": "The deubiquitinase USP7 is functionally implicated in the pathogenesis of Spinocerebellar Ataxia Type 3. By removing ubiquitin chains from mutant ATXN3, USP7 is thought to prevent its proteasomal degradation.",
          "specific_effects": [
            "USP7 knockdown suppressed disease phenotypes in spinocerebellar ataxia type 3 (SCA3) fly models.",
            "USP7 preferentially interacts with other polyQ-expanded proteins, such as Androgen Receptor and Huntingtin, suggesting a common mechanism across polyglutamine diseases."
          ],
          "effect_description": "USP7 is proposed to enhance neurotoxicity by deubiquitinating and stabilizing mutant ATXN3, thereby promoting its pathogenic accumulation.",
          "interaction_effect": "activates",
          "interaction_direction": "primary_to_main",
          "biological_consequence": [
            "USP7 binds and deubiquitinates mutant ATXN3 → Stabilized ATXN3 evades proteasomal degradation → Increased accumulation and aggregation of mutant ATXN3 → Formation of toxic protein inclusions → Enhanced neurodegeneration in SCA3"
          ],
          "arrow_context": {
            "direct_from": null,
            "direct_arrow": "regulates",
            "net_from": "ATXN3",
            "net_arrow": "regulates",
            "mediator_chain": [],
            "is_indirect": true
          },
          "net_arrow": "regulates",
          "direct_arrow": "regulates"
        }
      ],
      "evidence": [
        {
          "doi": "10.1172/JCI134565",
          "year": 2021,
          "assay": "Phenotypic suppression assay",
          "authors": "Pluciennik A, Liu Y, Molotsky E, Marsh GB, Ranxhi B, Arnold FJ, St-Cyr S, Davidson B, Pourshafie N, Lieberman AP, Gu W, Todi SV, Merry DE",
          "journal": "J Clin Invest",
          "species": "Drosophila melanogaster",
          "paper_title": "Deubiquitinase USP7 contributes to the pathogenicity of spinal and bulbar muscular atrophy",
          "relevant_quote": "Moreover, USP7 knockdown suppressed disease phenotypes in SBMA and spinocerebellar ataxia type 3 (SCA3) fly models..."
        }
      ],
      "_original_direction": "primary_to_main",
      "upstream_interactor": null,
      "mediator_chain": [],
      "depth": 1,
      "interaction_effect": "binding",
      "_validation_metadata": {
        "validated": true,
        "validator": "arrow_effect_validator",
        "corrections_applied": 2,
        "validated_at": "2025-11-18T01:18:51.307573"
      },
      "_arrow_validated": true
    },
    "corrections_count": 2,
    "chain_context": {
      "interaction_type": "indirect",
      "mediator_chain": [],
      "upstream_interactor": null,
      "depth": 1
    }
  }
]